Document:

Exhibit 10.2

 

Execution Version

 

PLEDGE AND
SECURITY AGREEMENT

 

PLEDGE AND SECURITY AGREEMENT, dated as of May 10,
2010, made by each of the Grantors listed on the signature pages hereto
(together with each other person that executes a supplement hereto and becomes
an “Additional Grantor” hereunder, each a “Grantor” and
collectively, jointly and severally, the “Grantors”), in favor of Harris
N.A., in its capacity as collateral agent for the Secured Parties referred to
below (in such capacity, together with its successors and assigns in such
capacity, if any, the “Collateral Agent”).

 

W I T N E S S E T H:

 

WHEREAS, Lantheus MI Intermediate, Inc., a
Delaware corporation (the “Parent”), Lantheus Medical Imaging, Inc.,
a Delaware corporation (the “Borrower”), the “Guarantors” from
time to time party thereto, the lenders from time to time party thereto (each a
“Lender” and collectively, the “Lenders”), the Collateral Agent,
Bank of Montreal, as administrative agent for the Lenders (in such capacity,
together with its successors and assigns in such capacity, if any, the “Administrative
Agent” and together with the Collateral Agent, each an “Agent” and
collectively, the “Agents”), Bank of Montreal and NATIXIS, as joint
bookrunners, Bank of Montreal and NATIXIS, as joint lead arrangers, NATIXIS, as
syndication agent, and Jefferies Finance, LLC, as documentation agent, dated as
of May 10, 2010 (such agreement, as amended, restated, supplemented,
modified or otherwise changed from time to time, including any replacement agreement
therefor, being hereinafter referred to as the “Credit Agreement”);

 

WHEREAS, pursuant to the Credit Agreement, the
Lenders have agreed to make revolving loans, which revolving loans will include
a subfacility for the issuance of letters of credit (each a “Revolving Loan”
and collectively, the “Revolving Loans”), to the Borrower;

 

WHEREAS, it is a condition precedent to the Lenders
making any Revolving Loan and providing any other financial accommodation to
the Borrower pursuant to the Credit Agreement that each Grantor shall have
executed and delivered to the Collateral Agent a pledge and security agreement
to the Collateral Agent, for the benefit of the Secured Parties, providing for,
among other things, the grant to the Collateral Agent, for the benefit of the
Secured Parties, of (a) a security interest in and Lien on the outstanding
shares of Capital Stock (as defined in the Credit Agreement) and indebtedness
from time to time owned by such Grantor of each Person now or hereafter
existing and in which such Grantor has any interest at any time (subject to any
express limitations set forth in Section 2), and (b) a security
interest in all other personal property and fixtures of such Grantor (subject
to any express limitations set forth in Section 2);

 

WHEREAS, the Grantors are mutually dependent on each
other in the conduct of their respective businesses as an integrated operation,
with credit needed from time to time by each Grantor often being provided
through financing obtained by the other Grantors and

 

 

the ability to obtain such financing being dependent on the successful
operations of all of the Grantors as a whole; and

 

WHEREAS, each Grantor has determined that the
execution, delivery and performance of this Agreement directly benefit, and are
in the best interest of, such Grantor;

 

NOW, THEREFORE, in consideration of the premises and
the agreements herein and in order to induce the Collateral Agent and the
Lenders to make and maintain the Revolving Loans and to assist in providing
Letters of Credit and other financial accommodations to the Borrower pursuant
to the Credit Agreement, the Grantors hereby jointly and severally agree with
the Collateral Agent, for the benefit of the Secured Parties, as follows:

 

1.             Definitions.

 

(a)           Reference
is hereby made to the Credit Agreement for a statement of the terms thereof.
All capitalized terms used in this Agreement and the recitals hereto which are
defined in the Credit Agreement or in Article 8 or 9 of the Uniform
Commercial Code as in effect from time to time in the State of New York (the “Code”)
and which are not otherwise defined herein shall have the same meanings herein
as set forth therein; provided  that terms used herein which are defined in
the Code as in effect in the State of New York on the date hereof shall
continue to have the same meaning notwithstanding any replacement or amendment
of such statute except as the Collateral Agent may otherwise determine.

 

(b)           The
following terms shall have the respective meanings provided for in the Code:
“Accounts”, “Account Debtor”, “Cash Proceeds”, “Certificate of Title”, “Chattel
Paper”, “Commercial Tort Claim”, “Commodity Account”, “Commodity Contracts”,
“Deposit Account”, “Documents”, “Electronic Chattel Paper”, “Equipment”,
“Fixtures”, “General Intangibles”, “Goods”, “Instruments”, “Inventory”,
“Investment Property”, “Letter-of-Credit Rights”, “Noncash Proceeds”, “Payment
Intangibles”, “Proceeds”, “Promissory Notes”, “Record”, “Securities Account”,
“Software”, “Supporting Obligations” and “Tangible Chattel Paper”.

 

(c)           As
used in this Agreement, the following terms shall have the respective meanings
indicated below, such meanings to be applicable equally to both the singular
and plural forms of such terms:

 

“Additional Collateral” has the meaning specified
therefor in Section 4(a)(i) hereof.

 

“Certificated Entities” has the meaning
specified therefor in Section 5(m) hereof.

 

“Copyright Licenses” means all licenses,
contracts or other agreements, whether written or oral, naming any Grantor as
licensee or licensor and providing for the grant of any right to use or sell
any works covered by any Copyright.

 

2

 

“Existing Issuer” has the meaning specified
therefor in the definition of the term “Pledged Shares”.

 

“Foreign Subsidiary” has the meaning
specified therefor in Section 2 hereof.

 

“Intellectual Property” means all rights in
all U.S and non-U.S. (i) published and unpublished works of authorship
(including, without limitation, computer software), copyrights therein and
thereto, and registrations and applications therefor, and all renewals,
extensions, restorations and reversions thereof, including, without limitation,
all copyright registrations and applications listed in Schedule II hereto
(collectively, “Copyrights”); (ii) inventions, discoveries and all
patents, registrations, and applications therefor, including, without
limitation, divisions, continuations, continuations-in-part and renewal
applications, and all renewals, extensions and reissues, including, without
limitation, all patents and patent applications listed in Schedule II hereto
(collectively, “Patents”); (iii) trademarks, service marks, brand
names, certification marks, collective marks, d/b/a’s, Internet domain
names, logos, symbols, trade dress, assumed names, fictitious names, trade
names, and other indicia of origin, all applications and registrations for all
of the foregoing, and all goodwill associated therewith and symbolized thereby,
and all extensions, modifications and renewals of same, including, without
limitation, all trademark registrations and applications listed in Schedule II
hereto (collectively, “Trademarks”); (iv) confidential and
proprietary information, trade secrets and know-how, including, without
limitation, processes, schematics, databases, formulae, drawings, prototypes,
models, designs and customer lists (collectively, “Trade Secrets”); and
(v) all other intellectual property or proprietary rights and claims or
causes of action arising out of or related to any infringement,
misappropriation or other violation of any of the foregoing, including, without
limitation, rights to recover for past, present and future violations thereof
(collectively, “Other Proprietary Rights”).

 

“Licenses” means the Copyright Licenses, the
Patent Licenses and the Trademark Licenses.

 

“Material Intellectual Property” means
Intellectual Property owned by or licensed to a Grantor and material to the
conduct of any Grantor’s business.

 

“Patent Licenses” means all licenses,
contracts or other agreements, whether written or oral, naming any Grantor as
licensee or licensor and providing for the grant of any right to manufacture,
use or sell any invention covered by any Patent.

 

“Pledged Debt” means the indebtedness
described in Schedule VI hereto and all indebtedness from time to time owned or
acquired by a Grantor, the promissory notes and other Instruments evidencing
any or all of such indebtedness, and all interest, cash, Instruments, Investment
Property, financial assets, securities, Capital Stock, other equity interests,
stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property from time to
time received, receivable or otherwise distributed in respect of or in exchange
for any or all of such indebtedness.

 

3

 

“Pledged Interests” means, collectively, (a) the
Pledged Debt, (b) the Pledged Shares and (c) all security
entitlements in any and all of the foregoing.

 

“Pledged Issuer” has the meaning specified
therefor in the definition of the term “Pledged Shares”.

 

“Pledged Shares” means (a) the shares of
Capital Stock described in Schedule VII hereto, whether or not evidenced or
represented by any stock certificate, certificated security or other
Instrument, issued by the Persons described in such Schedule VII (the “Existing
Issuers”), (b) the shares of Capital Stock at any time and from time
to time acquired by a Grantor of any and all Persons now or hereafter existing
(such Persons, together with the Existing Issuers, being hereinafter referred
to collectively as the “Pledged Issuers” and each individually as a “Pledged
Issuer”), whether or not evidenced or represented by any stock certificate,
certificated security or other Instrument, subject, however, to the limitations
set forth in Section 2 and (c) the certificates representing such
shares of Capital Stock, all options and other rights, contractual or
otherwise, in respect thereof and all dividends, distributions, cash, Instruments, Investment
Property, financial assets, securities, Capital Stock, other equity interests,
stock options and commodity contracts, notes, debentures, bonds, promissory
notes or other evidences of indebtedness and all other property (including,
without limitation, any stock dividend and any distribution in connection with
a stock split) from time to time received, receivable or otherwise distributed
in respect of or in exchange for any or all of such Capital Stock.

 

“Secured Parties” means, collectively, the
Agents and the Lenders.

 

“Secured Obligations” has the meaning
specified therefor in Section 3 hereof.

 

“Trademark Licenses” means all licenses,
contracts or other agreements, whether written or oral, naming any Grantor as
licensor or licensee and providing for the grant of any right concerning any
Trademark, together with any goodwill connected with and symbolized by any such
trademark licenses, contracts or agreements.

 

2.             Grant
of Security Interest. As collateral security for the payment, performance
and observance of all of the Secured Obligations, each Grantor hereby pledges
and assigns to the Collateral Agent (and its agents and designees), and grants
to the Collateral Agent (and its agents and designees), for the benefit of the
Secured Parties, a continuing security interest in, all personal property and
Fixtures of such Grantor, wherever located and whether now or hereafter
existing and whether now owned or hereafter acquired, of every kind and
description, tangible or intangible, including, without limitation, the
following (all being collectively referred to herein as the “Collateral”):

 

(a)           all
Accounts;

 

(b)           all
Chattel Paper (whether tangible or electronic);

 

(c)           the
Commercial Tort Claims specified on Schedule V;

 

4

 

(d)           all
Deposit Accounts, all cash, and all other property from time to time deposited
therein or otherwise credited thereto and the monies and property in the
possession or under the control of any Agent or any Lender or any affiliate,
representative, agent or correspondent of any Agent or any Lender;

 

(e)           all
Documents;

 

(f)            all
General Intangibles (including, without limitation, all Payment Intangibles, Intellectual
Property and Licenses);

 

(g)           all
Goods, including, without limitation, all Equipment, Fixtures and Inventory;

 

(h)           all
Instruments (including, without limitation, Promissory Notes);

 

(i)            all
Investment Property;

 

(j)            all
Letter-of-Credit Rights;

 

(k)           all
Pledged Interests;

 

(l)            all
Supporting Obligations;

 

(m)          all
other tangible and intangible personal property of such Grantor (whether or not
subject to the Code), including, without limitation, all bank and other
accounts and all cash and all investments therein, all proceeds, products,
offspring, accessions, rents, profits, income, benefits, substitutions and
replacements of and to any of the property of such Grantor described in the
preceding clauses of this Section 2 (including, without limitation, any
proceeds of insurance thereon and all causes of action, claims and warranties
now or hereafter held by such Grantor in respect of any of the items listed
above), and all books, correspondence, files and other Records, including,
without limitation, all tapes, disks, cards, Software, data and computer
programs in the possession or under the control of such Grantor or any other
Person from time to time acting for such Grantor that at any time evidence or
contain information relating to any of the property described in the preceding
clauses of this Section 2 or are otherwise necessary or helpful in the
collection or realization thereof; and

 

(n)           all
Proceeds, including all Cash Proceeds and Noncash Proceeds, and products of any
and all of the foregoing Collateral;

 

in each case howsoever such Grantor’s interest therein may arise or
appear (whether by ownership, security interest, claim or otherwise).

 

Notwithstanding anything herein to the contrary, the term “Collateral”
shall not include, and no Grantor is pledging, nor granting a security interest
hereunder in:

 

5

 

(i)            any of such Grantor’s right, title or interest in any
license, contract or agreement to which such Grantor is a party or any of its
right, title or interest thereunder to the extent, but only to the extent, that
such a grant would, under the express terms of such license, contract or
agreement result in a breach of the terms of, or constitute a default under,
such license, contract or agreement (other than to the extent that any such
term (A) has been waived or (B) would be rendered ineffective
pursuant to Sections 9-406, 9-408, 9-409 of the Code or other applicable
provisions of the Uniform Commercial Code of any relevant jurisdiction or any
other applicable law (including the Bankruptcy Code) or principles of equity); provided,
that (x) immediately upon the ineffectiveness, lapse, termination or
waiver of any such provision, the Collateral shall include, and such Grantor
shall be deemed to have granted a security interest in, all such right, title
and interest as if such provision had never been in effect, and (y) the
foregoing exclusion shall in no way be construed so as to limit, impair or
otherwise affect the Collateral Agent’s unconditional continuing security
interest in and liens upon any rights or interests of a Grantor in or to the
proceeds of, or any monies due or to become due under, any such license,
contract or agreement,

 

(ii)           any intent-to-use United States trademark applications (A) for
which an amendment to allege use or statement of use has not been filed under
15 U.S.C. § 1051(c) or 15 U.S.C. § 1051(d), respectively, or if filed, has
not been deemed in conformance with 15 U.S.C. § 1051(a) or examined and
accepted, respectively, by the United States Patent and Trademark Office, provided
that, upon such filing and acceptance, such intent-to-use applications shall be
included in the definition of Collateral, or (B) to the extent that and
for so long as such a grant would result in the abandonment, invalidation or
unenforceability of such intent-to-use United States trademark applications
under applicable law, provided, that (x) immediately upon such time
that the grant of a security interest in such intent-to-use United States
trademark applications would no longer result in the abandonment, invalidation
or unenforceability of such intent-to-use United States trademark applications
under applicable law, the Collateral shall include, and such Grantor shall be
deemed to have granted a security interest in, all such intent-to-use United
States trademark applications as if such applicable law had never been in
effect and (y) the foregoing exclusion shall in no way be construed so as
to limit, impair or otherwise affect the Collateral Agent’s unconditional
continuing security interest in and liens upon any rights or interests of a
Grantor in or to the proceeds of, or any monies due or to become due under, any
such intent-to-use United States trademark applications,

 

(iii)          any Excluded Account, or

 

(iv)          in the case of a Subsidiary of such Grantor organized under
the laws of a jurisdiction other than the United States, any of the states
thereof or the District of Columbia and which is a “controlled foreign
corporation” as such term is defined in Section 957 of the Internal
Revenue Code (a “Foreign Subsidiary”) and which is a “controlled foreign
corporation” (as such term is defined in Section 957 of

 

6

 

the Internal Revenue Code of 1986 (a “CFC”),
more than 65% of the issued and outstanding shares of Capital Stock entitled to
vote (within the meaning of Treas. Reg. Section 1.956 2(c)(2)) (it being
understood and agreed that the Collateral shall include 100% of the issued and
outstanding shares of Capital Stock not entitled to vote within the meaning of
Treas. Reg. Section 1.956 2(c)(2)) or other equity interest of such CFC
(and for the avoidance of doubt, each Loan Party will refrain from pledging the
Capital Stock of any CFC to any Person other than a pledge of 65% of its voting
Capital Stock and 100% of its non-voting Capital Stock to the Collateral Agent,
for the benefit of the Secured Parties.

 

3.             Security
for Secured Obligations. The security interest created hereby in the
Collateral constitutes continuing collateral security for all of the following
obligations, whether now existing or hereafter incurred (the “Secured
Obligations”):

 

(a)           the
prompt payment by each Grantor, as and when due and payable (whether by
scheduled maturity, required prepayment, acceleration, demand or otherwise), of
all amounts from time to time owing by it in respect of the Credit Agreement
and/or the other Loan Documents, including, without limitation, (i) all
Obligations, (ii) all Letter of Credit Obligations, (iii) in the case
of a Guarantor, all amounts from time to time owing by such Grantor in respect
of its guaranty made pursuant to Article XI of the Credit Agreement or
under any other Guaranty to which it is a party, including, without limitation,
all obligations guaranteed by such Grantor and (iv) all interest, fees,
commissions, charges, expense reimbursements, indemnifications and all other
amounts due or to become due under any Loan Document (including, without
limitation, all interest, fees, commissions, charges, expense reimbursements,
indemnifications and other amounts that accrue after the commencement of any
Insolvency Proceeding of any Loan Party, whether or not the payment of such
interest, fees, commissions, charges, expense reimbursements, indemnifications
and other amounts are unenforceable or are not allowable, in whole or in part,
due to the existence of such Insolvency Proceeding); and

 

(b)           the
due performance and observance by each Grantor of all of its other obligations
from time to time existing in respect of the Loan Documents.

 

4.             Delivery
of the Pledged Interests.

 

(a)           (i)            All promissory notes evidencing the
Pledged Debt on the Effective Date and all certificates representing the
Pledged Shares on the Effective Date shall be delivered to the Collateral Agent
(or its custodian, designee or other nominee) on or prior to the Effective
Date. All other promissory notes, certificates and Instruments constituting
Pledged Interests from time to time required to be pledged to the Collateral
Agent pursuant to the terms of this Agreement or the Credit Agreement (the “Additional
Collateral”) shall be delivered to the Collateral Agent (or its custodian,
designee or other nominee) promptly upon, but in any event within fourteen (14)
days (or such later date acceptable to the Collateral Agent) of, receipt
thereof by or on behalf of any of the Grantors, provided that such
delivery requirement shall not apply to any Pledged Debt having a face amount
of less

 

7

 

than $500,000 individually but only to the extent the aggregate face
amount of such Pledged Debt does not exceed $1,000,000 collectively. All such
promissory notes, certificates and Instruments shall be held by or on behalf of
the Collateral Agent (or its custodian, designee or other nominee) pursuant
hereto and shall be delivered in suitable form for transfer by delivery or
shall be accompanied by duly executed instruments of transfer or assignment or
undated stock powers executed in blank, all in form and substance reasonably
satisfactory to the Collateral Agent. If any Pledged Interests consists of
uncertificated securities, unless the immediately following sentence is
applicable thereto, such Grantor shall cause the Collateral Agent (or its
designated custodian or nominee) to become the registered holder thereof, or
cause each issuer of such securities to agree that it will comply with
instructions originated by the Collateral Agent with respect to such securities
without further consent by such Grantor. If any Pledged Interests consists of
security entitlements, such Grantor shall transfer such security entitlements
to the Collateral Agent (or its custodian, nominee or other designee), or cause
the applicable securities intermediary to agree that it will comply with
entitlement orders by the Collateral Agent without further consent by such
Grantor.

 

(ii)           Within twenty (20) days (or such later date acceptable to
the Collateral Agent) of the receipt by a Grantor of any Additional Collateral,
a Pledge Amendment, duly executed by such Grantor, in substantially the form of
Exhibit A hereto (a “Pledge Amendment”), shall be delivered to the
Collateral Agent, in respect of the Additional Collateral that must be pledged
pursuant to this Agreement and the Credit Agreement. The Pledge Amendment shall
from and after delivery thereof constitute part of Schedules VI and VII hereto.
Each Grantor hereby authorizes the Collateral Agent to attach each Pledge
Amendment to this Agreement and agrees that all promissory notes, certificates
or Instruments listed on any Pledge Amendment delivered to the Collateral Agent
(or its custodian, designee or other nominee) shall for all purposes hereunder
constitute Pledged Interests and such Grantor shall be deemed upon delivery
thereof to have made the representations and warranties set forth in Section 5
hereof with respect to such Additional Collateral.

 

(b)           If
any Grantor shall receive, by virtue of such Grantor’s being or having been an
owner of any Pledged Interests, any (i) stock certificate (including,
without limitation, any certificate representing a stock dividend or
distribution in connection with any increase or reduction of capital,
reclassification, merger, consolidation, sale of assets, combination of shares,
stock split, spin-off or split-off), promissory note or other Instrument, (ii) option
or right, whether as an addition to, substitution for, or in exchange for, any
Pledged Interests, or otherwise, (iii) dividends payable in cash (except
such dividends permitted to be retained by any such Grantor pursuant to Section 7
hereof) or in securities or other property or (iv) dividends,
distributions, cash, Instruments, Investment Property and other property in
connection with a partial or total liquidation or dissolution or in connection
with a reduction of capital, capital surplus or paid-in surplus, such Grantor
shall receive such stock certificate, promissory note, Instrument, option,
right, payment or distribution in trust for the benefit of the Collateral
Agent, shall segregate it from such Grantor’s other property and shall promptly
deliver it forthwith to the Collateral Agent, in the exact form received, with
any necessary indorsement and/or appropriate stock powers duly executed in
blank, to

 

8

 

be held by the Collateral Agent as Pledged Interests and as further
collateral security for the Secured Obligations.

 

5.             Representations
and Warranties. Each Grantor jointly and severally represents and warrants
as follows:

 

(a)          Schedule
I hereto sets forth as of the Effective Date (i) the exact legal name of
each Grantor, (ii) the state or jurisdiction of organization of each
Grantor, (iii) the type of organization of each Grantor, (iv) the
organizational identification number of each Grantor or states that no such
organizational identification number exists and (v) the federal employer
identification number of each Grantor.

 

(b)         This
Agreement is a legal, valid and binding obligation of such Grantor, enforceable
against such Grantor in accordance with its terms, except as may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or other similar
laws.

 

(c)          All
Equipment, Fixtures, Inventory and other Goods (other than Inventory in
transit to customers) located in the continental United States now existing
are, and all Equipment, Fixtures, Inventory and other Goods (other than
Inventory in transit to customers) located in the continental United States
hereafter existing will be, located at the addresses specified therefor in
Schedule III hereto (as amended, supplemented or otherwise modified from time
to time in accordance with Section 6(b)), except for any location where
the fair market value of the Equipment, Fixtures, Inventory and other
Goods at such location is less than $1,000,000 in the aggregate. Each Grantor’s
chief place of business and chief executive office, the place where such
Grantor keeps its Records concerning Accounts and all originals of all Chattel
Paper are located at the addresses specified therefor in Schedule III hereto
(as amended, supplemented or otherwise modified from time to time in accordance
with the terms hereof). None of the Accounts is evidenced by Promissory Notes
or other Instruments (except for Promissory Notes evidencing indebtedness of
not more than $500,000 individually and $1,000,000 in the aggregate) that have
not been delivered to the Collateral Agent in accordance with this Agreement.
Set forth in Schedule II hereto is a complete and correct list of each formal
legal name used by any Grantor during the past five years. Schedule VIII hereto
sets forth for each Grantor a true and complete list of all Investment
Property, including all securities, securities entitlements, Instruments,
Chattel Paper, Letters of Credit and any certificates or instruments evidencing
the foregoing held by or on behalf of or issued in favor of each Grantor
(excluding the assets already identified on Schedules VI and VII), whether or
not evidenced by certificates or Instruments.

 

(d)         [Reserved.]

 

(e)          (i)            The Grantors own and control, or
otherwise possess adequate rights to use, all Intellectual Property necessary
to conduct their business except as could not reasonably be expected to have a
Material Adverse Effect. Schedule II hereto sets forth a true and complete list
of all Intellectual Property that is the subject of U.S. registrations or
applications for registration in the U.S. owned by each Grantor as of the date
hereof. To the

 

9

 

applicable Grantor’s knowledge, all such Intellectual Property is
valid, subsisting and enforceable, has not been abandoned in whole or in part
and is not subject to any outstanding order, judgment or decree restricting its
use or adversely affecting the Grantor’s rights thereto, except to the extent
the loss of any such Intellectual Property (either individually or in the
aggregate) could not reasonably be expected to have a Material Adverse Effect.

 

(ii)           Such Grantor is not violating and has not violated any Intellectual
Property rights or any third party except as could not reasonably be expected to
have a Material Adverse Effect. There are no suits, actions, reissues,
reexaminations, public protests, interferences, arbitrations, mediations,
oppositions, cancellations, Internet domain name dispute resolutions or
other proceedings (collectively, “Suits”) pending, decided, asserted by
or against such Grantor or, to such Grantor’s knowledge, threatened concerning
the violation of any Intellectual Property rights or concerning the Material
Intellectual Property owned or controlled by a Grantor, and, to any Grantor’s
knowledge, no valid basis for any such Suits or claims exists, except as could
not reasonably be expected to have a Material Adverse Effect. To the Grantors’
knowledge, there are no Suits or claims pending, decided, threatened or
asserted against the Grantors concerning the Licenses or the right of the
Grantor to use the Licenses, and no valid basis for any such Suits or claims
exists, except as could not reasonably be expected to have a Material Adverse
Effect.

 

(f)            (i)            None of the Other Proprietary Rights
or Trade Secrets of any Grantor have been used, divulged, disclosed or
appropriated to the detriment of such Grantor for the benefit of any other
Person other than such Grantor; (ii) no employee, independent contractor
or agent of any Grantor has misappropriated any Other Proprietary Rights or
Trade Secrets of any other Person in the course of the performance of his or
her duties as an employee, independent contractor or agent of such Grantor; and
(iii) no employee, independent contractor or agent of any Grantor is in
default or breach of any term of any employment agreement, non-disclosure
agreement, assignment of inventions agreement or similar agreement, or contract
relating an any way to the protection, ownership, development, use or transfer
of such Grantor’s Intellectual Property Collateral, except to the extent any of
the foregoing could not reasonably be expected (either individually or in the
aggregate) to have a Material Adverse Effect.

 

(g)           The
Existing Issuers set forth in Schedule VII identified as a Subsidiary of a
Grantor are each such Grantor’s only Subsidiaries existing on the date hereof.
The Pledged Shares have been duly authorized and validly issued and are fully
paid and nonassessable and the holders thereof are not entitled to any
preemptive, first refusal or other similar rights. Except as noted in Schedule
VII hereto, the Pledged Shares constitute 100% of the issued shares of Capital
Stock of the Pledged Issuers as of the date hereof. All other shares of Capital
Stock constituting Pledged Interests will be duly authorized and validly
issued, fully paid and nonassessable.

 

(h)           The
promissory notes currently evidencing the Pledged Debt have been, and all other
promissory notes from time to time evidencing Pledged Debt, when

 

10

 

executed and delivered, will have been, duly authorized, executed and
delivered by the respective makers thereof, and all such promissory notes are
or will be, as the case may be, legal, valid and binding obligations of such
makers, enforceable against such makers in accordance with their respective
terms, except as may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws.

 

(i)           The
Grantors are and will be at all times the sole and exclusive owners of, or
otherwise have and will have adequate rights in, the Collateral free and clear
of any Lien except for the Permitted Liens. No effective financing statement or
other instrument similar in effect covering all or any part of the Collateral
is on file in any recording or filing office except (i) such as may have
been filed to perfect or protect any Permitted Lien, and (ii) in
connection with the Existing Credit Agreement; provided, that the liens
in connection with the Existing Credit Agreement shall be terminated concurrently
with the Effective Date.

 

(j)           The
exercise by the Collateral Agent of any of its rights and remedies hereunder
will not contravene any law or any Contractual Obligation binding on or
otherwise affecting any Grantor or any of its properties and will not result
in, or require the creation of, any Lien upon or with respect to any of its
properties other than Liens created pursuant to the Loan Documents.

 

(k)          No
authorization or approval or other action by, and no notice to or filing with,
any Governmental Authority or any other Person, is required for (i) the
due execution, delivery and performance by any Grantor of this Agreement, (ii) the
grant by any Grantor of the security interest purported to be created hereby in
the Collateral or (iii) the exercise by the Collateral Agent of any of its
rights and remedies hereunder, except, in the case of this clause (iii), as may
be required in connection with any sale of any Pledged Interests by laws
affecting the offering and sale of securities generally. No authorization or
approval or other action by, and no notice to or filing with, any Governmental
Authority or any other Person, is required for the perfection of the security
interest purported to be created hereby in the Collateral, except (A) for
the filing under the Uniform Commercial Code as in effect in the applicable
jurisdiction of the financing statements described in Schedule IV hereto, all
of which financing statements shall be duly filed on or around the Effective
Date and from such date shall be in full force and effect, (B) with
respect to the perfection of the security interest created hereby in the United
States Intellectual Property, for the recording of the appropriate Assignment
for Security, substantially in the form of Exhibit B hereto in the United
States Patent and Trademark Office or the United States Copyright Office, as
applicable, (C) with respect to any action that may be necessary to obtain
control of Collateral constituting Deposit Accounts, Electronic Chattel Paper, Investment
Property or Letter-of-Credit Rights, the taking of such actions, and (D) the
Collateral Agent’s having possession of all Documents, Chattel Paper, Instruments
and cash constituting Collateral (subclauses (A), (B), (C) and (D), each a
“Perfection Requirement” and collectively, the “Perfection
Requirements”).

 

(l)           This
Agreement creates a legal, valid and enforceable security interest in favor of
the Collateral Agent, for the benefit of the Secured Parties, in the
Collateral, as

 

11

 

security for the Secured Obligations. The satisfaction of the
Perfection Requirements will result in the perfection of such security
interests. After satisfaction of the Perfection Requirements, such security
interests are, or in the case of Collateral in which any Grantor obtains rights
after the date hereof, will be, perfected, first priority security interests,
subject in priority only to the Permitted Liens that, pursuant to the
definition of the term “Permitted Liens”, are not prohibited from being prior
to the Liens in favor of the Collateral Agent, for the benefit of the Secured
Parties, and the recording of such instruments of assignment described above.
Such Perfection Requirements and all other action necessary or desirable to
perfect and protect such security interest have been duly made or taken, except
for (i) the Collateral Agent’s having possession of all Instruments,
Documents, Chattel Paper and cash constituting Collateral after the date
hereof, (ii) the Collateral Agent’s having control of all Deposit
Accounts, Electronic Chattel Paper, Investment Property or
Letter-of-Credit Rights constituting Collateral after the date hereof, and
(iii) the other filings and recordations and actions described in Section 5(l) hereof.

 

(m)          As
of the date hereof, no Grantor holds any Commercial Tort Claims, except for
such claims described in Schedule V.

 

(n)           With
respect to each Grantor and its Subsidiaries that is a partnership or a limited
liability company, none of the partnership interests or membership interests of
such Person are (i) dealt in or traded on securities exchanges or in
securities markets, (ii) securities for purposes of Article 8 of any
relevant Uniform Commercial Code, (iii) investment company securities
within the meaning of Section 8-103 of any relevant Uniform Commercial
Code or (iv) evidenced by a certificate. The partnership interests or
membership interests of any Grantor and its Subsidiaries constitute General
Intangibles.

 

6.             Covenants
as to the Collateral. So long as any of the Secured Obligations (whether or not
due) shall remain unpaid or any Lender shall have any Revolving Credit
Commitment under the Credit Agreement, unless the Collateral Agent shall
otherwise consent in writing:

 

(a)           Further
Assurances. Each Grantor will at its expense, at any time and from time to
time, promptly execute and deliver all further instruments and documents and
take all further action that may be necessary or desirable or that the
Collateral Agent may reasonably request in order (i) to perfect and
protect, or maintain the perfection of, the security interest and Lien
purported to be created hereby; (ii) to enable the Collateral Agent to
exercise and enforce its rights and remedies hereunder in respect of the
Collateral; or (iii) otherwise to effect the purposes of this Agreement,
including, without limitation: (A) if a Default or an Event of Default has
occurred and is continuing, marking conspicuously all Chattel Paper, Instruments
and Licenses and, at the request of the Collateral Agent, all of its Records
pertaining to the Collateral with a legend, in form and substance reasonably
satisfactory to the Collateral Agent, indicating that such Chattel Paper, Instrument,
License or Collateral is subject to the security interest created hereby, (B) if
any Account shall be evidenced by a Promissory Note or other Instrument or
Chattel Paper, delivering and pledging to the Collateral Agent such Promissory
Note, other Instrument or Chattel Paper,

 

12

 

duly endorsed and accompanied by executed instruments of transfer or
assignment, all in form and substance satisfactory to the Collateral Agent, provided
that such delivery requirement shall not apply to any Pledged Debt having a
face amount of less than $500,000 individually but only to the extent the
aggregate face amount of such Pledged Debt does not exceed $1,000,000
collectively, (C) executing and filing (to the extent, if any, that such
Grantor’s signature is required thereon) or authenticating the filing of, such
financing or continuation statements, or amendments thereto, (D) with
respect to Intellectual Property hereafter existing and not covered by an
appropriate security interest grant, the executing and recording in the United
States Patent and Trademark Office or the United States Copyright Office, as
applicable, appropriate instruments granting a security interest, as may be
necessary or desirable or that the Collateral Agent may reasonably request in
order to perfect and preserve the security interest purported to be created
hereby, (E) delivering to the Collateral Agent irrevocable proxies in
respect of the Pledged Interests, (F) furnishing to the Collateral Agent
from time to time statements and schedules further identifying and describing
the Collateral and such other reports in connection with the Collateral as the
Collateral Agent may reasonably request, all in reasonable detail, (G) if
at any time after the date hereof, any Grantor acquires or holds any Commercial
Tort Claim (other than any Commercial Tort Claims having a value of less than
$500,000 individually and $1,000,000 in the aggregate,) immediately notifying
the Collateral Agent in a writing signed by such Grantor setting forth a brief
description of such Commercial Tort Claim and granting to the Collateral Agent
a security interest therein and in the proceeds thereof, which writing shall
incorporate the provisions hereof and shall be in form and substance reasonably
satisfactory to the Collateral Agent, and (H) taking all actions required
by law in any relevant Uniform Commercial Code jurisdiction, or by other law as
applicable in any foreign jurisdiction.

 

(b)         Location
of Equipment and Inventory. Each Grantor will keep the Equipment and
Inventory (other than Equipment and Inventory sold in the ordinary course of
business in accordance with Section 6(g) hereof or located outside of
the continental United States) at the locations specified in Schedule III
hereto or, upon prompt written notice thereafter to the Collateral Agent
accompanied by a new Schedule III hereto indicating each new location
containing Records concerning Accounts or Equipment and Inventory with an
aggregate fair market value in excess of $1,000,000, at such other locations as
the Grantors may elect. If any Grantor moves the location of its primary
Records concerning Accounts to a new leased location after the date hereof,
upon the reasonable request of Collateral Agent, each Grantor shall use
commercially reasonable efforts to (A) obtain written subordinations or
waivers, in form and substance satisfactory to the Collateral Agent, of all
present and future Liens to which the owner or lessor of such premises may be
entitled to assert against the Collateral located at such premises, and (B) obtain
written access agreements, in form and substance reasonably satisfactory to the
Collateral Agent, providing access to the Collateral located on such premises
in order to remove such Collateral from such premises during an Event of
Default.

 

(c)          Equipment.
Each Grantor will promptly furnish to the Collateral Agent a statement
describing in reasonable detail any loss or damage to any Equipment in excess
of $1,000,000.

 

13

 

(d)         Insurance.
Each Grantor will, at its own expense, maintain insurance with respect to the
Collateral in accordance with the terms of the Credit Agreement. Each Grantor
will, if so requested by the Collateral Agent, deliver to the Collateral Agent
original or duplicate insurance policies and, as often as the Collateral Agent
may reasonably request, a report of a reputable insurance broker with respect
to such insurance. Each Grantor will also, at the reasonable request of the
Collateral Agent, execute and deliver instruments of assignment of such insurance
policies and cause the respective insurers to acknowledge notice of such
assignment.

 

(e)          Provisions
Concerning the Accounts. Each Grantor will, except as otherwise provided in
this subsection (e), continue to collect, at its own expense, all amounts due
or to become due under the Accounts. In connection with such collections, each
Grantor may (and, if an Event of Default has occurred and is continuing, at the
Collateral Agent’s direction, will) take such action as such Grantor (or, if an
Event of Default has occurred and is continuing, the Collateral Agent) may
reasonably deem necessary or advisable to enforce collection or performance of
the Accounts; provided, however, that the Collateral Agent shall
have the right at any time, upon the occurrence and during the continuance of
an Event of Default, to notify the Account Debtors or obligors under any
Accounts of the assignment of such Accounts to the Collateral Agent and to
direct such Account Debtors or obligors to make payment of all amounts due or
to become due to such Grantor thereunder directly to the Collateral Agent or
its designated agent and, upon such notification and at the expense of such
Grantor and to the extent permitted by law, to enforce collection of any such
Accounts and to adjust, settle or compromise the amount or payment thereof, in
the same manner and to the same extent as such Grantor might have done. After
the occurrence and during the continuance of an Event of Default and after
receipt by any Grantor of a notice from the Collateral Agent that the
Collateral Agent has notified, intends to notify, or has enforced or intends to
enforce a Grantor’s rights against the Account Debtors or obligors under any
Accounts as referred to in the proviso to the immediately preceding sentence,
(A) all amounts and proceeds (including Instruments) received by such
Grantor in respect of the Accounts shall be received in trust for the benefit
of the Collateral Agent hereunder, shall be segregated from other funds of such
Grantor and shall be forthwith paid over to the Collateral Agent or its
designated agent in the same form as so received (with any necessary
endorsement) to be held as cash collateral and either (x) credited to the
Loan Account so long as no Event of Default shall have occurred and be continuing
or (y) if any Event of Default shall have occurred and be continuing,
applied as specified in Section 9(d) hereof, and (B) such
Grantor will not adjust, settle or compromise the amount or payment of any
Account or release wholly or partly any Account Debtor or obligor thereof or
allow any credit or discount thereon.

 

(f)          Provisions
Concerning the Pledged Interests. Each Grantor will

 

(i)            at the Grantors’ joint and several expense, promptly
deliver to the Collateral Agent a copy of each material notice or other
communication received by it in respect of the Pledged Interests;

 

14

 

(ii)           at the Grantors’ joint and several expense, defend the
Collateral Agent’s right, title and security interest in and to the Pledged
Interests against the claims of any Person; and

 

(iii)          with respect to any Subsidiary of the Parent, not permit
the issuance of (A) any additional shares of any class of Capital Stock of
any Pledged Issuer, (B) any securities convertible voluntarily by the
holder thereof or automatically upon the occurrence or non-occurrence of any
event or condition into, or exchangeable for, any such shares of Capital Stock
or (C) any warrants, options, contracts or other commitments entitling any
Person to purchase or otherwise acquire any such shares of Capital Stock,
unless in each case the applicable Grantor makes the deliveries and takes the
other actions required by Section 4.

 

(g)           Transfers
and Other Liens.

 

(i)            Except to the extent expressly permitted by Section 7.02(c) of
the Credit Agreement, no Grantor will sell, assign (by operation of law or
otherwise), lease, license, exchange or otherwise transfer or dispose of any of
the Collateral.

 

(ii)           Except to the extent expressly permitted by Section 7.02(a) of
the Credit Agreement, no Grantor will create, suffer to exist or grant any Lien
upon or with respect to any Collateral.

 

(h)           Intellectual
Property.

 

(i)            Each Grantor has duly executed and delivered the
applicable Grant of a Security Interest in the form attached hereto as Exhibit B.

 

(ii)           Each Grantor (either itself or through its licensees or
its sublicensees) agrees that it will not do any act or omit to do any act
whereby any Material Intellectual Property may become invalidated or dedicated
to the public, and agrees that it shall continue to mark any products covered
by a Patent with the relevant patent number as necessary to establish and
preserve its rights under applicable patent laws, except where the failure to
do so could not reasonably be expected to result in a Material Adverse Effect.

 

(iii)          Each Grantor (either itself or through its licensees or its
sublicensees) will, for each Trademark that constitutes Material Intellectual
Property, take such actions that in its commercially reasonable business
judgment are necessary to: (A) maintain such Trademark in full force free
from any claim of abandonment or invalidity for non use, (B) maintain the
quality of products and services offered under such Trademark, (C) display
such Trademark with notice of U.S. or non-U.S. registration to the extent
necessary to establish and preserve its rights under applicable law, except
where the failure to do so could not reasonably be expected to result in a
Material Adverse Effect and (D) not knowingly use or knowingly permit the
use of such Trademark in violation of any third party rights.

 

15

 

(iv)          Each Grantor (either itself or through its licensees or
sublicensees) will, for each work covered by a Copyright that constitutes
Material Intellectual Property, continue to publish, reproduce, display, adopt
and distribute the work with appropriate copyright notice as necessary to
establish and preserve its rights under applicable copyright laws, except where
the failure to do so could not reasonably be expected to result in a Material
Adverse Effect.

 

(v)           Each Grantor shall notify the Collateral Agent promptly if
it knows that any Material Intellectual Property may become abandoned, lost or
dedicated to the public in violation of the foregoing clauses (ii) and
(iii), or of any final determination (including the institution of, or any such
determination in, any proceeding in the United States Patent and Trademark
Office, United States Copyright Office or any court or similar office of any
country) that could reasonably be expected to result in a Material Adverse
Effect regarding such Grantor’s ownership of any Material Intellectual
Property, its right to register the same, or its right to keep and maintain the
same. Notwithstanding anything to the contrary contained herein, the Grantors
may abandon or otherwise dispose of immaterial Intellectual Property if, in
such Grantor’s commercially reasonable business judgment, such Intellectual
Property is no longer of any useful economic value.

 

(vi)          If any Grantor (A) files an application or
registration for any Intellectual Property with the United States Patent and
Trademark Office or United States Copyright Office, either itself or through
any agent, employee, licensee or designee or (B) obtains rights to or
develops any new Intellectual Property or any reissue, division, continuation,
renewal, extension or continuation-in-part of any existing Intellectual
Property, whether pursuant to any license or otherwise, the provisions of Section 2
hereof shall automatically apply thereto and such Grantor shall give to the
Collateral Agent notice of any applications or registrations on a quarterly
basis and, upon request of the Collateral Agent, execute and deliver any and
all agreements, instruments, documents and papers as the Collateral Agent may
reasonably request to evidence the Collateral Agent’s security interest in such
Intellectual Property.

 

(vii)         Each Grantor will take all necessary steps in its
commercially reasonable business judgment, in any proceeding before the United
States Patent and Trademark Office, United States Copyright Office, to maintain
and pursue each application relating to the Material Intellectual Property of
such Grantor (and to obtain the relevant grant or registration) and to maintain
each issued Patent and each registration of the Trademarks and Copyrights that
constitutes Material Intellectual Property.

 

(viii)        If any Grantor has reason to believe
that any Collateral consisting of any Grantor’s Material Intellectual Property
has been infringed, misappropriated or diluted by a third party, such Grantor
shall, consistent with its commercially reasonable business judgment, sue for
infringement, misappropriation

 

16

 

or dilution and to recover any and all damages for
such infringement, misappropriation or dilution, and take such other actions as
are appropriate under the circumstances to protect such Collateral and promptly
shall notify the Collateral Agent of the initiation of any such suit.

 

(ix)           Upon and during the continuance of an Event of Default,
(i) no Grantor shall abandon or otherwise permit any Intellectual Property
to become invalid and (ii) upon the reasonable request of the Collateral
Agent, each Grantor shall use its commercially reasonable efforts to obtain all
requisite consents or approvals by the licensor of each License that
constitutes Collateral owned by such Grantor to effect the assignment of all
such Grantor’s right, title and interest thereunder to the Collateral Agent or
its designee.

 

(x)            Each Grantor shall execute, authenticate and deliver any
and all assignments, agreements, instruments, documents and papers as the
Collateral Agent may reasonably request to evidence the Collateral Agent’s security
interest hereunder in such Intellectual Property and the General Intangibles of
such Grantor relating thereto or represented thereby, each Grantor hereby
appoints the Collateral Agent as its attorney in fact to execute and file such
writings for the foregoing purposes, all acts of such attorney being hereby
ratified and confirmed; such power, being coupled with an interest, is
irrevocable.

 

(i)            [Reserved.]

 

(j)            [Reserved.]

 

(k)           Control.
Each Grantor hereby agrees to take any or all action that may be necessary or
desirable or that the Collateral Agent may reasonably request in order for the
Collateral Agent to obtain control in accordance with Sections 9-104, 9-105,
9-106, and 9-107 of the Code with respect to the following Collateral: (i) Electronic
Chattel Paper, other than Electronic Chattel Paper having a face amount of less
than $500,000 individually but only to the extent the aggregate face amount of
such Electronic Chattel Paper does not exceed $500,000 collectively, (ii) Investment
Property and (iii) Letter-of-Credit Rights, other than any
Letter-of-Credit Rights having a face amount of less than $1,000,000
individually but only to the extent the aggregate face amount of such
Letter-of-Credit Rights does not exceed $1,000,000 collectively or any Letter-of-Credit
Right that constitutes a Supporting Obligation. Each Grantor hereby
acknowledges and agrees that any agent or designee of the Collateral Agent
shall be deemed to be a “secured party” with respect to the Collateral under
the control of such agent or designee for all purposes.

 

(l)           Records;
Inspection and Reporting.

 

(i)            Each Grantor shall keep adequate records concerning the Accounts,
Chattel Paper and Pledged Interests. Without limiting any rights, powers and
privileges of the Agents under the Credit Agreement, if any Event of Default shall
have occurred and be continuing, each Grantor shall permit the Agents, or any

 

17

 

agents or representatives thereof or such
professionals or other Persons as the Agents may designate (A) to examine
and make copies of and abstracts from such Grantor’s books and records, (B) to
visit and inspect its properties, (C) to verify materials, leases, notes,
Accounts, Inventory and other assets of such Grantor from time to time,
(D) to conduct audits, physical counts, appraisals and/or valuations,
environmental site assessments or examinations at the locations of such Grantor
and (E) to discuss such Grantor’s affairs, finances and accounts with any
of its directors, officers, managerial employees, independent accountants or
any of its other representatives, in each case as provided in the Credit
Agreement.

 

(ii)           Except as otherwise expressly permitted by Section 7.02(l) of
the Credit Agreement, no Grantor shall, without giving the Collateral Agent at
least ten Business Days’ prior written notice, change (A) its name,
identity or organizational structure, (B) its jurisdiction of
incorporation or organization as set forth in Schedule I hereto or (C) its
chief executive office as set forth in Schedule III hereto. In connection with
the foregoing, each Grantor shall take all actions necessary or reasonably
requested by the Collateral Agent to maintain the continuous validity,
perfection and the same or better priority of the Collateral Agent’s security
interest in the Collateral granted or intended to be granted pursuant to this
Agreement. Each Grantor shall immediately notify the Collateral Agent upon
obtaining an organizational identification number, if on the date hereof such
Grantor did not have such identification number.

 

(m)          Partnership
and Limited Liability Company Interest. Except with respect to partnership
interests and membership interests evidenced by a certificate, which
certificate has been pledged and delivered to the Collateral Agent pursuant to
Section 4 hereof, no Grantor that is a partnership or a limited liability
company shall, nor shall any Grantor with any Subsidiary that is a partnership
or a limited liability company, permit such partnership interests or membership
interests to (i) be dealt in or traded on securities exchanges or in
securities markets, (ii) become a security for purposes of Article 8
of any relevant Uniform Commercial Code, (iii) become an investment
company security within the meaning of Section 8-103 of any relevant
Uniform Commercial Code or (iv) be evidenced by a certificate unless such
certificate is delivered to the Collateral Agent. Each Grantor agrees that such
partnership interests or membership interests shall constitute General
Intangibles.

 

7.             Voting
Rights, Dividends, Etc. in Respect of the Pledged Interests.

 

(a)           So
long as no Event of Default shall have occurred and be continuing:

 

(i)           each Grantor may exercise any and all voting and other
consensual rights pertaining to any Pledged Interests for any purpose not
inconsistent with the terms of this Agreement, the Credit Agreement or the
other Loan Documents; and

 

(ii)          each of the Grantors may receive and retain any and all
dividends, interest or other distributions paid in respect of the Pledged
Interests to the

 

18

 

extent permitted by the Financing Agreement; provided,
however, that any and all (A) dividends and interest paid or
payable other than in cash in respect of, and Instruments and other property
received, receivable or otherwise distributed in respect of or in exchange for,
any Pledged Interests which at the time of such distribution was not permitted
by the Financing Agreement (B) dividends and other distributions paid or
payable in cash in respect of any Pledged Interests in connection with a
partial or total liquidation or dissolution or in connection with a reduction
of capital, capital surplus or paid-in surplus which at the time of such
distribution was not permitted by the Financing Agreement, and (C) cash
paid, payable or otherwise distributed in redemption of, or in exchange for, any
Pledged Interests, together with any dividend, interest or other distribution
or payment which at the time of such payment was not permitted by the Financing
Agreement, shall be, and shall forthwith be delivered to the Collateral Agent, to
hold as, Pledged Interests and shall, if received by any of the Grantors, be
received in trust for the benefit of the Collateral Agent, shall be segregated
from the other property or funds of the Grantors, and shall be forthwith
delivered to the Collateral Agent in the exact form received with any necessary
indorsement and/or appropriate stock powers duly executed in blank, to be held
by the Collateral Agent as Pledged Interests and as further collateral security
for the Secured Obligations; and

 

(iii)          the Collateral Agent will execute and deliver (or cause to
be executed and delivered) to a Grantor all such proxies and other instruments
as such Grantor may reasonably request for the purpose of enabling such Grantor
to exercise the voting and other rights which it is entitled to exercise
pursuant to Section 7(a)(i) hereof and to receive the dividends, interest
and/or other distributions which it is authorized to receive and retain
pursuant to Section 7(a)(ii) hereof.

 

(b)                                 Upon the
occurrence and during the continuance of an Event of Default:

 

(i)            upon notice from the Collateral Agent to such Grantor, all
rights of each Grantor to exercise the voting and other consensual rights which
it would otherwise be entitled to exercise pursuant to Section 7(a)(i) hereof,
and to receive the dividends, distributions, interest and other payments that
it would otherwise be authorized to receive and retain pursuant to Section 7(a)(ii) hereof,
shall cease, and all such rights shall thereupon become vested in the
Collateral Agent, which shall thereupon have the sole right to exercise such
voting and other consensual rights and to receive and hold as Pledged Interests
such dividends, distributions and interest payments;

 

(ii)           the Collateral Agent is authorized to notify each debtor
with respect to the Pledged Debt to make payment directly to the Collateral
Agent (or its designee) and may collect any and all moneys due or to become due
to any Grantor in respect of the Pledged Debt, and each of the Grantors hereby
authorizes each such

 

19

 

debtor to make such payment directly to the
Collateral Agent (or its designee) without any duty of inquiry;

 

(iii)          without limiting the generality of the foregoing, the
Collateral Agent may at its option exercise any and all rights of conversion, exchange,
subscription or any other rights, privileges or options pertaining to any of
the Pledged Interests as if it were the absolute owner thereof, including, without
limitation, the right to exchange, in its discretion, any and all of the
Pledged Interests upon the merger, consolidation, reorganization, recapitalization
or other adjustment of any Pledged Issuer, or upon the exercise by any Pledged
Issuer of any right, privilege or option pertaining to any Pledged Interests, and,
in connection therewith, to deposit and deliver any and all of the Pledged
Interests with any committee, depository, transfer agent, registrar or other
designated agent upon such terms and conditions as it may reasonably determine;
and

 

(iv)          all dividends, distributions, interest and other payments
that are received by any of the Grantors contrary to the provisions of Section 7(b)(i) hereof
shall be received in trust for the benefit of the Collateral Agent, shall be
segregated from other funds of the Grantors, and shall be forthwith paid over
to the Collateral Agent as Pledged Interests in the exact form received with
any necessary indorsement and/or appropriate stock powers duly executed in
blank, to be held by the Collateral Agent as Pledged Interests and as further
collateral security for the Secured Obligations.

 

8.                                       Additional
Provisions Concerning the Collateral.

 

(a)           To the maximum extent permitted by applicable law, and for
the purpose of taking any action that the Collateral Agent may deem necessary
or advisable to accomplish the purposes of this Agreement, each Grantor hereby
(i) authorizes the Collateral Agent to execute any such agreements, instruments
or other documents in such Grantor’s name and to file such agreements, instruments
or other documents in such Grantor’s name and in any appropriate filing office,
(ii) authorizes the Collateral Agent at any time and from time to time to
file, one or more financing or continuation statements and amendments thereto, relating
to the Collateral (including, without limitation, any such financing statements
that (A) describe the Collateral as “all assets” or “all personal property”
(or words of similar effect) or that describe or identify the Collateral by
type or in any other manner as the Collateral Agent may determine, regardless
of whether any particular asset of such Grantor falls within the scope of
Article 9 of the Uniform Commercial Code or whether any particular asset
of such Grantor constitutes part of the Collateral, and (B) contain any
other information required by Part 5 of Article 9 of the Code for the
sufficiency or filing office acceptance of any financing statement, continuation
statement or amendment, including, without limitation, whether such Grantor is
an organization, the type of organization and any organizational identification
number issued to such Grantor) and (iii) ratifies such authorization to
the extent that the Collateral Agent has filed any such financing statements, continuation
statements, or amendments thereto, prior to the date hereof. A photocopy or

 

20

 

other reproduction of this Agreement or any financing statement
covering the Collateral or any part thereof shall be sufficient as a financing
statement where permitted by law.

 

(b)           Each Grantor hereby irrevocably appoints the Collateral
Agent as its attorney-in-fact and proxy, with full authority in the place and
stead of such Grantor and in the name of such Grantor or otherwise, from time
to time in the Collateral Agent’s reasonable discretion, to take any action and
to execute any instrument that the Collateral Agent may deem necessary or
advisable to accomplish the purposes of this Agreement (subject to the rights
of a Grantor under Section 6 hereof and Section 7(a) hereof), including,
without limitation, (i) to obtain and adjust insurance required to be paid
to the Collateral Agent pursuant to the Credit Agreement, (ii) to ask, demand,
collect, sue for, recover, compound, receive and give acquittance and receipts
for moneys due and to become due under or in respect of any Collateral, (iii) to
receive, endorse, and collect any drafts or other Instruments, Documents and
Chattel Paper in connection with clause (i) or (ii) above, (iv) to
receive, indorse and collect all Instruments made payable to such Grantor
representing any dividend, interest payment or other distribution in respect of
any Pledged Interests and to give full discharge for the same, (v) upon
the occurrence and during the continuance of an Event of Default, to file any
claims or take any action or institute any proceedings which the Collateral
Agent may deem necessary or desirable for the collection of any Collateral or
otherwise to enforce the rights of the Collateral Agent and the Lenders with
respect to any Collateral, (vi) upon the occurrence and during the
continuance of an Event of Default, to execute assignments, licenses and other
documents to enforce the rights of the Collateral Agent and the Lenders with
respect to any Collateral, (vii) upon the occurrence and during the
continuance of an Event of Default, to pay or discharge taxes or Liens levied
or placed upon or threatened against the Collateral, the legality or validity
thereof and the amounts necessary to discharge the same to be determined by the
Collateral Agent in its sole discretion, and such payments made by the
Collateral Agent to become Obligations of such Grantor to the Collateral Agent,
due and payable immediately without demand, and (viii) upon the occurrence
and during the continuance of an Event of Default, to sign and endorse any
invoices, freight or express bills, bills of lading, storage or warehouse
receipts, assignments, verifications and notices in connection with Accounts, Chattel
Paper and other documents relating to the Collateral. This power is coupled
with an interest and is irrevocable until the date on which all of the Secured
Obligations have been indefeasibly paid in full in cash after the termination
of each Lender’s Revolving Credit Commitment and each of the Loan Documents.

 

(c)           For the purpose of enabling the Collateral Agent to
exercise rights and remedies hereunder, at such time as the Collateral Agent
shall be lawfully entitled to exercise such rights and remedies, and for no
other purpose, effective upon the occurrence and during the continuance of an
Event of Default each Grantor hereby grants to the Collateral Agent an
irrevocable, non-exclusive license (exercisable without payment of royalty or
other compensation to any Grantor) to use, assign, license or sublicense any
Intellectual Property now or hereafter owned by any Grantor, wherever the same may
be located, including in such license reasonable access to all media in which
any of the licensed items may be recorded or stored and to all computer
programs used for the compilation or printout thereof;

 

21

 

provided that the Collateral Agent shall exercise reasonable standards
of quality control over any goods bearing Grantor’s Trademarks. Notwithstanding
anything contained herein to the contrary, but subject to the provisions of the
Credit Agreement that limit the right of a Grantor to dispose of its property
and Section 6(i) hereof, so long as no Event of Default shall have
occurred and be continuing, each Grantor may exploit, use, enjoy, protect, license,
sublicense, assign, sell, dispose of or take other actions with respect to the
Intellectual Property in the ordinary course of its business. In furtherance of
the foregoing, unless an Event of Default shall have occurred and be continuing,
the Collateral Agent shall from time to time, upon the request of a Grantor, execute
and deliver any instruments, certificates or other documents, in the form so
requested, which such Grantor shall have certified are appropriate (in such
Grantor’s judgment) to allow it to take any action permitted above (including
relinquishment of the license provided pursuant to this clause (c) as to
any Intellectual Property). Further, upon the date on which all of the Secured
Obligations have been indefeasibly paid in full in cash after the termination
of each Lender’s Revolving Credit Commitment and each of the Loan Documents, the
Collateral Agent (subject to Section 13(e) hereof) shall release and
reassign to the Grantors all of the Collateral Agent’s right, title and
interest in and to the Intellectual Property, and the Licenses, all without
recourse, representation or warranty whatsoever and at the Grantors’ sole
expense. The exercise of rights and remedies hereunder by the Collateral Agent
shall not terminate the rights of the holders of any licenses or sublicenses
theretofore granted by any Grantor in accordance with the second sentence of
this clause (c). Each Grantor hereby releases the Collateral Agent from any
claims, causes of action and demands at any time arising out of or with respect
to any actions taken or omitted to be taken by the Collateral Agent under the
powers of attorney granted herein other than actions taken or omitted to be
taken through the Collateral Agent’s gross negligence or willful misconduct, as
determined by a final determination of a court of competent jurisdiction.

 

(d)           Upon the occurrence and during the continuance of any
Event of Default, if any Grantor fails to perform any agreement or obligation
contained herein, the Collateral Agent may itself perform, or cause performance
of, such agreement or obligation, in the name of such Grantor or the Collateral
Agent, and the expenses of the Collateral Agent incurred in connection
therewith shall be jointly and severally payable by the Grantors pursuant to
Section 10 hereof and shall be secured by the Collateral.

 

(e)           The powers conferred on the Collateral Agent hereunder are
solely to protect its interest in the Collateral and shall not impose any duty
upon it to exercise any such powers. Other than the exercise of reasonable care
to assure the safe custody of any Collateral in its possession and the
accounting for moneys actually received by it hereunder, the Collateral Agent
shall have no duty as to any Collateral or as to the taking of any necessary
steps to preserve rights against prior parties or any other rights pertaining
to any Collateral and shall be relieved of all responsibility for any
Collateral in its possession upon surrendering it or tendering surrender of it
to any of the Grantors (or whomsoever shall be lawfully entitled to receive the
same or as a court of competent jurisdiction shall direct). The Collateral
Agent shall be deemed to have exercised reasonable care in the custody and
preservation of any Collateral in its possession if such Collateral is accorded
treatment

 

22

 

substantially equal to that which the Collateral Agent accords its own
property, it being understood that the Collateral Agent shall not have
responsibility for ascertaining or taking action with respect to calls, conversions,
exchanges, maturities, tenders or other matters relating to any Collateral, whether
or not the Collateral Agent has or is deemed to have knowledge of such matters.
The Collateral Agent shall not be liable or responsible for any loss or damage
to any of the Collateral, or for any diminution in the value thereof, by reason
of the act or omission of any warehouseman, carrier, forwarding agency, consignee
or other agent or bailee selected by the Collateral Agent in good faith.

 

(f)            Anything herein to the contrary notwithstanding (i) each
Grantor shall remain liable under the Licenses and otherwise in respect of the
Collateral to the extent set forth therein to perform all of its obligations
thereunder to the same extent as if this Agreement had not been executed, (ii) the
exercise by the Collateral Agent of any of its rights hereunder shall not
release any Grantor from any of its obligations under the Licenses or otherwise
in respect of the Collateral, and (iii) the Collateral Agent shall not
have any obligation or liability by reason of this Agreement under the Licenses
or otherwise in respect of the Collateral, nor shall the Collateral Agent be
obligated to perform any of the obligations or duties of any Grantor thereunder
or to take any action to collect or enforce any claim for payment assigned
hereunder.

 

(g)           The Collateral Agent may at any time in its discretion (i) without
notice to any Grantor, transfer or register in the name of the Collateral Agent
or any of its nominees any or all of the Pledged Interests, subject only to the
revocable rights of such Grantor under Section 7(a) hereof, and (ii) exchange
certificates or Instruments constituting Pledged Interests for certificates or
Instruments of smaller or larger denominations.

 

9.             Remedies Upon Default. If any Event of Default
shall have occurred and be continuing:

 

(a)           The Collateral Agent may exercise in respect of the
Collateral, in addition to any other rights and remedies provided for herein or
otherwise available to it, all of the rights and remedies of a secured party
upon default under the Code (whether or not the Code applies to the affected
Collateral), and also may (i) take absolute control of the Collateral, including,
without limitation, transfer into the Collateral Agent’s name or into the name
of its nominee or nominees (to the extent the Collateral Agent has not
theretofore done so) and thereafter receive, for the benefit of the Collateral
Agent and the Lenders, all payments made thereon, give all consents, waivers
and ratifications in respect thereof and otherwise act with respect thereto as
though it were the outright owner thereof, (ii) require each Grantor to, and
each Grantor hereby agrees that it will at its expense and upon request of the
Collateral Agent forthwith, assemble all or part of the Collateral as directed
by the Collateral Agent and make it available to the Collateral Agent at a
place or places to be designated by the Collateral Agent that is reasonably
convenient to both parties, and the Collateral Agent may enter into and occupy
any premises owned or leased by any Grantor where the Collateral or any part
thereof is located or assembled for a reasonable period in order to effectuate
the Collateral Agent’s rights and remedies hereunder or under law,

 

23

 

without obligation to any Grantor in respect of such occupation, and
(iii) without notice except as specified below and without any obligation
to prepare or process the Collateral for sale, (A) sell the Collateral or
any part thereof in one or more parcels at public or private sale, at any of
the Collateral Agent’s offices, at any exchange or broker’s board or elsewhere,
for cash, on credit or for future delivery, and at such price or prices and
upon such other terms as the Collateral Agent may deem commercially reasonable
and/or (B) lease, license or otherwise dispose of the Collateral or any
part thereof upon such terms as the Collateral Agent may deem commercially
reasonable. Each Grantor agrees that, to the extent notice of sale or any other
disposition of the Collateral shall be required by law, at least five (5) Business
Days’ prior notice to the applicable Grantor of the time and place of any
public sale or the time after which any private sale or other disposition of the
Collateral is to be made shall constitute reasonable notification. The
Collateral Agent shall not be obligated to make any sale or other disposition
of Collateral regardless of notice of sale having been given. The Collateral
Agent may adjourn any public or private sale from time to time by announcement
at the time and place fixed therefor, and such sale may, without further notice,
be made at the time and place to which it was so adjourned. To the extent
permitted by law, each Grantor hereby waives any claims against the Collateral
Agent and the Lenders arising by reason of the fact that the price at which the
Collateral may have been sold at a private sale was less than the price which
might have been obtained at a public sale or was less than the aggregate amount
of the Secured Obligations, even if the Collateral Agent accepts the first
offer received and does not offer the Collateral to more than one offeree, and
waives all rights that such Grantor may have to require that all or any part of
the Collateral be marshaled upon any sale (public or private) thereof. Each
Grantor hereby acknowledges that (i) any such sale of the Collateral by
the Collateral Agent shall be made without warranty, (ii) the Collateral
Agent may specifically disclaim any warranties of title, possession, quiet
enjoyment or the like, (iii) the Collateral Agent may bid (which bid may
be, in whole or in part, in the form of cancellation of indebtedness), if
permitted by law, for the purchase, lease, license or other disposition of the Collateral
or any portion thereof for the account of the Collateral Agent (on behalf of
itself and the Lenders) and (iv) such actions set forth in clauses (i), (ii) and
(iii) above shall not adversely affect the commercial reasonableness of
any such sale of the Collateral. In addition to the foregoing, (i) upon
written notice to any Grantor from the Collateral Agent, each Grantor shall
cease any use of the Intellectual Property for any purpose described in such
notice; (ii) the Collateral Agent may, at any time and from time to time, upon
five (5) Business Days’ prior notice to any Grantor, license, whether
general, special or otherwise, and whether on an exclusive or non-exclusive
basis, any of the Intellectual Property, throughout the universe for such term
or terms, on such conditions, and in such manner, as the Collateral Agent shall
in its sole discretion determine; and (iii) the Collateral Agent may, at
any time, pursuant to the authority granted in Section 8 hereof (such
authority being effective upon the occurrence and during the continuance of an
Event of Default), execute and deliver on behalf of a Grantor, one or more
instruments of assignment of the Intellectual Property (or any application or
registration thereof), in form suitable for filing, recording or registration
in any country.

 

(b)           In the event that the Collateral Agent determines to
exercise its right to sell all or any part of the Pledged Interests pursuant to
Section 9(a) hereof, each Grantor will,

 

24

 

at such Grantor’s expense and upon request by the Collateral Agent: (i) execute
and deliver, and cause each issuer of such Pledged Interests and the directors
and officers thereof to execute and deliver, all such instruments and documents,
and do or cause to be done all such other acts and things, as may be necessary
or, in the opinion of the Collateral Agent, advisable to register such Pledged
Interests under the provisions of the Securities Act, and to cause the
registration statement relating thereto to become effective and to remain
effective for such period as prospectuses are required by law to be furnished, and
to make all amendments and supplements thereto and to the related prospectus
which, in the opinion of the Collateral Agent, are necessary or advisable, all
in conformity with the requirements of the Securities Act and the rules and
regulations of the SEC applicable thereto, (ii) cause each issuer of such
Pledged Interests to qualify such Pledged Interests under the state securities
or “Blue Sky” laws of each jurisdiction, and to obtain all necessary
governmental approvals for the sale of the Pledged Interests, as requested by
the Collateral Agent, (iii) cause each Pledged Issuer to make available to
its securityholders, as soon as practicable, an earnings statement which will
satisfy the provisions of Section 11(a) of the Securities Act, and
(iv) do or cause to be done all such other acts and things as may be
necessary to make such sale of such Pledged Interests valid and binding and in
compliance with applicable law.

 

(c)           Notwithstanding the provisions of Section 9(b) hereof,
each Grantor recognizes that the Collateral Agent may deem it impracticable to
effect a public sale of all or any part of the Pledged Shares or any other
securities constituting Pledged Interests and that the Collateral Agent may, therefore,
determine to make one or more private sales of any such securities to a
restricted group of purchasers who will be obligated to agree, among other
things, to acquire such securities for their own account, for investment and
not with a view to the distribution or resale thereof. Each Grantor
acknowledges that any such private sale may be at prices and on terms less
favorable to the seller than the prices and other terms which might have been
obtained at a public sale and, notwithstanding the foregoing, agrees that such
private sales shall be deemed to have been made in a commercially reasonable
manner and that the Collateral Agent shall have no obligation to delay the sale
of any such securities for the period of time necessary to permit the issuer of
such securities to register such securities for public sale under the
Securities Act. Each Grantor further acknowledges and agrees that any offer to
sell such securities which has been (i) publicly advertised on a bona fide
basis in a newspaper or other publication of general circulation in the
financial community of New York, New York (to the extent that such an offer may
be so advertised without prior registration under the Securities Act) or (ii) made
privately in the manner described above to not less than fifteen bona fide
offerees shall be deemed to involve a “public disposition” for the purposes of
Section 9-610(c) of the Code (or any successor or similar, applicable
statutory provision) as then in effect in the State of New York, notwithstanding
that such sale may not constitute a “public offering” under the Securities Act,
and that the Collateral Agent may, in such event, bid for the purchase of such
securities.

 

(d)           Any cash held by the Collateral Agent (or its agent or
designee) as Collateral and all Cash Proceeds received by the Collateral Agent
(or its agent or designee) in respect of any sale of or collection from, or
other realization upon, all or any part of the Collateral may, in the
discretion of the Collateral Agent, be held by the Collateral Agent (or

 

25

 

its agent or designee) as collateral for, and/or then or at any time
thereafter applied (after payment of any amounts payable to the Collateral
Agent pursuant to Section 10 hereof) in whole or in part by the Collateral
Agent against, all or any part of the Secured Obligations in such order as the
Collateral Agent shall elect, consistent with the provisions of the Credit
Agreement. Any surplus of such cash or Cash Proceeds held by the Collateral
Agent (or its agent or designee) and remaining after the date on which all of
the Secured Obligations have been indefeasibly paid in full in cash after the
termination of each Lender’s Revolving Credit Commitment and each of the Loan
Documents, shall be paid over to whomsoever shall be lawfully entitled to
receive the same or as a court of competent jurisdiction shall direct.

 

(e)             In the event that the proceeds of any such sale, collection
or realization are insufficient to pay all amounts to which the Collateral
Agent and the Lenders are legally entitled, the Grantors shall be jointly and
severally liable for the deficiency, together with interest thereon at the
highest rate specified in any applicable Loan Document for interest on overdue
principal thereof or such other rate as shall be fixed by applicable law, together
with the costs of collection and the reasonable fees, costs, expenses and other
client charges of any attorneys employed by the Collateral Agent to collect
such deficiency.

 

(f)              Each Grantor hereby acknowledges that if the Collateral
Agent complies with any applicable requirements of law in connection with a
disposition of the Collateral, such compliance will not adversely affect the
commercial reasonableness of any sale or other disposition of the Collateral.

 

(g)             The Collateral Agent shall not be required to marshal
any present or future collateral security (including, but not limited to, this
Agreement and the Collateral) for, or other assurances of payment of, the
Secured Obligations or any of them or to resort to such collateral security or
other assurances of payment in any particular order, and all of the Collateral
Agent’s rights hereunder and in respect of such collateral security and other
assurances of payment shall be cumulative and in addition to all other rights, however
existing or arising. To the extent that any Grantor lawfully may, such Grantor
hereby agrees that it will not invoke any law relating to the marshalling of
collateral which might cause delay in or impede the enforcement of the
Collateral Agent’s rights under this Agreement or under any other instrument
creating or evidencing any of the Secured Obligations or under which any of the
Secured Obligations is outstanding or by which any of the Secured Obligations
is secured or payment thereof is otherwise assured, and, to the extent that it
lawfully may, each Grantor hereby irrevocably waives the benefits of all such
laws.

 

10.           Indemnity and Expenses.

 

(a)           Each Grantor jointly and severally agrees to defend, protect,
indemnify and hold harmless each Agent and each other Indemnitee from and
against any and all claims, losses, damages, liabilities, obligations, penalties,
fees, reasonable out-of-pocket costs and expenses (including, without
limitation, reasonable out-of-pocket attorneys’ fees, costs, expenses and
disbursements, which will be limited to one primary counsel and, if necessary, one
local counsel per jurisdiction for the indemnified parties, unless a conflict
of

 

26

 

interest exists) incurred by such Agent or such Indemnitee to the
extent that they arise out of or otherwise result from or relate to or are in
connection with this Agreement (including, without limitation, enforcement of
this Agreement), except claims, losses or liabilities resulting from such
Agent’s or such Indemnitee’s gross negligence, willful misconduct or bad faith,
or material breach of the Loan Documents by such Agent or Indemnitee, in each
case as determined by a final judgment of a court of competent jurisdiction.

 

(b)           Each Grantor jointly and severally agrees to pay to the
Agents upon demand the amount of any and all reasonable costs and expenses, including
the reasonable fees, costs, expenses and disbursements of one primary counsel
and if necessary one local counsel per jurisdiction for the Agents and of any
experts and agents (including, without limitation, any collateral trustee which
may act as agent of the Agents), which the Agents may incur in connection with
(i) the preparation, negotiation, execution, delivery, recordation, administration,
amendment, waiver or other modification or termination of this Agreement, (ii) the
custody, preservation, use or operation of, or the sale of, collection from, or
other realization upon, any Collateral, (iii) the exercise or enforcement
of any of the rights of the Agents hereunder, or (iv) the failure by any
Grantor to perform or observe any of the provisions hereof.

 

11.           Notices, Etc. All notices and other
communications provided for hereunder shall be given in accordance with the
notice provision of the Credit Agreement.

 

12.           Security Interest Absolute; Joint and Several
Obligations.

 

(a)           All rights of the Secured Parties and the L/C Issuer, all
Liens and all obligations of each of the Grantors hereunder shall be absolute
and unconditional irrespective of (i) any lack of validity or
enforceability of the Credit Agreement or any other Loan Document, (ii) any
change in the time, manner or place of payment of, or in any other term in
respect of, all or any of the Secured Obligations, or any other amendment or
waiver of or consent to any departure from the Credit Agreement or any other
Loan Document, (iii) any exchange or release of, or non-perfection of any
Lien on any Collateral, or any release or amendment or waiver of or consent to
departure from any guaranty, for all or any of the Secured Obligations, or (iv) any
other circumstance that might otherwise constitute a defense available to, or a
discharge of, any of the Grantors in respect of the Secured Obligations. All
authorizations and agencies contained herein with respect to any of the
Collateral are irrevocable and powers coupled with an interest.

 

(b)             Each Grantor hereby waives, to the extent permitted by
law, (i) promptness and diligence, (ii) notice of acceptance and
notice of the incurrence of any Obligation by the Borrower, (iii) notice
of any actions taken by any Agent, any Lender, any Guarantor or any other
Person under any Loan Document or any other agreement, document or instrument
relating thereto, (iv) all other notices, demands and protests, and all
other formalities of every kind in connection with the enforcement of the
Obligations, the omission of or delay in which, but for the provisions of this
subsection (b), might constitute grounds for relieving such Grantor of any such
Grantor’s obligations hereunder and (v) any

 

27

 

requirement that any Agent or any Lender protect, secure, perfect or
insure any security interest or other lien on any property subject thereto or
exhaust any right or take any action against any Grantor or any other Person or
any collateral.

 

(c)           All of the obligations of the Grantors hereunder are joint
and several. The Collateral Agent may, in its sole and absolute discretion, enforce
the provisions hereof against any of the Grantors and shall not be required to
proceed against all Grantors jointly or seek payment from the Grantors ratably.
In addition, the Collateral Agent may, in its sole and absolute discretion, select
the Collateral of any one or more of the Grantors for sale or application to
the Secured Obligations, without regard to the ownership of such Collateral, and
shall not be required to make such selection ratably from the Collateral owned
by all of the Grantors. The release or discharge of any Grantor by the
Collateral Agent shall not release or discharge any other Grantor from the
obligations of such Person hereunder.

 

13.           Miscellaneous.

 

(a)           No amendment of any provision of this Agreement (including
any Schedule attached hereto) shall be effective unless it is in writing and
signed by each Grantor affected thereby and the Collateral Agent, and no waiver
of any provision of this Agreement, and no consent to any departure by any
Grantor therefrom, shall be effective unless it is in writing and signed by the
Collateral Agent, and then such waiver or consent shall be effective only in
the specific instance and for the specific purpose for which given.

 

(b)           No failure on the part of the Secured Parties or the L/C
Issuer to exercise, and no delay in exercising, any right hereunder or under
any other Loan Document shall operate as a waiver thereof; nor shall any single
or partial exercise of any such right preclude any other or further exercise
thereof or the exercise of any other right. The rights and remedies of the
Secured Parties and the L/C Issuer provided herein and in the other Loan
Documents are cumulative and are in addition to, and not exclusive of, any
rights or remedies provided by law. The rights of the Secured Parties and the
L/C Issuer under any Loan Document against any party thereto are not
conditional or contingent on any attempt by such Person to exercise any of its
rights under any other Loan Document against such party or against any other
Person, including but not limited to, any Grantor.

 

(c)           This Agreement shall create a continuing security interest
in the Collateral and shall (i) remain in full force and effect, subject
to paragraph (e) below, until the date on which all of the Secured
Obligations have been indefeasibly paid in full (other than Contingent
Indemnification Obligations) in cash after the termination of each Lender’s
Revolving Credit Commitment and each of the Loan Documents and (ii) be
binding on each Grantor all other Persons who become bound as debtor to this
Agreement in accordance with Section 9-203(d) of the Code, and shall
inure, together with all rights and remedies of the Secured Parties and the L/C
Issuer hereunder, to the benefit of the Secured Parties and the L/C Issuer and
their respective successors, transferees and assigns. Without limiting the
generality of clause (ii) of the immediately preceding sentence, the
Secured Parties and the L/C Issuer may assign or otherwise transfer their
respective rights and obligations under this

 

28

 

Agreement and any other Loan Document to any other Person pursuant to
the terms of the Credit Agreement, and such other Person shall thereupon become
vested with all of the benefits in respect thereof granted to the Secured
Parties and the L/C Issuer herein or otherwise. Upon any such assignment or
transfer, all references in this Agreement to any Secured Party or the L/C Issuer
shall mean the assignee of any such Secured Party or such L/C Issuer. Except to
the extent expressly permitted by the Credit Agreement, none of the rights or
obligations of any Grantor hereunder may be assigned or otherwise transferred
without the prior written consent of the Collateral Agent, and any such
assignment or transfer shall be null and void.

 

(d)           Upon the date on which all of the Secured Obligations have
been indefeasibly paid in full in cash (other than Contingent Indemnification
Obligations) after the termination of each Lender’s Revolving Credit Commitment
and each of the Loan Documents, (i) subject to paragraph (e) below, this
Agreement and the security interests and licenses created hereby shall
terminate and all rights to the Collateral shall revert to the Grantors and
(ii) the Collateral Agent will, upon the Grantors’ request and at the
Grantors’ expense, without any representation, warranty or recourse whatsoever,
(A) return to the Grantors (or whomsoever shall be lawfully entitled to
receive the same or as a court of competent jurisdiction shall direct) such of
the Collateral as shall not have been sold or otherwise disposed of or applied
pursuant to the terms hereof and (B) execute and deliver to the Grantors
such documents as the Grantors shall reasonably request to evidence such
termination. In addition, upon the incurrence or assumption of Indebtedness by
a Grantor in a transaction permitted by clause (e) of the definition of
Permitted Liens and Section 7.02(b), upon the Grantors’ request and at the
Grantors’ expense, without any representation, warranty or recourse whatsoever,
the Collateral Agent agrees to execute and deliver to the Grantors such
documents as the Grantors shall reasonably request to evidence the release of
the Collateral Agent’s security interest in the items of property that are the
subject of such transaction.

 

(e)           This Agreement shall remain in full force and effect and
continue to be effective should any petition be filed by or against any Grantor
for liquidation or reorganization, should any Grantor become insolvent or make
an assignment for the benefit of any creditor or creditors or should a receiver
or trustee be appointed for all or any significant part of any Grantor’s assets,
and shall continue to be effective or be reinstated, as the case may be, if at
any time payment or performance of the Secured Obligations, or any part thereof,
is, pursuant to applicable law, rescinded or reduced in amount, or must
otherwise be restored or returned by any obligee of the Secured Obligations, whether
as a “voidable preference,” “fraudulent conveyance,” or otherwise, all as
though such payment or performance had not been made. In the event that any
payment, or any part thereof, is rescinded, reduced, restored or returned, the
Secured Obligations shall be reinstated and deemed reduced only by such amount
paid and not so rescinded, reduced, restored or returned.

 

(f)            Upon the execution and delivery, or authentication, by
any Person of a security agreement supplement in substantially the form of Exhibit C
hereto (each a

 

29

 

“Security Agreement Supplement”), (i) such Person shall be
referred to as an “Additional Grantor” and shall be and become a
Grantor, and each reference in this Agreement to “Grantor” shall also mean and
be a reference to such Additional Grantor, and each reference in this Agreement
and the other Loan Documents to “Collateral” shall also mean and be a reference
to the Collateral of such Additional Grantor, and (ii) the supplemental Schedules
I-VIII attached to each Security Agreement Supplement shall be incorporated
into and become a part of and supplement Schedules I-VIII, respectively,
hereto, and the Collateral Agent may attach such Schedules as supplements to
such Schedules, and each reference to such Schedules shall mean and be a
reference to such Schedules, as supplemented pursuant hereto.

 

(g)           THIS AGREEMENT SHALL BE GOVERNED BY,
CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK,
EXCEPT AS REQUIRED BY MANDATORY PROVISIONS OF LAW AND EXCEPT TO THE EXTENT THAT
THE VALIDITY AND PERFECTION OR THE PERFECTION AND THE EFFECT OF PERFECTION OR
NON-PERFECTION OF THE SECURITY INTEREST CREATED HEREBY, OR REMEDIES
HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED BY THE LAW
OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK.

 

(h)           In addition to and without limitation of any of the
foregoing, this Agreement shall be deemed to be a Loan Document and shall
otherwise be subject to all of terms and conditions contained in Sections 12.10
and 12.11 of the Credit Agreement, mutatis mutandi.

 

(i)            Each Grantor irrevocably and unconditionally waives any
right it may have to claim or recover in any legal action, suit or proceeding
with respect to this Agreement any special, exemplary, punitive or
consequential damages.

 

(j)            Any provision of this Agreement which is prohibited or
unenforceable in any jurisdiction shall, as to such jurisdiction, be
ineffective to the extent of such prohibition or unenforceability without
invalidating the remaining portions hereof or thereof or affecting the validity
or enforceability of such provision in any other jurisdiction.

 

(k)           Section headings herein are included for convenience
of reference only and shall not constitute a part of this Agreement for any
other purpose.

 

(l)            This Agreement may be executed in any number of
counterparts and by the different parties hereto on separate counterparts, each
of which shall be deemed an original, but all of such counterparts taken
together shall constitute one and the same agreement. Delivery of an executed
counterpart of this Agreement by facsimile or electronic mail shall be equally
effective as delivery of an original executed counterpart.

 

[REMAINDER
OF THIS PAGE INTENTIONALLY LEFT BLANK]

 

30

 

IN WITNESS WHEREOF, each Grantor has caused this
Agreement to be executed and delivered by its officer thereunto duly
authorized, as of the date first above written.

 

 

	
   

  	
  GRANTORS:

  
	
   

  	
   

  
	
   

  	
  LANTHEUS MEDICAL IMAGING, INC.

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Donald Kiepert

  
	
   

  	
  Name: Donald Kiepert

  
	
   

  	
  Title: President and Chief Executive Officer

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  LANTHEUS MI INTERMEDIATE, INC. 

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Donald Kiepert

  
	
   

  	
  Name: Donald Kiepert

  
	
   

  	
  Title: President and Chief Executive Officer

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  LANTHEUS MI REAL ESTATE, LLC

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  Lantheus Medical Imaging, Inc., its sole member

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
  /s/ Donald Kiepert

  
	
   

  	
   

  	
  Name: Donald Kiepert

  
	
   

  	
   

  	
  Title: President and Chief Executive Officer

  

 

Signature Page to Pledge and
Security Agreement

 

 

SCHEDULE
I

 

LEGAL
NAMES; ORGANIZATIONAL IDENTIFICATION NUMBERS; STATES OR JURISDICTIONS OF
ORGANIZATION; TYPE OF ORGANIZATION; FEDERAL EMPLOYER IDENTIFICATION NUMBER

 

	
   

  	
   

  	
  Organizational

  	
   

  	
  State/Jurisdiction

  	
   

  	
  Type
  of

  	
   

  	
   

  
	
  Company Name

  	
   

  	
  ID
  Number

  	
   

  	
  of
  Organization

  	
   

  	
  Organization

  	
   

  	
  FEIN

  
	
  Lantheus
  Medical Imaging, Inc.

  	
   

  	
  3098309

  	
   

  	
  Delaware

  	
   

  	
  Corporation

  	
   

  	
  51-0396366

  
	
  Lantheus
  MI Intermediate, Inc.

  	
   

  	
  4465403

  	
   

  	
  Delaware

  	
   

  	
  Corporation

  	
   

  	
  32-0225450

  
	
  Lantheus
  MI Real Estate, LLC

  	
   

  	
  4469098

  	
   

  	
  Delaware

  	
   

  	
  Limited
  Liability Company

  	
   

  	
  61-1549164

  

 

1

 

SCHEDULE
II

 

INTELLECTUAL
PROPERTY

 

A.            COPYRIGHTS

None

 

B.            PATENTS

See
attached

 

C.            TRADEMARKS

See
attached

 

D.            LEGAL NAMES
USED BY ANY GRANTOR DURING THE PAST FIVE YEARS

 

	
  Current Name

  	
   

  	
  Former Name

  
	
  Lantheus
  Medical Imaging, Inc..

  	
   

  	
  Bristol-Myers
  Squibb Imaging, Inc..

  
	
  Lantheus
  MI Intermediate, Inc.

  	
   

  	
  ACP
  Lantern Intermediate Holdings, Inc.

  
	
  Lantheus
  MI Real Estate, LLC

  	
   

  	
  ACP
  Lantern Real Estate, LLC

  

 

1

 

Patents and
Patent Applications

 

	
  Country

  	
   

  	
  Title

  	
   

  	
  Application No.

  	
   

  	
  Filing Date

  	
   

  	
  Patent No.

  	
   

  	
  Issue Date

  	
   

  	
  Status

  
	
  USA

  	
   

  	
  ESTER-SUBSTITUTED
  DIAMINEDITHIOLS AND RADIOLABELED COMPLEXES THEREOF

  	
   

  	
  08/139894

  	
   

  	
  20-Oct-93

  	
   

  	
  5431900

  	
   

  	
  11-Jul-95

  	
   

  	
  Granted

  
	
  Argentina 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  P990100124

  	
   

  	
  15-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Australia 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  21155/99

  	
   

  	
  14-Jan-99

  	
   

  	
  746067

  	
   

  	
  25-Jul-02

  	
   

  	
  Granted

  
	
  Australia 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  2006200015

  	
   

  	
  14-Jan-99

  	
   

  	
  2006200015

  	
   

  	
  8-May-08

  	
   

  	
  Granted

  
	
  Brazil 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  PI9907066-9

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  2317921

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Chile 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  54-1999

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  China 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  99802102.4

  	
   

  	
  14-Jan-99

  	
   

  	
  ZL
  99802102.4

  	
   

  	
  9-Mar-05

  	
   

  	
  Granted

  
	
  Europe 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  04075388.1

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Granted

  
	
  Hong Kong 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  04107194.5

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Hungary 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  P0100206

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Israel 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  137018

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Japan 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  2000-539875

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Korea 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  10-2000-7007716

  	
   

  	
  14-Jan-99

  	
   

  	
  10-0711663

  	
   

  	
  19-Apr-07

  	
   

  	
  Granted

  
	
  Mexico 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  006299

  	
   

  	
  14-Jan-99

  	
   

  	
  265347

  	
   

  	
  23-Mar-09

  	
   

  	
  Granted

  
	
  Norway 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  20003471

  	
   

  	
  14-Jan-99

  	
   

  	
  321866

  	
   

  	
  16-Jul-06

  	
   

  	
  Granted

  
	
  New Zealand 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  505082

  	
   

  	
  14-Jan-99

  	
   

  	
  505082

  	
   

  	
  3-Mar-03

  	
   

  	
  Granted

  
	
  Philippines 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  11999000083

  	
   

  	
  14-Jan-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Russia 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  200000765

  	
   

  	
  14-Jan-99

  	
   

  	
  /002978

  	
   

  	
  26-Dec-02

  	
   

  	
  Granted

  
	
  Poland 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  P342473

  	
   

  	
  14-Jan-99

  	
   

  	
  193672

  	
   

  	
  5-Feb-08

  	
   

  	
  Granted

  
	
  Singapore 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND 

  	
   

  	
  200003772-1

  	
   

  	
  14-Jan-99

  	
   

  	
  74468
  [WO 99/36104]

  	
   

  	
  31-Jul-02

  	
   

  	
  Granted

  
	
  Slovakia 

  	
   

  	
  PREPARATION OF A LIPID BLEND
  AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS
  BASED ON THESE 

  	
   

  	
  PV1031-2000S

  	
   

  	
  14-Jan-99

  	
   

  	
  285333

  	
   

  	
  6-Sep-06

  	
   

  	
  Granted

  
	
  Taiwan 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  088100521

  	
   

  	
  22-Feb-99

  	
   

  	
  I242448

  	
   

  	
  1-Nov-05

  	
   

  	
  Granted

  
	
  USA 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  10/667931

  	
   

  	
  22-Sep-03

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  South Africa 

  	
   

  	
  PREPARATION OF A LIPID
  BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST
  AGENTS BASED ON THESE 

  	
   

  	
  99/0247

  	
   

  	
  14-Jan-99

  	
   

  	
  99/0247

  	
   

  	
  27-Sep-00

  	
   

  	
  Granted

  
	
  Australia 

  	
   

  	
  APPARATUS AND METHODS FOR
  ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL 

  	
   

  	
  2002243807

  	
   

  	
  1-Feb-02

  	
   

  	
  2002243807

  	
   

  	
  7-Jun-07

  	
   

  	
  Granted

  
	
  Canada 

  	
   

  	
  APPARATUS AND METHODS FOR
  ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL 

  	
   

  	
  2437217

  	
   

  	
  1-Feb-02

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  Confidential

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  5/7/2010

  

 

1

 

	
  Europe

  	
   

  	
  APPARATUS AND METHODS FOR
  ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL

  	
   

  	
  02709316.0

  	
   

  	
  1-Feb-02

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Norway

  	
   

  	
  APPARATUS AND METHODS FOR
  ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL

  	
   

  	
  20033435

  	
   

  	
  1-Feb-02

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  APPARATUS AND METHODS FOR
  ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL

  	
   

  	
  10/062206

  	
   

  	
  1-Feb-02

  	
   

  	
  6943692

  	
   

  	
  13-Sep-05

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  LIPOSOMES AS CONTRAST
  AGENTS FOR ULTRASONIC IMAGING

  	
   

  	
  2069759

  	
   

  	
  19-Dec-90

  	
   

  	
  2069759

  	
   

  	
  16-Jan-07

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  LIPOSOMES AS CONTRAST
  AGENTS FOR ULTRASONIC IMAGING

  	
   

  	
  503276/91

  	
   

  	
  19-Dec-90

  	
   

  	
  3309356

  	
   

  	
  24-May-02

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LIPOSOMES AS CONTRAST
  AGENTS FOR ULTRASONIC IMAGING AND METHODS FOR PREPARING THE SAME

  	
   

  	
  07/818069

  	
   

  	
  8-Jan-92

  	
   

  	
  5230882

  	
   

  	
  27-Jul-93

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IONOPHORE CONTAINING
  LIPOSOMERS FOR ULTRASOUND IMAGING

  	
   

  	
  07/967974

  	
   

  	
  27-Oct-92

  	
   

  	
  5352435

  	
   

  	
  4-Oct-94

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LIPOSOMES AS CONTRAST
  AGENTS FOR ULTRASONIC IMAGING

  	
   

  	
  08/395683

  	
   

  	
  28-Feb-95

  	
   

  	
  5456901

  	
   

  	
  10-Oct-95

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  NOVEL THERAPEUTIC DELIVERY
  SYSTEMS RELATED APPLICATIONS

  	
   

  	
  08/160232

  	
   

  	
  30-Nov-93

  	
   

  	
  5542935

  	
   

  	
  6-Aug-96

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  ATE203148
  T2

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  GAS FILLED LIPOSOMES AND THEIR
  USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  20020/92

  	
   

  	
  31-Mar-92

  	
   

  	
  667471

  	
   

  	
  13-Aug-96

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  2110491

  	
   

  	
  31-Mar-92

  	
   

  	
  2110491

  	
   

  	
  24-Jul-07

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  69231950.6-08

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  35846
  BE/2004

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  500847/93

  	
   

  	
  31-Mar-92

  	
   

  	
  3456584

  	
   

  	
  1-Aug-03

  	
   

  	
  Granted

  
	
  Liechtenstein

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  GAS FILLED LIPOSOMES AND THEIR
  USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  Sweden

  	
   

  	
  GAS FILLED LIPOSOMES AND THEIR
  USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  92912456.8

  	
   

  	
  31-Mar-92

  	
   

  	
  0616508

  	
   

  	
  18-Jul-01

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  07/717084

  	
   

  	
  18-Jun-91

  	
   

  	
  5228446

  	
   

  	
  20-Jul-93

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  08/017683

  	
   

  	
  12-Feb-93

  	
   

  	
  5305757

  	
   

  	
  26-Apr-94

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  08/088268

  	
   

  	
  7-Jul-93

  	
   

  	
  5348016

  	
   

  	
  20-Sep-94

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  GAS FILLED LIPOSOMES AND
  THEIR USE AS ULTRASONIC CONTRAST AGENTS

  	
   

  	
  08/199462

  	
   

  	
  22-Feb-94

  	
   

  	
  5769080

  	
   

  	
  23-Jun-98

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  ATE233574
  T1

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  70431/94

  	
   

  	
  20-May-94

  	
   

  	
  683900

  	
   

  	
  6-Aug-98

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  56271/98

  	
   

  	
  24-Feb-98

  	
   

  	
  713127

  	
   

  	
  9-Mar-00

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Brazil

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  PI1100994-2

  	
   

  	
  14-May-97

  	
   

  	
  PI1100994-2

  	
   

  	
  7-Dec-99

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  2164845

  	
   

  	
  20-May-94

  	
   

  	
  2164845

  	
   

  	
  29-Apr-08

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  China

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94192402.5

  	
   

  	
  20-May-94

  	
   

  	
  ZL94192402.5

  	
   

  	
  19-Oct-03

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  69432219.9-08

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Europe

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  

 

2

 

	
  Spain

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  France

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Hong Kong

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  99105053.5

  	
   

  	
  20-Feb-04

  	
   

  	
  HK1028943

  	
   

  	
  14-May-04

  	
   

  	
  Granted

  
	
  Ireland

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Italy

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  24556
  BE/2003

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Japan

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  501839/95

  	
   

  	
  20-May-94

  	
   

  	
  4274387

  	
   

  	
  13-Mar-09

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  2007-190697

  	
   

  	
  23-Jul-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Liechtenstein

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Netherlands

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Portugal

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  Sweden

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  94919208.2

  	
   

  	
  20-May-94

  	
   

  	
  0712293

  	
   

  	
  5-Mar-03

  	
   

  	
  Granted
  - SPC

  
	
  USA

  	
   

  	
  METHODS OF PREPARING GAS
  AND GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  08/159687

  	
   

  	
  30-Nov-93

  	
   

  	
  5585112

  	
   

  	
  17-Dec-96

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  METHODS OF PREPARING
  GASEOUS PRECURSOR-FILLED MICROSPHERES

  	
   

  	
  08/487230

  	
   

  	
  6-Jun-95

  	
   

  	
  5853752

  	
   

  	
  29-Dec-98

  	
   

  	
  Granted

  
	
  Argentina

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  P960101458

  	
   

  	
  21-Feb-96

  	
   

  	
  AR003110B1

  	
   

  	
  28-Dec-05

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  31465/95

  	
   

  	
  26-Jul-95

  	
   

  	
  708341

  	
   

  	
  18-Nov-99

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  2200061

  	
   

  	
  26-Jul-95

  	
   

  	
  2200061

  	
   

  	
  10-Apr-07

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Chile

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  217-1996

  	
   

  	
  15-Feb-96

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  China

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95195094.0

  	
   

  	
  26-Jul-95

  	
   

  	
  ZL95195094.0

  	
   

  	
  8-Jan-03

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  69533261.9-08

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  04076135.5

  	
   

  	
  26-Jul-95

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  

 

3

 

	
  Ireland

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  0788348

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  95927429.1

  	
   

  	
  26-Jul-95

  	
   

  	
  31278
  BE/2004

  	
   

  	
  14-Jul-04

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  510174/96

  	
   

  	
  26-Jul-95

  	
   

  	
  4004063

  	
   

  	
  31-Aug-07

  	
   

  	
  Granted

  
	
  Mexico

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  PA/a/1997/001969

  	
   

  	
  26-Jul-95

  	
   

  	
  210448

  	
   

  	
  25-Sep-02

  	
   

  	
  Granted

  
	
  Mexico

  	
   

  	
  CONTAINER WITH MULTI-PHASE
  COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS

  	
   

  	
  PA/a/2002/006115

  	
   

  	
  19-Jun-02

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  NOVEL COMPOSITIONS OF
  LIPIDS AND STABILIZING MATERIALS

  	
   

  	
  08/417238

  	
   

  	
  5-Apr-95

  	
   

  	
  5705187

  	
   

  	
  6-Jan-98

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  75947/96

  	
   

  	
  6-Jun-96

  	
   

  	
  703846

  	
   

  	
  15-Jul-99

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  2218860

  	
   

  	
  6-Jun-96

  	
   

  	
  2218860

  	
   

  	
  5-Dec-06

  	
   

  	
  Granted

  
	
  China

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96194425.0

  	
   

  	
  6-Jun-96

  	
   

  	
  ZL96194425.0

  	
   

  	
  5-Oct-05

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  Hong Kong

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  98111007.1

  	
   

  	
  28-Sep-98

  	
   

  	
  1010127

  	
   

  	
  4-May-06

  	
   

  	
  Granted

  
	
  Ireland

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  96938613.5

  	
   

  	
  6-Jun-96

  	
   

  	
  0840570

  	
   

  	
  13-Aug-03

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  503846/97

  	
   

  	
  6-Jun-96

  	
   

  	
  3645909

  	
   

  	
  10-Feb-05

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  APPARATUS AND METHOD FOR
  MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE

  	
   

  	
  08/482294

  	
   

  	
  7-Jun-95

  	
   

  	
  5656211

  	
   

  	
  12-Aug-97

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  ATE227960

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Ireland

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  20774
  BE/2003

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Liechtenstein

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Portugal

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  Sweden

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  94919184.5

  	
   

  	
  19-May-94

  	
   

  	
  0711127

  	
   

  	
  20-Nov-02

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  08/076239

  	
   

  	
  11-Jun-93

  	
   

  	
  5469854

  	
   

  	
  28-Nov-95

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  METHODS OF PREPARING
  GAS-FILLED LIPOSOMES

  	
   

  	
  08/471250

  	
   

  	
  6-Jun-95

  	
   

  	
  5715824

  	
   

  	
  10-Feb-98

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  17442/92

  	
   

  	
  18-Mar-92

  	
   

  	
  660676

  	
   

  	
  14-Nov-95

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  33103/95

  	
   

  	
  18-Mar-92

  	
   

  	
  698209

  	
   

  	
  2-May-02

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  14280/99

  	
   

  	
  18-Mar-92

  	
   

  	
  740155

  	
   

  	
  14-Feb-02

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Brazil

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  PI1100619-6

  	
   

  	
  13-May-97

  	
   

  	
  PI1100619-6

  	
   

  	
  1-Aug-00

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  2107466

  	
   

  	
  18-Mar-92

  	
   

  	
  2107466

  	
   

  	
  3-Jul-01

  	
   

  	
  Granted

  

 

4

 

	
  Switzerland

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  69229342.6

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  509585/92

  	
   

  	
  18-Mar-92

  	
   

  	
  3518548

  	
   

  	
  6-Feb-04

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  2002-339373

  	
   

  	
  18-Mar-92

  	
   

  	
  3888684

  	
   

  	
  8-Dec-06

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  92910021.2

  	
   

  	
  18-Mar-92

  	
   

  	
  0580726

  	
   

  	
  2-Jun-99

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  07/680984

  	
   

  	
  5-Apr-91

  	
   

  	
  5205290

  	
   

  	
  27-Apr-93

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  07/980594

  	
   

  	
  19-Jan-93

  	
   

  	
  5281408

  	
   

  	
  25-Jan-94

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  08/116982
  have C of C

  	
   

  	
   7-Sep-93

  	
   

  	
  5456900

  	
   

  	
  10-Oct-95

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  08/449090

  	
   

  	
  24-May-95

  	
   

  	
  5547656

  	
   

  	
  20-Aug-96

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY, AND IN OTHER
  APPLICATIONS

  	
   

  	
  90/004720

  	
   

  	
  8-Aug-97

  	
   

  	
  5547656

  	
   

  	
  3-Oct-00

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  08/456738

  	
   

  	
  1-Jun-95

  	
   

  	
  5527521

  	
   

  	
  18-Jun-96

  	
   

  	
  Granted
  (PTE)

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY AND IN OTHER
  APPLICATIONS

  	
   

  	
  08/878233

  	
   

  	
  18-Jun-97

  	
   

  	
  6528039

  	
   

  	
  4-Mar-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  10/280844

  	
   

  	
  25-Oct-02

  	
   

  	
  6773696

  	
   

  	
  10-Aug-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  10/864965

  	
   

  	
  10-Jun-04

  	
   

  	
  6998107

  	
   

  	
  14-Feb-06

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERE
  AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY

  	
   

  	
  11/252659

  	
   

  	
  18-Oct-05

  	
   

  	
  7344705

  	
   

  	
  18-Mar-08

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  COMPOSITION COMPRISING LOW
  DENSITY MICROSPHERES

  	
   

  	
  12/014154

  	
   

  	
  15-Jan-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  USA

  	
   

  	
  LOW DENSITY MICROSPHERES
  AND SUSPENSIONS AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY AND
  IN OTHER APPLICATIONS

  	
   

  	
  90/004719

  	
   

  	
  8-Aug-97

  	
   

  	
  5527521

  	
   

  	
  9-Nov-99

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  3313197

  	
   

  	
  16-Jun-97

  	
   

  	
  733492

  	
   

  	
  30-Aug-01

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  6188501

  	
   

  	
  16-Jun-97

  	
   

  	
  774666

  	
   

  	
  14-Oct-04

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  2256592

  	
   

  	
  16-Jun-97

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Germany

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  97928998.0

  	
   

  	
  16-Jun-97

  	
   

  	
  0930844

  	
   

  	
  3-Sep-08

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  97928998.0

  	
   

  	
  16-Jun-97

  	
   

  	
  0930844

  	
   

  	
  3-Sep-08

  	
   

  	
  Granted

  

 

5

 

	
  France

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  97928998.0

  	
   

  	
  16-Jun-97

  	
   

  	
  0930844

  	
   

  	
  3-Sep-08

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  97928998.0

  	
   

  	
  16-Jun-97

  	
   

  	
  0930844

  	
   

  	
  3-Sep-08

  	
   

  	
  Granted

  
	
  Hong Kong

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  99104828.2

  	
   

  	
  16-Jun-97

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  97928998.0

  	
   

  	
  16-Jun-97

  	
   

  	
  0930844

  	
   

  	
  3-Sep-08

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT

  	
   

  	
  08/666129

  	
   

  	
  19-Jun-96

  	
   

  	
  6033645

  	
   

  	
  7-Mar-00

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMPROVED METHODS FOR
  ULTRASOUND IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND MULTIPLE IMAGES
  AND PROCESSING OF SAME

  	
   

  	
  08/982829

  	
   

  	
  2-Dec-97

  	
   

  	
  6231834

  	
   

  	
  15-May-01

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  40898/97

  	
   

  	
  26-Aug-97

  	
   

  	
  732813

  	
   

  	
  16-Aug-01

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  2263924

  	
   

  	
  26-Aug-97

  	
   

  	
  2263924

  	
   

  	
  18-Nov-08

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  97938609.1

  	
   

  	
  26-Aug-97

  	
   

  	
  1017425

  	
   

  	
  17-Oct-07

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  97938609.1

  	
   

  	
  26-Aug-97

  	
   

  	
  1017425

  	
   

  	
  17-Oct-07

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  97938609.1

  	
   

  	
  26-Aug-97

  	
   

  	
  1017425

  	
   

  	
  17-Oct-07

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  97938609.1

  	
   

  	
  26-Aug-97

  	
   

  	
  1017425

  	
   

  	
  17-Oct-07

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  97938609.1

  	
   

  	
  26-Aug-97

  	
   

  	
  19026
  BE/2008

  	
   

  	
  17-Oct-07

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY
  VASODILATOR

  	
   

  	
  09/573265

  	
   

  	
  18-May-00

  	
   

  	
  6884407

  	
   

  	
  26-Apr-05

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  42356/97

  	
   

  	
  26-Aug-97

  	
   

  	
  736056

  	
   

  	
  8-Nov-01

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  2263568

  	
   

  	
  26-Aug-97

  	
   

  	
  2263568

  	
   

  	
  2-Dec-08

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  69718519.2-08

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  69738223.0-08

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  

 

6

 

	
  Spain

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Finland

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Finland

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Hong Kong

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  00104933.2

  	
   

  	
  26-Aug-97

  	
   

  	
  HK1026139

  	
   

  	
  23-May-03

  	
   

  	
  Granted

  
	
  Hong Kong

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03106479.4

  	
   

  	
  26-Aug-97

  	
   

  	
  HK1062802

  	
   

  	
  14-Mar-08

  	
   

  	
  Granted

  
	
  Ireland

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  23096
  BE/2003

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  31735
  BE/2007

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  513669/98

  	
   

  	
  26-Aug-97

  	
   

  	
  4139440

  	
   

  	
  13-Jun-08

  	
   

  	
  Granted

  
	
  Liechtenstein

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Liechtenstein

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  Sweden

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  97940615.4

  	
   

  	
  26-Aug-97

  	
   

  	
  0977597

  	
   

  	
  15-Jan-03

  	
   

  	
  Granted

  
	
  Sweden

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  03000267.9

  	
   

  	
  26-Aug-97

  	
   

  	
  1323434

  	
   

  	
  11-Jul-07

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  08/790550

  	
   

  	
  30-Jan-97

  	
   

  	
  5846517

  	
   

  	
  8-Dec-98

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMPROVED METHODS FOR
  DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR

  	
   

  	
  09/143304

  	
   

  	
  28-Aug-98

  	
   

  	
  6071494

  	
   

  	
  6-Jun-00

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  NOVEL CATIONIC LIPIDS AND
  THE USE THEREOF

  	
   

  	
  08/391938

  	
   

  	
  21-Feb-95

  	
   

  	
  5830430

  	
   

  	
  3-Nov-98

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  NOVEL CATIONIC LIPIDS AND
  THE USE THEREOF

  	
   

  	
  09/073181

  	
   

  	
  5-May-98

  	
   

  	
  6056938

  	
   

  	
  2-May-00

  	
   

  	
  Granted

  
	
  USA 

  	
   

  	
  PREPARATION OF
  PARAMAGNETIC NANOPARTICLES CONJUGATED TO LEUKOTRIENE B4 (LTB 4) RECEPTOR
  ANTAGONISTS AND THEIR USE AS MRI CONTRAST AGENTS FOR THE DETECTION OF
  INFECTION AND INFLAMMATION 

  	
   

  	
  11/959569
  

  	
   

  	
  19-Dec-07
  

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending
  

  
	
  Canada

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST COMPOUNDS AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALS

  	
   

  	
  2525396

  	
   

  	
  12-May-04

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
   

  	
   

  	
  12/713890

  	
   

  	
  26-Feb-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  NOVEL INTEGRIN RECEPTOR
  ANTAGONISTS

  	
   

  	
  08/980016

  	
   

  	
  26-Nov-97

  	
   

  	
  6130231

  	
   

  	
  10-Oct-00

  	
   

  	
  Granted

  

 

7

 

	
  USA

  	
   

  	
  INTEGRIN RECEPTOR
  ANTAGONISTS

  	
   

  	
  09/510379

  	
   

  	
  22-Feb-00

  	
   

  	
  6358976

  	
   

  	
  19-Mar-02

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  2324555

  	
   

  	
  29-Mar-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Germany

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  69925262.8-08

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  Ireland

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  28490
  BE/2005

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  2000-548013

  	
   

  	
  29-Mar-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Luxembourg

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  99941944.3

  	
   

  	
  29-Mar-99

  	
   

  	
  1068224

  	
   

  	
  11-May-05

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  09/599295

  	
   

  	
  21-Jun-00

  	
   

  	
  6537520

  	
   

  	
  25-Mar-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  10/342081

  	
   

  	
  14-Jan-03

  	
   

  	
  6800273

  	
   

  	
  5-Oct-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  PHARMACEUTICALS FOR THE
  IMAGING OF ANGIOGENIC DISORDERS

  	
   

  	
  10/622246

  	
   

  	
  18-Jul-03

  	
   

  	
  7052673

  	
   

  	
  30-May-06

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  2412854

  	
   

  	
  21-Jun-01

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Germany

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  01952180.6

  	
   

  	
  21-Jun-01

  	
   

  	
  1307226

  	
   

  	
  19-Nov-08

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  01952180.6

  	
   

  	
  21-Jun-01

  	
   

  	
  1307226

  	
   

  	
  19-Nov-08

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  01952180.6

  	
   

  	
  21-Jun-01

  	
   

  	
  1307226

  	
   

  	
  19-Nov-08

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  01952180.6

  	
   

  	
  21-Jun-01

  	
   

  	
  1307226

  	
   

  	
  19-Nov-08

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  2349501

  	
   

  	
  17-Dec-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  QUINOLONE VITRONECTIN
  RECEPTOR ANTAGONIST PHARMACEUTICALS

  	
   

  	
  09/281209

  	
   

  	
  30-Mar-99

  	
   

  	
  6524553

  	
   

  	
  25-Feb-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  09/465300

  	
   

  	
  17-Dec-99

  	
   

  	
  6511648

  	
   

  	
  28-Jan-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  09/948807

  	
   

  	
  7-Sep-01

  	
   

  	
  6683163

  	
   

  	
  27-Jan-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR ANTAGONIST
  PHARMACEUTICALS

  	
   

  	
  09/948390

  	
   

  	
  7-Sep-01

  	
   

  	
  6689337

  	
   

  	
  10-Feb-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  09/947783

  	
   

  	
  7-Sep-01

  	
   

  	
  6743412

  	
   

  	
  1-Jun-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  09/599364

  	
   

  	
  21-Jun-00

  	
   

  	
  6511649

  	
   

  	
  28-Jan-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  VITRONECTIN RECEPTOR
  ANTAGONIST PHARMACEUTICALS

  	
   

  	
  10/281015

  	
   

  	
  26-Oct-02

  	
   

  	
  7018611

  	
   

  	
  28-Mar-06

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2005214898

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Brazil

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  PI0507684-6

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2556213

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  China

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  200580006479.9

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Europe

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  05723066.6

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Israel

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  177275

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  India

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  4441/DELNP/2006

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Japan

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2006-553329

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Korea

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  10-2006-7016221

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Mexico

  	
   

  	
  CONTRAST AGENTS FOR MYOCARDIAL
  PERFUSION IMAGING

  	
   

  	
  PA/a/
  2006/008993

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Norway

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  20064011

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Russian Fed.

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2006132814

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Singapore

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  200900799-8

  	
   

  	
  11-Feb-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Taiwan

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  94112302

  	
   

  	
  18-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  11/055498

  	
   

  	
  10-Feb-05

  	
   

  	
  7344702

  	
   

  	
  18-Mar-08

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  12/014161

  	
   

  	
  15-Jan-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  South Africa

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2006/06429

  	
   

  	
  11-Feb-05

  	
   

  	
  2006/06429

  	
   

  	
  27-Feb-08

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2005238080

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  2564737

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  China

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  200580021474.3

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Colombia

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  06109678

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Europe

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  05756378.5

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Israel

  	
   

  	
  CONTRAST AGENTS FOR MYOCARDIAL
  PERFUSION IMAGING

  	
   

  	
  178911

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Korea

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  10-2006-7022493

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Singapore

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  200606895-1

  	
   

  	
  27-Apr-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Granted

  
	
  Singapore

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  11/113486

  	
   

  	
  25-Apr-05

  	
   

  	
  7485283

  	
   

  	
  3-Feb-09

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  CONTRAST AGENTS FOR
  MYOCARDIAL PERFUSION IMAGING

  	
   

  	
  12/339694

  	
   

  	
  19-Dec-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  PCT

  	
   

  	
   

  	
   

  	
  TBD

  	
   

  	
  15-Apr-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  PCT

  	
   

  	
  CONTRAST AGENTS FOR
  APPLICATIONS INCLUDING PERFUSION IMAGING

  	
   

  	
  PCT/US
  2009/001247

  	
   

  	
  27-Feb-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  

 

8

 

	
  PCT

  	
   

  	
  CONTRAST AGENTS FOR
  APPLICATIONS INCLUDING PERFUSION IMAGING

  	
   

  	
  PCT/US
  2009/001296

  	
   

  	
  27-Feb-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  MATRIX METALLOPROTEINASE
  INHIBITORS AS TARGETING COMPONENTS IN DIAGNOSTIC AGENTS

  	
   

  	
  09/783249

  	
   

  	
  14-Feb-01

  	
   

  	
  6656448

  	
   

  	
  2-Dec-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  MATRIX METALLOPROTEINASE
  INHIBITORS AS TARGETING COMPONENTS IN DIAGNOSTIC AGENTS

  	
   

  	
  10/645272

  	
   

  	
  21-Aug-03

  	
   

  	
  7060248

  	
   

  	
  13-Jun-06

  	
   

  	
  Granted

  
	
  Taiwan

  	
   

  	
  N-ALKOXYAMIDE CONJUGATES
  AS IMAGING AGENTS

  	
   

  	
  98100454

  	
   

  	
  8-Jan-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  N-ALKOXYAMIDE CONJUGATES
  AS IMAGING AGENTS

  	
   

  	
  12/350628

  	
   

  	
  8-Jan-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  PCT

  	
   

  	
  N-ALKOXYAMIDE CONJUGATES
  AS IMAGING AGENTS

  	
   

  	
  PCT/US
  2009/000096

  	
   

  	
  8-Jan-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Taiwan

  	
   

  	
  LIGANDS FOR IMAGING
  CONGESTIVE HEART FAILURE

  	
   

  	
  096149600

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Australia

  	
   

  	
  LIGANDS FOR IMAGING CARDIAC
  INNERVATION

  	
   

  	
  2007339954

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Brazil

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US
  2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US
  2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  China

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US
  2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Colombia

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  09-076173

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Europe

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  7869717.4

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Israel

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  199563

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  India

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US
  2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Japan

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Korea

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  10-2009-7015613

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Mexico

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  MX/a/2009/007018

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Russia

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  2009128591

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Singapore

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  200904382-9

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  South Africa

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  PCT/US2007/088500

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  LIGANDS FOR IMAGING
  CARDIAC INNERVATION

  	
   

  	
  12/448,575

  	
   

  	
  21-Dec-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  METHOD AND APPARATUS FOR
  SEPARATING IONS OF METALLIC ELEMENTS IN AQUEOUS SOLUTION

  	
   

  	
  10/762990

  	
   

  	
  22-Jan-04

  	
   

  	
  7138643

  	
   

  	
  21-Nov-06

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  APPARATUS AND METHOD FOR
  THE PREPARATION OF A RADIOPHARMACEUTICAL FORMULATION

  	
   

  	
  08/167685

  	
   

  	
  15-Dec-93

  	
   

  	
  5397902

  	
   

  	
  14-Mar-95

  	
   

  	
  Granted

  
	
  Austria

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Belgium

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Switzerland

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Germany

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  69126893.2-08

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Denmark

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Europe

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Spain

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  France

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  United Kingdom

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Greece

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Italy

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Liechtenstein

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Luxembourg

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  Netherlands

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  

 

9

 

	
  Sweden

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  92902283.8

  	
   

  	
  9-Oct-91

  	
   

  	
  0646273

  	
   

  	
  16-Jul-97

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  STERILIZABLE RADIONUCLIDE
  GENERATOR AND METHOD FOR STERILIZING THE SAME

  	
   

  	
  07/596273

  	
   

  	
  12-Oct-90

  	
   

  	
  5109160

  	
   

  	
  28-Apr-92

  	
   

  	
  Granted

  
	
  Japan

  	
   

  	
  METHOD AND APPARATUS FOR
  SEPARATING IONS OF METALLIC ELEMENTS IN AQUEOUS SOLUTION

  	
   

  	
  2003-552418

  	
   

  	
  12/18/2002

  	
   

  	
  4162141

  	
   

  	
  8/1/2008

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
   

  	
   

  	
  61/178,006

  	
   

  	
  13-May-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  PCT

  	
   

  	
   

  	
   

  	
  PCT/US2009/002998

  	
   

  	
  13-May-09

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  METHODS OF MAKING
  RADIOLABELED TRACERS AND PRECURSORS THEREOF

  	
   

  	
  11/492,729

  	
   

  	
  27-Jul-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada

  	
   

  	
  METHODS OF MAKING
  RADIOLABELED TRACERS AND PRECURSORS THEREOF

  	
   

  	
  2618988

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
   

  	
   

  	
  61/302,477

  	
   

  	
  8-Feb-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
   

  	
   

  	
  61/315,376

  	
   

  	
  18-Mar-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  10/034,522

  	
   

  	
  20-Dec-01

  	
   

  	
  6676929

  	
   

  	
  13-Jan-04

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  10/354,723

  	
   

  	
  30-Jan-03

  	
   

  	
  7011815

  	
   

  	
  14-Mar-06

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  10/755,506

  	
   

  	
  12-Jan-04

  	
   

  	
  7060250

  	
   

  	
  13-Jun-06

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  10/755,507

  	
   

  	
  12-Jan-04

  	
   

  	
  7229606

  	
   

  	
  12-Jun-07

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  11/472,842

  	
   

  	
  22-Jun-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  11/526,302

  	
   

  	
  25-Sep-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  USA

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  11/526,312

  	
   

  	
  25-Sep-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Australia

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  46543/96

  	
   

  	
  16-Jan-96

  	
   

  	
  689700

  	
   

  	
  16-Jul-98

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  DIAGNOSTIC IMAGING
  CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION

  	
   

  	
  2211100

  	
   

  	
  16-Jan-96

  	
   

  	
  2211100

  	
   

  	
  20-Mar-07

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  PROCESS FOR SYNTHESIZING
  PHOSPHODIESTERS

  	
   

  	
  08/833,745

  	
   

  	
  11-Apr-97

  	
   

  	
  5919967

  	
   

  	
  06-Jul-99

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  PROCESS FOR SYNTHESIZING
  PHOSPHODIESTERS

  	
   

  	
  60425/98

  	
   

  	
  27-Jan-98

  	
   

  	
  728902

  	
   

  	
  03-May-01

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  PROCESS FOR SYNTHESIZING
  PHOSPHODIESTERS

  	
   

  	
  2285417

  	
   

  	
  27-Jan-98

  	
   

  	
  2285417

  	
   

  	
  24-Jan-06

  	
   

  	
  Granted

  
	
  USA 

  	
   

  	
  CONTRAST-ENHANCED
  DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES 

  	
   

  	
  09/887,706

  	
   

  	
  08-Sep-00

  	
   

  	
  6861045

  	
   

  	
  01-Mar-05

  	
   

  	
  Granted

  
	
  USA 

  	
   

  	
  CONTRAST-ENHANCED
  DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES 

  	
   

  	
  10/961,872

  	
   

  	
  08-Oct-04

  	
   

  	
  7175829

  	
   

  	
  13-Feb-07

  	
   

  	
  Granted

  
	
  Australia

  	
   

  	
  CONTRAST-ENHANCED
  DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES 

  	
   

  	
  96686/98

  	
   

  	
  24-Sep-98

  	
   

  	
  742438

  	
   

  	
  18-Apr-02

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  CONTRAST-ENHANCED
  DIAGNOSTIC IMAGING METHOD FOR MONITORINGINTERVENTIONAL THERAPIES

  	
   

  	
  2303426

  	
   

  	
  24-Sep-98

  	
   

  	
  2303426

  	
   

  	
  23-Sep-08

  	
   

  	
  Granted

  
	
  Canada

  	
   

  	
  METHODS FOR LYMPH SYSTEM
  IMAGING

  	
   

  	
  2660717

  	
   

  	
  16-Aug-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  METHODS FOR LYMPH SYSTEM
  IMAGING

  	
   

  	
  11/840,070

  	
   

  	
  16-Aug-07

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  USA

  	
   

  	
  IMAGING SEXUAL RESPONSE

  	
   

  	
  09/718,161

  	
   

  	
  21-Nov-00

  	
   

  	
  6548044

  	
   

  	
  15-Apr-03

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMAGING SEXUAL RESPONSE

  	
   

  	
  10/291,900

  	
   

  	
  08-Nov-02

  	
   

  	
  6969507

  	
   

  	
  29-Nov-05

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  IMAGING SEXUAL RESPONSE

  	
   

  	
  11/184,271

  	
   

  	
  18-Jul-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  USA

  	
   

  	
  STEADY STATE PERFUSION
  METHODS

  	
   

  	
  11/346,884

  	
   

  	
  03-Feb-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  Australia

  	
   

  	
  STEADY STATE PERFUSION
  METHODS

  	
   

  	
  2006210398

  	
   

  	
  03-Feb-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  Canada

  	
   

  	
  STEADY STATE PERFUSION
  METHODS

  	
   

  	
  2596863

  	
   

  	
  03-Feb-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  USA

  	
   

  	
  INTEGRIN TARGETED IMAGING
  AGENTS

  	
   

  	
  11/971818

  	
   

  	
  09-Jan-08

  	
   

  	
  7566442

  	
   

  	
  28-Jul-09

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  INTEGRIN TARGETED IMAGING
  AGENTS

  	
   

  	
  10/351463

  	
   

  	
  24-Jan-03

  	
   

  	
  7255875

  	
   

  	
  14-Aug-07

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  INTEGRIN TARGETED IMAGING
  AGENTS

  	
   

  	
  11/305416

  	
   

  	
  16-Dec-05

  	
   

  	
  7344698

  	
   

  	
  18-Mar-08

  	
   

  	
  Granted

  
	
  USA

  	
   

  	
  THERMAL PREACTIVATION OF
  GASEOUS PRECURSOR FILLED COMPOSITIONS

  	
   

  	
  08/929847

  	
   

  	
  15-Sep-97

  	
   

  	
  6548047

  	
   

  	
  15-Apr-03

  	
   

  	
  Granted

  

 

10

 

Trademarks and Trademark Applications

 

	
  Mark

  	
   

  	
  Country

  	
   

  	
  Application No.

  	
   

  	
  Filing Date

  	
   

  	
  Reg No.

  	
   

  	
  Reg Date

  	
   

  	
  Status

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2642605

  	
   

  	
  2-Jan-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM8773/2005

  	
   

  	
  29-Dec-05

  	
   

  	
  231337

  	
   

  	
  24-Apr-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1054235

  	
   

  	
  6-May-05

  	
   

  	
  1054235

  	
   

  	
  19-Dec-05

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  827589522

  	
   

  	
  15-Jul-05

  	
   

  	
  827589522

  	
   

  	
  18-Dec-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  1098847

  	
   

  	
  23-Dec-05

  	
   

  	
  788831

  	
   

  	
  6-Apr-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1256778

  	
   

  	
  6-May-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  55642/2005

  	
   

  	
  8-Jul-05

  	
   

  	
  536787

  	
   

  	
  18-Aug-05

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  4775929

  	
   

  	
  12-Jul-05

  	
   

  	
  4775929

  	
   

  	
  14-Jan-09

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Cyprus, Republic of

  	
   

  	
  71986

  	
   

  	
  2-Jan-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  432910

  	
   

  	
  29-Dec-05

  	
   

  	
  282088

  	
   

  	
  26-Jul-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  305269844/05

  	
   

  	
  9-May-05

  	
   

  	
  30526984

  	
   

  	
  4-Nov-05

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA 2005 05903

  	
   

  	
  29-Dec-05

  	
   

  	
  VR 2006 01176

  	
   

  	
  30-Mar-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200501718

  	
   

  	
  29-Dec-05

  	
   

  	
  43492

  	
   

  	
  22-Jan-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4390464

  	
   

  	
  15-Apr-05

  	
   

  	
  4390464

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2650581(9)

  	
   

  	
  9-May-05

  	
   

  	
  2650581

  	
   

  	
  23-Mar-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200503494

  	
   

  	
  29-Dec-05

  	
   

  	
  236462

  	
   

  	
  31-Jul-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  France

  	
   

  	
  053357818

  	
   

  	
  9-May-05

  	
   

  	
  053357818

  	
   

  	
  14-Oct-05

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2391178

  	
   

  	
  6-May-05

  	
   

  	
  2391178

  	
   

  	
  21-Oct-05

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  151178

  	
   

  	
  30-Dec-05

  	
   

  	
  151178

  	
   

  	
  17-Apr-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0600105

  	
   

  	
  11-Jan-06

  	
   

  	
  188565

  	
   

  	
  8-Feb-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2005/02681

  	
   

  	
  29-Dec-05

  	
   

  	
  233320

  	
   

  	
  19-Jul-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  4147/2005

  	
   

  	
  29-Dec-05

  	
   

  	
  186/2006

  	
   

  	
  3-Feb-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO2005 C001418

  	
   

  	
  9-May-05

  	
   

  	
  1174404

  	
   

  	
  5-Mar-09

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-40339

  	
   

  	
  9-May-05

  	
   

  	
  4955744

  	
   

  	
  26-May-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  2005 2270

  	
   

  	
  29-Dec-05

  	
   

  	
  54034

  	
   

  	
  1-Sep-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M-05-1848

  	
   

  	
  30-Dec-05

  	
   

  	
  M57473

  	
   

  	
  20-Apr-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Malta

  	
   

  	
  44677

  	
   

  	
  29-Dec-05

  	
   

  	
  44677

  	
   

  	
  19-Jun-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  727377

  	
   

  	
  8-Jul-05

  	
   

  	
  920285

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200514758

  	
   

  	
  30-Dec-05

  	
   

  	
  234225

  	
   

  	
  10-Aug-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-304421

  	
   

  	
  3-Jan-06

  	
   

  	
  194640

  	
   

  	
  11-Sep-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  396869

  	
   

  	
  6-Jan-06

  	
   

  	
  396869

  	
   

  	
  25-May-07

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2005/09882

  	
   

  	
  30-Dec-05

  	
   

  	
  380541

  	
   

  	
  28-Apr-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200571839

  	
   

  	
  29-Dec-05

  	
   

  	
  200571839

  	
   

  	
  22-Jun-06

  	
   

  	
  Registered

  
	
  ABLAVAR (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  2456-2005

  	
   

  	
  29-Dec-05

  	
   

  	
  216455

  	
   

  	
  11-Jan-07

  	
   

  	
  Registered

  

 

Confidential

 

1

 

	
  ABLAVAR (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  78/929561

  	
   

  	
  14-Jul-06

  	
   

  	
  3769439

  	
   

  	
  30-Mar-10

  	
   

  	
  Registered

  
	
  AROLUME (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53834/2005

  	
   

  	
  9-May-05

  	
   

  	
  535032

  	
   

  	
  27-Jun-05

  	
   

  	
  Registered

  
	
  AROLUME (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4421591

  	
   

  	
  4-May-05

  	
   

  	
  4421591

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  AROLUME (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1236/2005

  	
   

  	
  9-May-05

  	
   

  	
  556/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  AROLUME (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504403

  	
   

  	
  11-May-05

  	
   

  	
  231175

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  ASPECTIV (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1211/2005

  	
   

  	
  9-May-05

  	
   

  	
  531/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  ASPECTIV (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504396

  	
   

  	
  11-May-05

  	
   

  	
  231161

  	
   

  	
  3-Mar-06

  	
   

  	
  Registered

  
	
  AU COEUR DE L’INNOVATION
  (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1174870

  	
   

  	
  15-Apr-03

  	
   

  	
  TMA663062

  	
   

  	
  21-Apr-06

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  31093

  	
   

  	
  28-Apr-99

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2308142

  	
   

  	
  22-Sep-00

  	
   

  	
  1889547

  	
   

  	
  9-Oct-02

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM3202/88

  	
   

  	
  15-Jul-88

  	
   

  	
  122358

  	
   

  	
  11-Nov-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  465624

  	
   

  	
  21-May-87

  	
   

  	
  465624

  	
   

  	
  22-May-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Bosnia and Herzegovina

  	
   

  	
  BAZ058668A

  	
   

  	
  26-Apr-05

  	
   

  	
  BAZ058668A

  	
   

  	
  4-Nov-09

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  49417

  	
   

  	
  3-Aug-06

  	
   

  	
  49417

  	
   

  	
  3-Aug-06

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  813573521

  	
   

  	
  11-Jun-87

  	
   

  	
  813573521

  	
   

  	
  27-Nov-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  0058861

  	
   

  	
  26-May-87

  	
   

  	
  430568

  	
   

  	
  26-May-87

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  0592765

  	
   

  	
  1-Oct-87

  	
   

  	
  TMA355389

  	
   

  	
  5-May-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  5106

  	
   

  	
  15-Jul-88

  	
   

  	
  364924

  	
   

  	
  21-Dec-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  677859

  	
   

  	
  1-Mar-05

  	
   

  	
  727742

  	
   

  	
  16-Jun-05

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  9004153

  	
   

  	
  16-Feb-90

  	
   

  	
  595940

  	
   

  	
  20-May-92

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  374939

  	
   

  	
  5-Feb-93

  	
   

  	
  185322

  	
   

  	
  28-Feb-95

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  83836

  	
   

  	
  26-Aug-93

  	
   

  	
  83836

  	
   

  	
  30-Aug-93

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  D433985WZ

  	
   

  	
  26-May-87

  	
   

  	
  1163253

  	
   

  	
  30-Aug-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  1988 04954

  	
   

  	
  18-Jul-88

  	
   

  	
  1990 00859

  	
   

  	
  16-Feb-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  89620

  	
   

  	
  10-Jan-94

  	
   

  	
  89620

  	
   

  	
  31-May-97

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  6800551

  	
   

  	
  2-Apr-08

  	
   

  	
  6800551

  	
   

  	
  18-Dec-08

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  1,198,786

  	
   

  	
  12-Jun-87

  	
   

  	
  1,198,786

  	
   

  	
  5-Oct-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  3111/88

  	
   

  	
  19-Jul-88

  	
   

  	
  109747

  	
   

  	
  5-Dec-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  France

  	
   

  	
  858531

  	
   

  	
  27-May-87

  	
   

  	
  1411084

  	
   

  	
  27-May-87

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  1310679

  	
   

  	
  21-May-87

  	
   

  	
  1310679

  	
   

  	
  8-Sep-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  89978

  	
   

  	
  1-Aug-88

  	
   

  	
  89978

  	
   

  	
  17-Oct-91

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  300683631

  	
   

  	
  19-Jul-06

  	
   

  	
  300683631

  	
   

  	
  6-Feb-07

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Croatia

  	
   

  	
  Z20050481

  	
   

  	
  19-Apr-05

  	
   

  	
  Z20050481

  	
   

  	
  28-Feb-06

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M9301931

  	
   

  	
  29-Jul-88

  	
   

  	
  127666

  	
   

  	
  23-Jan-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Indonesia

  	
   

  	
  D99-13523

  	
   

  	
  4-Aug-99

  	
   

  	
  511371

  	
   

  	
  1-Jul-02

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  72262

  	
   

  	
  17-Apr-89

  	
   

  	
  72262

  	
   

  	
  17-Mar-93

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  India

  	
   

  	
  497824

  	
   

  	
  14-Sep-88

  	
   

  	
  497824

  	
   

  	
  14-Sep-88

  	
   

  	
  Registered

  

 

2

 

	
  CARDIOLITE (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  36032C/88

  	
   

  	
  9-Aug-88

  	
   

  	
  844131

  	
   

  	
  14-Jun-91

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Jordan

  	
   

  	
  87575

  	
   

  	
  23-Jul-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  57085/87

  	
   

  	
  25-May-87

  	
   

  	
  2212950

  	
   

  	
  23-Feb-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  88-20575

  	
   

  	
  10-Sep-88

  	
   

  	
  40-192678

  	
   

  	
  31-May-90

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  78557

  	
   

  	
  19-Jul-06

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Macedonia

  	
   

  	
  Z-2005/233

  	
   

  	
  15-Apr-05

  	
   

  	
  12756

  	
   

  	
  13-Mar-07

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  656568

  	
   

  	
  17-May-04

  	
   

  	
  838248

  	
   

  	
  17-Jun-04

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  872079

  	
   

  	
  22-May-07

  	
   

  	
  134431

  	
   

  	
  1-Dec-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  233259

  	
   

  	
  6-Jan-94

  	
   

  	
  233259

  	
   

  	
  5-Jul-96

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Oman

  	
   

  	
  40911

  	
   

  	
  25-Jul-06

  	
   

  	
  40911

  	
   

  	
  10-Jul-07

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Panama

  	
   

  	
  074219

  	
   

  	
  27-Jan-95

  	
   

  	
  074219

  	
   

  	
  16-May-96

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  4-1998-005736

  	
   

  	
  31-Jul-98

  	
   

  	
  4-1998-005736

  	
   

  	
  30-Jul-05

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-86307

  	
   

  	
  8-Aug-88

  	
   

  	
  63998

  	
   

  	
  8-Aug-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  354442

  	
   

  	
  13-Mar-01

  	
   

  	
  354442

  	
   

  	
  30-Jun-04

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Russian Federation

  	
   

  	
  I09652

  	
   

  	
  9-Aug-88

  	
   

  	
  85120

  	
   

  	
  3-Apr-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  7416

  	
   

  	
  11-Sep-88

  	
   

  	
  192/16

  	
   

  	
  27-Feb-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  87-4401

  	
   

  	
  14-Jun-87

  	
   

  	
  215044

  	
   

  	
  3-Nov-89

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  S/439/94

  	
   

  	
  19-Jan-94

  	
   

  	
  T94/00439E

  	
   

  	
  19-Jan-94

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200570518

  	
   

  	
  14-Apr-05

  	
   

  	
  Z-200570518

  	
   

  	
  6-Feb-06

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  259749

  	
   

  	
  3-Feb-94

  	
   

  	
  TM28685

  	
   

  	
  12-May-95

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  43591

  	
   

  	
  24-Aug-88

  	
   

  	
  107201

  	
   

  	
  24-Aug-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  29883

  	
   

  	
  3-Jun-87

  	
   

  	
  388319

  	
   

  	
  16-Jan-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  73/662052

  	
   

  	
  21-May-87

  	
   

  	
  1484982

  	
   

  	
  19-Apr-88

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Uruguay

  	
   

  	
  266038

  	
   

  	
  21-Oct-93

  	
   

  	
  358.403

  	
   

  	
  11-Jan-95

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  94-16939

  	
   

  	
  20-Dec-94

  	
   

  	
  188034-P

  	
   

  	
  9-Feb-96

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  Viet Nam

  	
   

  	
  4-1993-14734

  	
   

  	
  27-Jul-93

  	
   

  	
  12212

  	
   

  	
  16-Jun-94

  	
   

  	
  Registered

  
	
  CARDIOLITE (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  88/5957

  	
   

  	
  18-Jul-88

  	
   

  	
  88/5957

  	
   

  	
  7-Nov-90

  	
   

  	
  Registered

  
	
  CARDIOLITE IN KATAKANA

  	
   

  	
  Japan

  	
   

  	
  95714/87

  	
   

  	
  25-Aug-87

  	
   

  	
  2266312

  	
   

  	
  21-Sep-90

  	
   

  	
  Registered

  
	
  CLEARAGE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53869/2005

  	
   

  	
  10-May-05

  	
   

  	
  534934

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  CLEARAGE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430229

  	
   

  	
  10-May-05

  	
   

  	
  4430229

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  CLEARAGE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1225/2005

  	
   

  	
  9-May-05

  	
   

  	
  545/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CLEARAGE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504405

  	
   

  	
  11-May-05

  	
   

  	
  231180

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  CONSTALITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53925/2005

  	
   

  	
  11-May-05

  	
   

  	
  535348

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  CONSTALITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388518

  	
   

  	
  15-Apr-05

  	
   

  	
  4388518

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  CONSTALITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1212/2005

  	
   

  	
  9-May-05

  	
   

  	
  532/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CONSTALITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504368

  	
   

  	
  11-May-05

  	
   

  	
  231265

  	
   

  	
  8-Mar-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM 6792/2005

  	
   

  	
  11-Oct-05

  	
   

  	
  229 298

  	
   

  	
  10-Jan-06

  	
   

  	
  Registered

  

 

3

 

	
  CONSTELITE (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1079053

  	
   

  	
  4-Oct-05

  	
   

  	
  1079053

  	
   

  	
  22-May-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  1086689

  	
   

  	
  3-Oct-05

  	
   

  	
  784455

  	
   

  	
  7-Mar-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53929/2005

  	
   

  	
  11-May-05

  	
   

  	
  535350

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  4932556

  	
   

  	
  8-Oct-05

  	
   

  	
  4932556

  	
   

  	
  21-Feb-09

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  O-430240

  	
   

  	
  3-Oct-05

  	
   

  	
  280408

  	
   

  	
  19-Apr-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  305 58 724.2/05

  	
   

  	
  4-Oct-05

  	
   

  	
  30558724

  	
   

  	
  12-Dec-05

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA200504171

  	
   

  	
  3-Oct-05

  	
   

  	
  VR200503905

  	
   

  	
  11-Oct-05

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200501257

  	
   

  	
  3-Oct-05

  	
   

  	
  43142

  	
   

  	
  22-Sep-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388641

  	
   

  	
  15-Apr-05

  	
   

  	
  4388641

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2672702

  	
   

  	
  4-Oct-05

  	
   

  	
  2672702

  	
   

  	
  30-May-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200502575

  	
   

  	
  3-Oct-05

  	
   

  	
  236053

  	
   

  	
  31-May-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  France

  	
   

  	
  053383474

  	
   

  	
  3-Oct-05

  	
   

  	
  053383474

  	
   

  	
  10-Mar-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2402993

  	
   

  	
  3-Oct-05

  	
   

  	
  2402993

  	
   

  	
  24-Mar-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  150994

  	
   

  	
  10-Oct-05

  	
   

  	
  150994

  	
   

  	
  19-Mar-07

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0503233

  	
   

  	
  6-Oct-05

  	
   

  	
  187777

  	
   

  	
  11-Dec-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2005/02036

  	
   

  	
  3-Oct-05

  	
   

  	
  232693

  	
   

  	
  10-Apr-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1214/2005

  	
   

  	
  9-May-05

  	
   

  	
  534/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO2005C002840

  	
   

  	
  5-Oct-05

  	
   

  	
  1175186

  	
   

  	
  6-Mar-09

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-92510

  	
   

  	
  4-Oct-05

  	
   

  	
  4999886

  	
   

  	
  2-Nov-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  2005 1732

  	
   

  	
  3-Oct-05

  	
   

  	
  53451

  	
   

  	
  15-May-07

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M051426

  	
   

  	
  30-Nov-05

  	
   

  	
  M57210

  	
   

  	
  20-Jan-07

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Malta

  	
   

  	
  44352

  	
   

  	
  5-Oct-05

  	
   

  	
  44352

  	
   

  	
  1-Feb-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504369

  	
   

  	
  11-May-05

  	
   

  	
  231267

  	
   

  	
  8-Mar-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-300785

  	
   

  	
  4-Oct-05

  	
   

  	
  191177

  	
   

  	
  5-Dec-07

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  394593

  	
   

  	
  14-Oct-05

  	
   

  	
  394593

  	
   

  	
  11-Aug-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2005/07289

  	
   

  	
  4-Oct-05

  	
   

  	
  378117

  	
   

  	
  13-Jan-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T05/19228Z

  	
   

  	
  4-Oct-05

  	
   

  	
  T05/19228

  	
   

  	
  13-Jul-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200571366

  	
   

  	
  3-Oct-05

  	
   

  	
  200571366

  	
   

  	
  24-Apr-06

  	
   

  	
  Registered

  
	
  CONSTELITE (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  1819-2005

  	
   

  	
  3-Oct-05

  	
   

  	
  215213

  	
   

  	
  11-Sep-06

  	
   

  	
  Registered

  
	
  CONSTILITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53927/2005

  	
   

  	
  11-May-05

  	
   

  	
  535349

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  CONSTILITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388559

  	
   

  	
  15-Apr-05

  	
   

  	
  4388559

  	
   

  	
  31-Mar-06

  	
   

  	
  Registered

  
	
  CONSTILITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1213/2005

  	
   

  	
  9-May-05

  	
   

  	
  533/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CONSTILITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504397

  	
   

  	
  11-May-05

  	
   

  	
  231268

  	
   

  	
  8-Mar-06

  	
   

  	
  Registered

  
	
  CORRELITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53864/2005

  	
   

  	
  10-May-05

  	
   

  	
  534929

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  CORRELITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430427

  	
   

  	
  10-May-05

  	
   

  	
  4430427

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  CORRELITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1220/2005

  	
   

  	
  9-May-05

  	
   

  	
  540/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CORRELITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504373

  	
   

  	
  11-May-05

  	
   

  	
  231303

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  

 

4

 

	
  CRESONATE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53868/2005

  	
   

  	
  10-May-05

  	
   

  	
  534933

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  CRESONATE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430369

  	
   

  	
  10-May-05

  	
   

  	
  4430369

  	
   

  	
  5-Apr-06

  	
   

  	
  Registered

  
	
  CRESONATE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1224/2005

  	
   

  	
  9-May-05

  	
   

  	
  544/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  CRESONATE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504376

  	
   

  	
  11-May-05

  	
   

  	
  231312

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  DEFINITY

  	
   

  	
  Austria

  	
   

  	
  AM6773/2003

  	
   

  	
  14-Oct-03

  	
   

  	
  214791

  	
   

  	
  13-Jan-04

  	
   

  	
  Registered

  
	
  DEFINITY

  	
   

  	
  Benelux

  	
   

  	
  1041399

  	
   

  	
  7-Oct-03

  	
   

  	
  744968

  	
   

  	
  7-Oct-03

  	
   

  	
  Registered

  
	
  DEFINITY

  	
   

  	
  Denmark

  	
   

  	
  VA200303637

  	
   

  	
  8-Oct-03

  	
   

  	
  VR200304229

  	
   

  	
  23-Dec-03

  	
   

  	
  Registered

  
	
  DEFINITY

  	
   

  	
  European Community

  	
   

  	
  4043428

  	
   

  	
  24-Sep-04

  	
   

  	
  4043428

  	
   

  	
  16-Jun-06

  	
   

  	
  Registered

  
	
  DEFINITY

  	
   

  	
  Italy

  	
   

  	
  T02004C002801

  	
   

  	
  27-Sep-04

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  DEFINITY

  	
   

  	
  Jordan

  	
   

  	
   

  	
   

  	
  9-Dec-03

  	
   

  	
  72919

  	
   

  	
  16-Jun-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  58056

  	
   

  	
  30-Dec-03

  	
   

  	
  49158

  	
   

  	
  31-Oct-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2481681

  	
   

  	
  4-Dec-03

  	
   

  	
  2038737

  	
   

  	
  19-Aug-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Bulgaria

  	
   

  	
  73798

  	
   

  	
  24-Sep-04

  	
   

  	
  55703

  	
   

  	
  20-Sep-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  40543

  	
   

  	
  19-Jan-04

  	
   

  	
  40543

  	
   

  	
  3-Aug-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  821165925

  	
   

  	
  23-Oct-98

  	
   

  	
  821165925

  	
   

  	
  2-May-07

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  917629

  	
   

  	
  11-Jun-98

  	
   

  	
  647455

  	
   

  	
  11-Jun-98

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  885825

  	
   

  	
  29-Jul-98

  	
   

  	
  TMA604670

  	
   

  	
  10-Mar-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  04519

  	
   

  	
  5-Jun-98

  	
   

  	
  456755

  	
   

  	
  4-Dec-98

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  56283/2004

  	
   

  	
  17-Sep-04

  	
   

  	
  528677

  	
   

  	
  14-Dec-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  627594

  	
   

  	
  11-Nov-03

  	
   

  	
  695895

  	
   

  	
  22-Jun-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  2000175322

  	
   

  	
  13-Nov-00

  	
   

  	
  1684547

  	
   

  	
  21-Dec-01

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  T2003/095330

  	
   

  	
  27-Oct-03

  	
   

  	
  288124

  	
   

  	
  9-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  359595

  	
   

  	
  23-Sep-04

  	
   

  	
  277224

  	
   

  	
  22-Dec-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  398325103

  	
   

  	
  10-Jun-98

  	
   

  	
  39832510

  	
   

  	
  6-Nov-98

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  303520582/82

  	
   

  	
  9-Oct-03

  	
   

  	
  30352058

  	
   

  	
  6-Apr-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA199802556

  	
   

  	
  10-Jun-98

  	
   

  	
  VR199803549

  	
   

  	
  4-Nov-98

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200401427

  	
   

  	
  22-Sep-04

  	
   

  	
  42075

  	
   

  	
  11-Jan-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
   

  	
   

  	
  25-Oct-03

  	
   

  	
  162754

  	
   

  	
  16-Mar-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2614823 (4)

  	
   

  	
  23-Sep-04

  	
   

  	
  2614823

  	
   

  	
  2-Feb-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200400588

  	
   

  	
  10-Mar-04

  	
   

  	
  231633

  	
   

  	
  30-Nov-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  France

  	
   

  	
  03 3 250 257

  	
   

  	
  9-Oct-03

  	
   

  	
  03 3 250 257

  	
   

  	
  19-Mar-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2374021

  	
   

  	
  24-Sep-04

  	
   

  	
  2374021

  	
   

  	
  18-Mar-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  137184

  	
   

  	
  12-Jun-98

  	
   

  	
  137184

  	
   

  	
  19-Feb-01

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  150072

  	
   

  	
  7-Oct-04

  	
   

  	
  150072

  	
   

  	
  18-Apr-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  300118539

  	
   

  	
  27-Nov-03

  	
   

  	
  300118539

  	
   

  	
  10-Aug-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0403974

  	
   

  	
  27-Sep-04

  	
   

  	
  184834

  	
   

  	
  12-Jun-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Indonesia

  	
   

  	
  DOO-28189

  	
   

  	
  24-Nov-00

  	
   

  	
  491755

  	
   

  	
  1-Oct-01

  	
   

  	
  Registered

  

 

5

 

	
  DEFINITY (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  98/2416

  	
   

  	
  8-Jun-98

  	
   

  	
  209318

  	
   

  	
  31-Mar-00

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2003/01875

  	
   

  	
  7-Oct-03

  	
   

  	
  228069

  	
   

  	
  7-May-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  167544

  	
   

  	
  24-Oct-03

  	
   

  	
  167544

  	
   

  	
  5-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  India

  	
   

  	
  970339

  	
   

  	
  14-Nov-00

  	
   

  	
  970339

  	
   

  	
  31-Mar-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1091/1998

  	
   

  	
  10-Jun-98

  	
   

  	
  1181/1998

  	
   

  	
  24-Nov-98

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  2418/2004

  	
   

  	
  17-Sep-04

  	
   

  	
  841/2004

  	
   

  	
  6-Oct-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  RM98C003094

  	
   

  	
  17-Jun-98

  	
   

  	
  839885

  	
   

  	
  8-Mar-01

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  40-2000-52536

  	
   

  	
  11-Nov-00

  	
   

  	
  40-0516449

  	
   

  	
  29-Mar-02

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  61869

  	
   

  	
  30-Nov-03

  	
   

  	
  52503

  	
   

  	
  30-Nov-03

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Lebanon

  	
   

  	
  96379

  	
   

  	
  8-Jan-04

  	
   

  	
  96379

  	
   

  	
  8-Jan-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  20041886

  	
   

  	
  22-Sep-04

  	
   

  	
  51288

  	
   

  	
  14-Mar-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M-04-1443

  	
   

  	
  22-Sep-04

  	
   

  	
  M55649

  	
   

  	
  20-Nov-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Macao

  	
   

  	
  N/017396

  	
   

  	
  1-Jun-05

  	
   

  	
  N/017396

  	
   

  	
  6-Oct-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Malta

  	
   

  	
   

  	
   

  	
  30-Sep-04

  	
   

  	
  42705

  	
   

  	
  21-Mar-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  626695

  	
   

  	
  28-Oct-03

  	
   

  	
  821941

  	
   

  	
  25-Feb-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  00015872

  	
   

  	
  8-Nov-00

  	
   

  	
  00015872

  	
   

  	
  29-Nov-07

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200309427

  	
   

  	
  9-Oct-03

  	
   

  	
  223995

  	
   

  	
  9-Aug-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  705127

  	
   

  	
  27-Nov-03

  	
   

  	
  705127

  	
   

  	
  5-Jul-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Oman

  	
   

  	
   

  	
   

  	
  16-Dec-03

  	
   

  	
  32096

  	
   

  	
  10-Jul-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  4-2003-009869

  	
   

  	
  27-Oct-03

  	
   

  	
  4-2003-009869

  	
   

  	
  17-Aug-06

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Pakistan

  	
   

  	
  648

  	
   

  	
  10-Nov-00

  	
   

  	
  167487

  	
   

  	
  10-Nov-00

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-285820

  	
   

  	
  24-Sep-04

  	
   

  	
  188252

  	
   

  	
  24-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  375909

  	
   

  	
  16-Oct-03

  	
   

  	
  375909

  	
   

  	
  3-Nov-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Romania

  	
   

  	
  M2004 08155

  	
   

  	
  22-Sep-04

  	
   

  	
  NR63773

  	
   

  	
  22-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  86886

  	
   

  	
  27-Dec-03

  	
   

  	
  747/49

  	
   

  	
  20-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  1998/04656

  	
   

  	
  11-Jun-98

  	
   

  	
  338235

  	
   

  	
  9-Jun-00

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2004/07226

  	
   

  	
  29-Oct-04

  	
   

  	
  373766

  	
   

  	
  22-Jul-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T02/16112Z

  	
   

  	
  16-Oct-02

  	
   

  	
  T02/11612Z

  	
   

  	
  16-Oct-02

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z200471683

  	
   

  	
  22-Sep-04

  	
   

  	
  200471683

  	
   

  	
  13-Jun-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  2898-2004

  	
   

  	
  22-Sep-04

  	
   

  	
  211567

  	
   

  	
  10-Oct-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  439865

  	
   

  	
  28-Nov-00

  	
   

  	
  146090

  	
   

  	
  27-Oct-01

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  2004030777

  	
   

  	
  24-Sep-04

  	
   

  	
  2004030777

  	
   

  	
  24-Sep-04

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  89065181

  	
   

  	
  10-Nov-00

  	
   

  	
  983838

  	
   

  	
  16-Feb-02

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  75/479438

  	
   

  	
  5-May-98

  	
   

  	
  2478324

  	
   

  	
  14-Aug-01

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  15475/2003

  	
   

  	
  27-Oct-03

  	
   

  	
  P261256

  	
   

  	
  25-May-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Viet Nam

  	
   

  	
  4-2003-11883

  	
   

  	
  26-Dec-03

  	
   

  	
  62986

  	
   

  	
  24-May-05

  	
   

  	
  Registered

  
	
  DEFINITY (BLOCK)

  	
   

  	
  Serbia (Old Code)

  	
   

  	
  Z-522/05

  	
   

  	
  5-May-05

  	
   

  	
  50885

  	
   

  	
  7-Jun-06

  	
   

  	
  Registered

  

 

6

 

	
  DEFINITY (DI FEN LI TI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636959 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636959 

  	
   

  	
  14-Sep-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN LI) (SIMPLIFIED CHINESE CHARACTERS) (VERSION 1)
  (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636957 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636957 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN LI) (SIMPLIFIED CHINESE CHARACTERS) (VERSION 2)
  (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636953 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636953 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN NI TI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636951 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636951 

  	
   

  	
  14-Sep-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK)

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636952 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636952 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) VERSION 1
  (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636958 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636958 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) VERSION 2
  (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636954 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636954 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY (DI FEN) (SIMPLIFIED CHINESE CHARACTERS) VERSION 2
  (BLOCK) 

  	
   

  	
  China (People's Republic) 

  	
   

  	
  4636955 

  	
   

  	
  30-Apr-05 

  	
   

  	
  4636955 

  	
   

  	
  28-Aug-08 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DE FEN LI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415692 

  	
   

  	
  5-May-05 

  	
   

  	
  300415692 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DE FEN LI) (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017399 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017399 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI TI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415746 

  	
   

  	
  5-May-05 

  	
   

  	
  300415746 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI TI) (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017404 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017404 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI) - VERSION 2 (BLOCK)

  	
   

  	
  Macao 

  	
   

  	
  N/017400 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017400 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415728 

  	
   

  	
  5-May-05 

  	
   

  	
  300415728 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415737 

  	
   

  	
  5-May-05 

  	
   

  	
  300415737 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN LI) (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017402 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017402 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN NI TI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415773 

  	
   

  	
  5-May-05 

  	
   

  	
  300415773 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN NI TI) (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017405 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017405 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI FEN NI) - VERSION 2 (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415755 

  	
   

  	
  5-May-05 

  	
   

  	
  300415755 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  

 

 

	
  DEFINITY IN CHINESE (DI
  FEN NI) - VERSION 2 (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017403 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017403 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI
  FEN NI) (BLOCK) 

  	
   

  	
  Hong Kong 

  	
   

  	
  300415764 

  	
   

  	
  5-May-05 

  	
   

  	
  300415764 

  	
   

  	
  18-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI
  FEN NI) (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017401 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017401 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI
  FEN) - VERSION 2 (BLOCK) 

  	
   

  	
  Macao 

  	
   

  	
  N/017398 

  	
   

  	
  1-Jun-05 

  	
   

  	
  N/017398 

  	
   

  	
  6-Oct-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE (DI
  FEN) (BLOCK) 

  	
   

  	
  Macao

  	
   

  	
  N/017397

  	
   

  	
  1-Jun-05

  	
   

  	
  N/017397

  	
   

  	
  6-Oct-05

  	
   

  	
  Registered

  
	
  DEFINITY IN CHINESE
  (DI-FEN) - VERSION 2 (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020928 

  	
   

  	
  3-May-05 

  	
   

  	
  01197686 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN) (BLOCK) 

  	
   

  	
  Taiwan

  	
   

  	
  094020927

  	
   

  	
  3-May-05

  	
   

  	
  01197685

  	
   

  	
  1-Mar-06

  	
   

  	
  Registered

  
	
  DEFINITY IN CHINESE
  (DI-FEN-LI) - VERSION 2 (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020930 

  	
   

  	
  3-May-05 

  	
   

  	
  01197688 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN-LI) (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020926 

  	
   

  	
  3-May-05 

  	
   

  	
  01197684 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN-LI-TI) (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020922 

  	
   

  	
  3-May-05 

  	
   

  	
  01185604 

  	
   

  	
  16-Dec-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN-NI) - VERSION 2 (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020929 

  	
   

  	
  3-May-05 

  	
   

  	
  01197687 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN-NI) (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020943 

  	
   

  	
  3-May-05 

  	
   

  	
  01197690 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (DI-FEN-NI-TI) (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020920 

  	
   

  	
  3-May-05 

  	
   

  	
  01183223 

  	
   

  	
  1-Dec-05 

  	
   

  	
  Registered 

  
	
  DEFINITY IN CHINESE
  (TE-FEN-LI) (BLOCK) 

  	
   

  	
  Taiwan 

  	
   

  	
  094020932 

  	
   

  	
  3-May-05 

  	
   

  	
  01197689 

  	
   

  	
  1-Mar-06 

  	
   

  	
  Registered 

  
	
  DEFINITY WITH KATAKANA
  (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  914981999

  	
   

  	
  12-Oct-99

  	
   

  	
  4412056

  	
   

  	
  25-Aug-00

  	
   

  	
  Registered

  
	
  DEFINTY (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  980075

  	
   

  	
  27-Nov-03

  	
   

  	
  980075

  	
   

  	
  7-Sep-04

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM6794/2005

  	
   

  	
  11-Oct-05

  	
   

  	
  229 300

  	
   

  	
   

  	
   

  	
  Pending

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1079051

  	
   

  	
  4-Oct-05

  	
   

  	
  1079051

  	
   

  	
  22-May-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  1086688

  	
   

  	
  3-Oct-05

  	
   

  	
  0784453

  	
   

  	
  7-Mar-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53833/2005

  	
   

  	
  9-May-05

  	
   

  	
  535031

  	
   

  	
  27-Jun-05

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  4932557

  	
   

  	
  8-Oct-05

  	
   

  	
  4932557

  	
   

  	
  21-Feb-09

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Cyprus, Republic of

  	
   

  	
  71783

  	
   

  	
  5-Oct-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  O-430238

  	
   

  	
  3-Oct-05

  	
   

  	
  280406

  	
   

  	
  19-Apr-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  30558722.6/05

  	
   

  	
  4-Oct-05

  	
   

  	
  30558722

  	
   

  	
  12-Dec-05

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA200504170

  	
   

  	
  3-Oct-05

  	
   

  	
  VR200503903

  	
   

  	
  11-Oct-05

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200501255

  	
   

  	
  3-Oct-05

  	
   

  	
  43140

  	
   

  	
  22-Sep-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  004421632

  	
   

  	
  4-May-05

  	
   

  	
  004421632

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2672704

  	
   

  	
  4-Oct-05

  	
   

  	
  2672704

  	
   

  	
  30-May-06

  	
   

  	
  Registered

  

 

8

 

	
  DEPICTRA (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200502573

  	
   

  	
  3-Oct-05

  	
   

  	
  236051

  	
   

  	
  31-May-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  France

  	
   

  	
  053383469

  	
   

  	
  3-Oct-05

  	
   

  	
  053383469

  	
   

  	
  3-Oct-05

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2402991

  	
   

  	
  3-Oct-05

  	
   

  	
  2402991

  	
   

  	
  24-Mar-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  150992

  	
   

  	
  10-Oct-05

  	
   

  	
  150992

  	
   

  	
  19-Mar-07

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0503231

  	
   

  	
  6-Oct-05

  	
   

  	
  187775

  	
   

  	
  11-Dec-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2005/02034

  	
   

  	
  3-Oct-05

  	
   

  	
  232689

  	
   

  	
  10-Apr-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1235/2005

  	
   

  	
  9-May-05

  	
   

  	
  555/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO2005C002838

  	
   

  	
  5-Oct-05

  	
   

  	
  1175184

  	
   

  	
  6-Mar-09

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-92511

  	
   

  	
  4-Oct-05

  	
   

  	
  4959290

  	
   

  	
  9-Jun-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  2005 1730

  	
   

  	
  3-Oct-05

  	
   

  	
  53449

  	
   

  	
  15-May-07

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M-05-1424

  	
   

  	
  30-Nov-05

  	
   

  	
  M57208

  	
   

  	
  20-Jan-07

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Malta

  	
   

  	
  44351

  	
   

  	
  5-Oct-05

  	
   

  	
  44351

  	
   

  	
  1-Feb-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504372

  	
   

  	
  11-May-05

  	
   

  	
  231295

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-300787

  	
   

  	
  4-Oct-05

  	
   

  	
  191179

  	
   

  	
  5-Dec-07

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  394584

  	
   

  	
  14-Oct-05

  	
   

  	
  394584

  	
   

  	
  11-Aug-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2005/07290

  	
   

  	
  4-Oct-05

  	
   

  	
  378118

  	
   

  	
  13-Jan-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T05/19226C

  	
   

  	
  4-Oct-05

  	
   

  	
  T05/19226C

  	
   

  	
  6-Jun-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200571368

  	
   

  	
  3-Oct-05

  	
   

  	
  200571368

  	
   

  	
  24-Apr-06

  	
   

  	
  Registered

  
	
  DEPICTRA (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  1820-2005

  	
   

  	
  3-Oct-05

  	
   

  	
  215214

  	
   

  	
  11-Sep-06

  	
   

  	
  Registered

  
	
  FORELUME (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53870/2005

  	
   

  	
  10-May-05

  	
   

  	
  534935

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  FORELUME (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430146

  	
   

  	
  10-May-05

  	
   

  	
  4430146

  	
   

  	
  31-Mar-06

  	
   

  	
  Registered

  
	
  FORELUME (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1226/2005

  	
   

  	
  9-May-05

  	
   

  	
  546/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  FORELUME (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504378

  	
   

  	
  11-May-05

  	
   

  	
  231314

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  GLUDEF (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1466957

  	
   

  	
  25-Jan-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  GLUDEF (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  77/917593

  	
   

  	
  22-Jan-10

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  ILLUSTREL (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53871/2005

  	
   

  	
  10-May-05

  	
   

  	
  534936

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  ILLUSTREL (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4429742

  	
   

  	
  10-May-05

  	
   

  	
  4429742

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  ILLUSTREL (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1227/2005

  	
   

  	
  9-May-05

  	
   

  	
  547/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  ILLUSTREL (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504406

  	
   

  	
  11-May-05

  	
   

  	
  231201

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2426151

  	
   

  	
  24-Apr-03

  	
   

  	
  1988805

  	
   

  	
  24-Aug-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  947429

  	
   

  	
  18-Mar-03

  	
   

  	
  947429

  	
   

  	
  9-Oct-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  33216

  	
   

  	
  11-May-03

  	
   

  	
  33216

  	
   

  	
  26-Dec-05

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  825542944

  	
   

  	
  27-May-03

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1171363

  	
   

  	
  17-Mar-03

  	
   

  	
  TMA669731

  	
   

  	
  14-Aug-06

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  604884

  	
   

  	
  17-Apr-03

  	
   

  	
  675787

  	
   

  	
  15-Oct-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  3550190

  	
   

  	
  8-May-03

  	
   

  	
  3550190

  	
   

  	
  28-Jan-09

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  T2003/032097

  	
   

  	
  15-Apr-03

  	
   

  	
  284624

  	
   

  	
  30-Apr-04

  	
   

  	
  Registered

  

 

9

 

	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  2003-0002801

  	
   

  	
  13-May-03

  	
   

  	
  145862

  	
   

  	
  17-Mar-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  159020

  	
   

  	
  29-Apr-03

  	
   

  	
  159020

  	
   

  	
  25-Jul-06

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  003168176

  	
   

  	
  6-May-03

  	
   

  	
  003168176

  	
   

  	
  15-Dec-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2327461

  	
   

  	
  25-Mar-03

  	
   

  	
  2327461

  	
   

  	
  26-Sep-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2003/00533

  	
   

  	
  25-Mar-03

  	
   

  	
  227896

  	
   

  	
  25-Mar-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  163951

  	
   

  	
  24-Apr-03

  	
   

  	
  163951

  	
   

  	
  4-Jan-05

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Jordan

  	
   

  	
  71333

  	
   

  	
  4-Aug-03

  	
   

  	
  71333

  	
   

  	
  26-Feb-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2003-29892

  	
   

  	
  14-Apr-03

  	
   

  	
  4714745

  	
   

  	
  3-Oct-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  40-2003-20578

  	
   

  	
  7-May-03

  	
   

  	
  40-586813

  	
   

  	
  6-Jul-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  59150

  	
   

  	
  23-Apr-03

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  597827

  	
   

  	
  22-Apr-03

  	
   

  	
  798463

  	
   

  	
  30-Jun-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  2003/05663

  	
   

  	
  19-May-03

  	
   

  	
  2003/05663

  	
   

  	
  3-Feb-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Oman

  	
   

  	
  30510

  	
   

  	
  6-May-03

  	
   

  	
  30510

  	
   

  	
  2-Jul-05

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Panama

  	
   

  	
  127224

  	
   

  	
  20-May-03

  	
   

  	
  127224

  	
   

  	
  20-May-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  42003002819

  	
   

  	
  26-Mar-03

  	
   

  	
  42003002819

  	
   

  	
  14-Apr-08

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  82529

  	
   

  	
  23-Apr-03

  	
   

  	
  735/13

  	
   

  	
   

  	
   

  	
  Published

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T03/06048C

  	
   

  	
  25-Apr-03

  	
   

  	
  T03/06048 C

  	
   

  	
  25-Apr-03

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  092018264

  	
   

  	
  16-Apr-03

  	
   

  	
  1089258

  	
   

  	
  16-Mar-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  78/210142

  	
   

  	
  3-Feb-03

  	
   

  	
  3276023

  	
   

  	
  7-Aug-07

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  04611/2003

  	
   

  	
  22-Apr-03

  	
   

  	
  P254452

  	
   

  	
  14-Sep-04

  	
   

  	
  Registered

  
	
  INNOVATORS AT HEART
  (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  2003/04645

  	
   

  	
  19-Mar-03

  	
   

  	
  2003/04645

  	
   

  	
  20-Feb-08

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1046747

  	
   

  	
  17-Mar-05

  	
   

  	
  1046747

  	
   

  	
  24-Oct-05

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  827273975

  	
   

  	
  18-Mar-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1250924

  	
   

  	
  16-Mar-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  58050/2005

  	
   

  	
  3-Oct-05

  	
   

  	
  540105

  	
   

  	
  6-Dec-05

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4346102

  	
   

  	
  18-Mar-05

  	
   

  	
  4346102

  	
   

  	
  8-Mar-06

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  2774/2005

  	
   

  	
  3-Oct-05

  	
   

  	
  980/2005

  	
   

  	
  3-Nov-05

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-024285

  	
   

  	
  18-Mar-05

  	
   

  	
  4959316

  	
   

  	
  9-Jun-06

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  711147

  	
   

  	
  8-Apr-05

  	
   

  	
  891151

  	
   

  	
  25-Jul-05

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200510192

  	
   

  	
  4-Oct-05

  	
   

  	
  232962

  	
   

  	
  31-May-06

  	
   

  	
  Registered

  
	
  INTELLIPIN (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  78/436013

  	
   

  	
  16-Jun-04

  	
   

  	
  3127726

  	
   

  	
  8-Aug-06

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING

  	
   

  	
  Brazil

  	
   

  	
  829916156

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING

  	
   

  	
  Peru

  	
   

  	
  362643

  	
   

  	
  7-Aug-08

  	
   

  	
  150330

  	
   

  	
  26-Mar-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  117813

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  117812

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2846697

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK) 

  	
   

  	
  Argentina

  	
   

  	
  2846698

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  

 

10

 

	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2846696

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1254050

  	
   

  	
  25-Jul-08

  	
   

  	
  1254050

  	
   

  	
  9-Dec-08

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  71833

  	
   

  	
  19-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  71834

  	
   

  	
  19-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Bolivia

  	
   

  	
  3745-2008

  	
   

  	
  8-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Bolivia

  	
   

  	
  3744-2008

  	
   

  	
  8-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  829916172

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  829916199

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1404829

  	
   

  	
  25-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Allowed

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  59431/2008

  	
   

  	
  29-Jul-08

  	
   

  	
  582123

  	
   

  	
  27-Jan-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  831148

  	
   

  	
  30-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  831147

  	
   

  	
  30-Jul-08

  	
   

  	
  845.152

  	
   

  	
  26-Mar-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  6891457

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  6891456

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  6891458

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  08083009

  	
   

  	
  11-Aug-08

  	
   

  	
  385894

  	
   

  	
  31-Jul-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  08083012

  	
   

  	
  11-Aug-08

  	
   

  	
  385895

  	
   

  	
  31-Jul-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  2008-9852

  	
   

  	
  3-Oct-08

  	
   

  	
  187183

  	
   

  	
  27-Feb-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  2008-0009851

  	
   

  	
  3-Oct-08

  	
   

  	
  190722

  	
   

  	
  29-May-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Ecuador

  	
   

  	
  202742

  	
   

  	
  30-Jul-08

  	
   

  	
  1529-09

  	
   

  	
  21-Jan-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Ecuador

  	
   

  	
  202741

  	
   

  	
  30-Jul-08

  	
   

  	
  1528-09

  	
   

  	
  21-Jan-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  219988

  	
   

  	
  27-Jul-08

  	
   

  	
  219988

  	
   

  	
  17-Jan-10

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  219989

  	
   

  	
  27-Jul-08

  	
   

  	
  219989

  	
   

  	
  17-Jan-10

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  7119712

  	
   

  	
  1-Aug-08

  	
   

  	
  7119712

  	
   

  	
  11-May-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  301168975

  	
   

  	
  25-Jul-08

  	
   

  	
  301168975

  	
   

  	
  5-Feb-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Croatia

  	
   

  	
  Z20081644

  	
   

  	
  25-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Indonesia

  	
   

  	
  D002008029143

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Indonesia

  	
   

  	
  D002008029141

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  214010

  	
   

  	
  10-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  214011

  	
   

  	
  10-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  214009

  	
   

  	
  10-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  India

  	
   

  	
  1719854

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  2532/2008

  	
   

  	
  25-Jul-08

  	
   

  	
  945/2008

  	
   

  	
  1-Sep-08

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2008-065825

  	
   

  	
  8-Aug-08

  	
   

  	
  5266851

  	
   

  	
  18-Sep-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  45-2008-3435

  	
   

  	
  8-Aug-08

  	
   

  	
  45-29150

  	
   

  	
  1-Oct-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  99301

  	
   

  	
  16-Nov-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  99302

  	
   

  	
  16-Nov-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  

 

11

 

	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Liechtenstein

  	
   

  	
  15053

  	
   

  	
  6-Aug-08

  	
   

  	
  15053

  	
   

  	
  6-Aug-08

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  953911

  	
   

  	
  11-Aug-08

  	
   

  	
  1085795

  	
   

  	
  19-Feb-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  953912

  	
   

  	
  11-Aug-08

  	
   

  	
  1078471

  	
   

  	
  13-Jan-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  08015849

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  08015848

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200810102

  	
   

  	
  19-Aug-08

  	
   

  	
  248235

  	
   

  	
  21-Oct-08

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  793323

  	
   

  	
  25-Jul-08

  	
   

  	
  793323

  	
   

  	
  29-Jan-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Peru

  	
   

  	
  362644

  	
   

  	
  7-Aug-08

  	
   

  	
  150331

  	
   

  	
  26-Mar-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  4-2008-009677

  	
   

  	
  11-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Pakistan

  	
   

  	
  253882

  	
   

  	
  31-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Pakistan

  	
   

  	
  253883

  	
   

  	
  31-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Russian Federation

  	
   

  	
  2008725562

  	
   

  	
  8-Aug-08

  	
   

  	
  390038

  	
   

  	
  28-Sep-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  135890

  	
   

  	
  11-Oct-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  135891

  	
   

  	
  11-Oct-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T08/10387C

  	
   

  	
  5-Aug-08

  	
   

  	
  T0810387C

  	
   

  	
  11-Jun-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  703875

  	
   

  	
  1-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  703874

  	
   

  	
  1-Aug-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  2008/44719

  	
   

  	
  30-Jul-08

  	
   

  	
  2008 44719

  	
   

  	
  7-Sep-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  097037777

  	
   

  	
  11-Aug-08

  	
   

  	
  1369375

  	
   

  	
  1-Jul-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  77/394021

  	
   

  	
  11-Feb-08

  	
   

  	
  3699730

  	
   

  	
  20-Oct-09

  	
   

  	
  Registered

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  14944-2008

  	
   

  	
  31-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  14945-2008

  	
   

  	
  31-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  2008/17501

  	
   

  	
  29-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  2008/17502

  	
   

  	
  29-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LANTHEUS MEDICAL IMAGING
  (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  2008/17503

  	
   

  	
  29-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  LUMIFY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53831/2005

  	
   

  	
  9-May-05

  	
   

  	
  535029

  	
   

  	
  27-Jun-05

  	
   

  	
  Registered

  
	
  LUMIFY (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4421558

  	
   

  	
  4-May-05

  	
   

  	
  4421558

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  LUMIFY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1233/2005

  	
   

  	
  9-May-05

  	
   

  	
  553/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  LUMIFY (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504371

  	
   

  	
  11-May-05

  	
   

  	
  231170

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM 6795/2005

  	
   

  	
  11-Oct-05

  	
   

  	
  229 301

  	
   

  	
  10-Jan-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1079052

  	
   

  	
  4-Oct-05

  	
   

  	
  1079052

  	
   

  	
  22-May-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  1086686

  	
   

  	
  3-Oct-05

  	
   

  	
  784452

  	
   

  	
  7-Mar-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53872/2005

  	
   

  	
  10-May-05

  	
   

  	
  534937

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  4932558

  	
   

  	
  28-Dec-05

  	
   

  	
  4932558

  	
   

  	
  21-Feb-09

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  O-430237

  	
   

  	
  3-Oct-05

  	
   

  	
  280405

  	
   

  	
  19-Apr-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  305587218/05

  	
   

  	
  4-Oct-05

  	
   

  	
  30558721

  	
   

  	
  12-Dec-05

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  V A 2005 04169

  	
   

  	
  3-Oct-05

  	
   

  	
  VR 2005 03906

  	
   

  	
  11-Oct-05

  	
   

  	
  Registered

  

 

12

 

	
  LUMINITY (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200501254

  	
   

  	
  3-Oct-05

  	
   

  	
  43139

  	
   

  	
  22-Sep-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4429676

  	
   

  	
  10-May-05

  	
   

  	
  4429676

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2672701(3)

  	
   

  	
  4-Oct-05

  	
   

  	
  2672701

  	
   

  	
  30-May-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200502572

  	
   

  	
  3-Oct-05

  	
   

  	
  236050

  	
   

  	
  31-May-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  France

  	
   

  	
  053383470

  	
   

  	
  3-Oct-05

  	
   

  	
  053383470

  	
   

  	
  3-Oct-05

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2402990

  	
   

  	
  3-Oct-05

  	
   

  	
  2402990

  	
   

  	
  24-Mar-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  150991

  	
   

  	
  10-Oct-05

  	
   

  	
  150991

  	
   

  	
  19-Mar-07

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0503230

  	
   

  	
  6-Oct-05

  	
   

  	
  188266

  	
   

  	
  11-Jan-07

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  2005/02035

  	
   

  	
  3-Oct-05

  	
   

  	
  232691

  	
   

  	
  10-Apr-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1229/2005

  	
   

  	
  9-May-05

  	
   

  	
  549/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO2005C002841

  	
   

  	
  5-Oct-05

  	
   

  	
  1175187

  	
   

  	
  6-Mar-09

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-92513

  	
   

  	
  4-Oct-05

  	
   

  	
  4959291

  	
   

  	
  9-Jun-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  20051729

  	
   

  	
  3-Oct-05

  	
   

  	
  53448

  	
   

  	
  15-Dec-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M-05-1423

  	
   

  	
  30-Nov-05

  	
   

  	
  M57207

  	
   

  	
  20-Jan-07

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Malta

  	
   

  	
  44350

  	
   

  	
  5-Oct-05

  	
   

  	
  44350

  	
   

  	
  1-Feb-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504389

  	
   

  	
  11-May-05

  	
   

  	
  231348

  	
   

  	
  13-Mar-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-300788

  	
   

  	
  4-Oct-05

  	
   

  	
  191180

  	
   

  	
  5-Dec-07

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  394592

  	
   

  	
  14-Oct-05

  	
   

  	
  394592

  	
   

  	
  11-Aug-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2005/073333

  	
   

  	
  5-Oct-05

  	
   

  	
  378428

  	
   

  	
  3-Feb-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T05/19224G

  	
   

  	
  4-Oct-05

  	
   

  	
  T05/19924G

  	
   

  	
  4-Oct-05

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200571369

  	
   

  	
  3-Oct-05

  	
   

  	
  200571369

  	
   

  	
  24-Apr-06

  	
   

  	
  Registered

  
	
  LUMINITY (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  POZ-1822-2005

  	
   

  	
  3-Oct-05

  	
   

  	
  215216

  	
   

  	
  11-Sep-06

  	
   

  	
  Registered

  
	
  MIBI (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T200000804

  	
   

  	
  9-Mar-00

  	
   

  	
  219718

  	
   

  	
  15-Dec-00

  	
   

  	
  Registered

  
	
  MIBI (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200002833

  	
   

  	
  9-Mar-00

  	
   

  	
  204759

  	
   

  	
  14-Sep-00

  	
   

  	
  Registered

  
	
  MIBI (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  00-01987

  	
   

  	
  10-Mar-00

  	
   

  	
  346010

  	
   

  	
  4-May-01

  	
   

  	
  Registered

  
	
  MIRALUMA

  	
   

  	
  Switzerland

  	
   

  	
  5243/1997

  	
   

  	
  1-Jul-97

  	
   

  	
  P447024

  	
   

  	
  24-Nov-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM 3516/97

  	
   

  	
  30-Jun-97

  	
   

  	
  171 776

  	
   

  	
  30-Sep-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  896692

  	
   

  	
  1-Jul-97

  	
   

  	
  616726

  	
   

  	
  5-Jun-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  850538

  	
   

  	
  11-Jul-97

  	
   

  	
  TMA497274

  	
   

  	
  16-Jul-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  97036448

  	
   

  	
  2-Jul-97

  	
   

  	
  205111

  	
   

  	
  28-Jan-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  397 30 205.3

  	
   

  	
  30-Jun-97

  	
   

  	
  397 30 205

  	
   

  	
  5-Sep-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA 1997/03341

  	
   

  	
  2-Jul-97

  	
   

  	
  VA 1998 01749

  	
   

  	
  10-Apr-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Ecuador

  	
   

  	
  79521

  	
   

  	
  30-Jun-97

  	
   

  	
  5711-98

  	
   

  	
  6-Oct-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  006800461

  	
   

  	
  2-Apr-08

  	
   

  	
  006800461

  	
   

  	
  9-Jun-09

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2102469

  	
   

  	
  3-Jul-97

  	
   

  	
  2102469

  	
   

  	
  5-Jan-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T199702696

  	
   

  	
  8-Jul-97

  	
   

  	
  210212

  	
   

  	
  15-Jun-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  France

  	
   

  	
  97/685106

  	
   

  	
  1-Jul-97

  	
   

  	
  97685106

  	
   

  	
  1-Jul-97

  	
   

  	
  Registered

  

 

13

 

	
  MIRALUMA (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2137649

  	
   

  	
  2-Jul-97

  	
   

  	
  2137649

  	
   

  	
  26-Dec-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  133802

  	
   

  	
  10-Jul-97

  	
   

  	
  133802

  	
   

  	
  17-Mar-99

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  97/2447

  	
   

  	
  1-Jul-97

  	
   

  	
  205192

  	
   

  	
  1-Jul-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  875/1997

  	
   

  	
  4-Jul-97

  	
   

  	
  1162/1997

  	
   

  	
  29-Aug-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  M197C007563

  	
   

  	
  7-Aug-97

  	
   

  	
  810717

  	
   

  	
  13-Apr-00

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Nicaragua

  	
   

  	
  97-02359

  	
   

  	
  17-Jul-97

  	
   

  	
  38314

  	
   

  	
  14-Aug-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  975329

  	
   

  	
  2-Jul-97

  	
   

  	
  190858

  	
   

  	
  18-Jun-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Panama

  	
   

  	
  089875

  	
   

  	
  12-Sep-97

  	
   

  	
  089875

  	
   

  	
  28-Aug-99

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Peru

  	
   

  	
  056152

  	
   

  	
  30-Jan-98

  	
   

  	
  045442

  	
   

  	
  30-Apr-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  324794

  	
   

  	
  3-Jul-97

  	
   

  	
  324794

  	
   

  	
  2-Feb-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  11991

  	
   

  	
  15-Aug-97

  	
   

  	
  187438

  	
   

  	
  15-Aug-97

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  Trinidad and Tobago

  	
   

  	
  27459

  	
   

  	
  9-Sep-97

  	
   

  	
  27459

  	
   

  	
  20-Aug-98

  	
   

  	
  Registered

  
	
  MIRALUMA (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  75/237528

  	
   

  	
  6-Feb-97

  	
   

  	
  2276361

  	
   

  	
  7-Sep-99

  	
   

  	
  Registered

  
	
  MISCELLANEOUS DESIGN
  (MEDICAL IMAGING LOGO) (Miscellaneous Design)

  	
   

  	
  Argentina

  	
   

  	
  2582023

  	
   

  	
  7-Apr-05

  	
   

  	
  2107504

  	
   

  	
  23-Aug-06

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  84456

  	
   

  	
  20-Aug-06

  	
   

  	
  93914

  	
   

  	
  23-Mar-09

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2510828

  	
   

  	
   

  	
   

  	
  1997972

  	
   

  	
  9-Nov-04

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM1415/88

  	
   

  	
  30-Mar-88

  	
   

  	
  121071

  	
   

  	
  31-Aug-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  484320

  	
   

  	
  28-Mar-88

  	
   

  	
  A484320

  	
   

  	
  27-Nov-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Bosnia and Herzegovina

  	
   

  	
  BAZ058667A

  	
   

  	
  26-Apr-05

  	
   

  	
  BAZ058667A

  	
   

  	
  4-Nov-09

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  818278820

  	
   

  	
  29-Dec-94

  	
   

  	
  818278820

  	
   

  	
  12-Feb-97

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  62760

  	
   

  	
  5-Apr-88

  	
   

  	
  444513

  	
   

  	
  5-Apr-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  621320

  	
   

  	
  13-Dec-88

  	
   

  	
  441704

  	
   

  	
  14-Apr-95

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  2145

  	
   

  	
  28-Mar-88

  	
   

  	
  362123

  	
   

  	
  10-Aug-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  677.858

  	
   

  	
  7-Jan-94

  	
   

  	
  727.741

  	
   

  	
  16-Jun-05

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  95009559

  	
   

  	
  24-Jan-95

  	
   

  	
  904635

  	
   

  	
  28-Nov-96

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  008910

  	
   

  	
  7-Mar-94

  	
   

  	
  165863

  	
   

  	
  30-Jun-94

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  85662

  	
   

  	
  20-Sep-93

  	
   

  	
  85662

  	
   

  	
  21-Jan-94

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  56088

  	
   

  	
  27-Jan-89

  	
   

  	
  167547

  	
   

  	
  26-Jan-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  W57127

  	
   

  	
  22-Nov-88

  	
   

  	
  DD646376

  	
   

  	
  1-Feb-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  D44039/5WZ

  	
   

  	
  28-Nov-87

  	
   

  	
  1186914

  	
   

  	
  5-Feb-93

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA 1988/02332

  	
   

  	
  30-Mar-88

  	
   

  	
  VR 1990/01372

  	
   

  	
  2-Mar-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  1245600

  	
   

  	
  12-Apr-88

  	
   

  	
  1245600

  	
   

  	
  5-Jul-93

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  T198801399

  	
   

  	
  29-Mar-88

  	
   

  	
  107627

  	
   

  	
  21-May-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  France

  	
   

  	
  918206

  	
   

  	
  5-Apr-88

  	
   

  	
  1604283

  	
   

  	
  5-Apr-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  1340170

  	
   

  	
  31-Mar-88

  	
   

  	
  1340170

  	
   

  	
  31-Mar-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  88987

  	
   

  	
  5-May-88

  	
   

  	
  88987

  	
   

  	
  19-May-92

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  300683622

  	
   

  	
  19-Jul-06

  	
   

  	
  300683622

  	
   

  	
  6-Feb-07

  	
   

  	
  Registered

  

 

14

 

	
  NEUROLITE (BLOCK)

  	
   

  	
  Croatia

  	
   

  	
  Z20050482A

  	
   

  	
  19-Apr-05

  	
   

  	
  Z20050482

  	
   

  	
  28-Feb-06

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M9300814

  	
   

  	
  10-Nov-88

  	
   

  	
  128006

  	
   

  	
  22-Jun-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  87657

  	
   

  	
  7-Jun-93

  	
   

  	
  87657

  	
   

  	
  6-Apr-95

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  India

  	
   

  	
  679529

  	
   

  	
  8-Sep-95

  	
   

  	
  679529

  	
   

  	
  2-Jul-05

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  RM98C002191

  	
   

  	
  9-May-88

  	
   

  	
  521940

  	
   

  	
  6-Feb-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  40-2006-37106

  	
   

  	
  19-Apr-06

  	
   

  	
  40-0714201

  	
   

  	
  20-Jun-07

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Macedonia

  	
   

  	
  Z-2005/234

  	
   

  	
  15-Apr-05

  	
   

  	
  12757

  	
   

  	
  13-Mar-07

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  88.1416

  	
   

  	
  29-Mar-88

  	
   

  	
  137161

  	
   

  	
  22-Jun-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  751574

  	
   

  	
  19-Jul-06

  	
   

  	
  751574

  	
   

  	
  25-Jan-07

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Panama

  	
   

  	
  074220

  	
   

  	
  27-Jan-95

  	
   

  	
  074220

  	
   

  	
  16-May-96

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-86738

  	
   

  	
  10-Nov-88

  	
   

  	
  64438

  	
   

  	
  29-Jun-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  354443

  	
   

  	
  19-Mar-01

  	
   

  	
  354443

  	
   

  	
  28-May-03

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Russian Federation

  	
   

  	
  110459

  	
   

  	
  11-Nov-88

  	
   

  	
  87404

  	
   

  	
  25-Dec-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  88-2869

  	
   

  	
  30-Mar-88

  	
   

  	
  242651

  	
   

  	
  27-Nov-92

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T06/14391F

  	
   

  	
  20-Jul-06

  	
   

  	
  T06/14391F

  	
   

  	
  20-Jul-06

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200570517

  	
   

  	
  15-Apr-05

  	
   

  	
  Z-200570517

  	
   

  	
  6-Feb-06

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  56088-89

  	
   

  	
  27-Jan-89

  	
   

  	
  167547

  	
   

  	
  26-Jan-90

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  259750

  	
   

  	
  3-Feb-94

  	
   

  	
  TM22866

  	
   

  	
  30-Dec-94

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  5115

  	
   

  	
  25-Jan-89

  	
   

  	
  109937

  	
   

  	
  25-Jan-89

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  73/700614

  	
   

  	
  14-Dec-87

  	
   

  	
  1496535

  	
   

  	
  19-Jul-88

  	
   

  	
  Registered

  
	
  NEUROLITE (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  88/9680

  	
   

  	
  1-Nov-88

  	
   

  	
  88/9680

  	
   

  	
  3-Jul-91

  	
   

  	
  Registered

  
	
  NEUROLITE IN KATAKANA
  (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  36541/88

  	
   

  	
  1-Apr-88

  	
   

  	
  2286501

  	
   

  	
  30-Nov-90

  	
   

  	
  Registered

  
	
  ONSISTA (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53867/2005

  	
   

  	
  10-May-05

  	
   

  	
  534932

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  ONSISTA (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  004430377

  	
   

  	
  10-May-05

  	
   

  	
  004430377

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  ONSISTA (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1223/2005

  	
   

  	
  9-May-05

  	
   

  	
  543/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  ONSISTA (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504404

  	
   

  	
  11-May-05

  	
   

  	
  231177

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  OSPECTIV (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53930/2005

  	
   

  	
  11-May-05

  	
   

  	
  535351

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  OSPECTIV (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  004390225

  	
   

  	
  15-Apr-05

  	
   

  	
  004390225

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  OSPECTIV (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1215/2005

  	
   

  	
  9-May-05

  	
   

  	
  535/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  OSPECTIV (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504398

  	
   

  	
  11-May-05

  	
   

  	
  231162

  	
   

  	
  3-Mar-06

  	
   

  	
  Registered

  
	
  PRODICTRA (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  003736824

  	
   

  	
  30-Mar-04

  	
   

  	
  003736824

  	
   

  	
  16-Jun-05

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  AM 5796/93

  	
   

  	
  7-Dec-93

  	
   

  	
  151676

  	
   

  	
  17-Mar-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  617745

  	
   

  	
  6-Dec-93

  	
   

  	
  A617745

  	
   

  	
  1-May-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  817795405

  	
   

  	
  2-May-94

  	
   

  	
  817795405

  	
   

  	
  2-Jan-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  76438

  	
   

  	
  10-Dec-93

  	
   

  	
  546472

  	
   

  	
  3-Nov-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  12392/1993

  	
   

  	
  6-Dec-93

  	
   

  	
  417515

  	
   

  	
  3-Jul-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  261269

  	
   

  	
  10-Dec-93

  	
   

  	
  709206

  	
   

  	
  26-Oct-94

  	
   

  	
  Registered

  

 

15

 

	
  RECON-O-STAT (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  94012786

  	
   

  	
  16-Feb-94

  	
   

  	
  812541

  	
   

  	
  7-Feb-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  421571

  	
   

  	
  7-Dec-93

  	
   

  	
  159022

  	
   

  	
  17-May-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
   

  	
   

  	
  7-Jun-95

  	
   

  	
  94673

  	
   

  	
  8-Feb-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  85838-94

  	
   

  	
  14-Jan-94

  	
   

  	
  194151

  	
   

  	
  23-Oct-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  D53859/10Wz

  	
   

  	
  7-Dec-93

  	
   

  	
  2087751

  	
   

  	
  19-Dec-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA199307913

  	
   

  	
  8-Dec-93

  	
   

  	
  VR199407061

  	
   

  	
  21-Oct-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  89236

  	
   

  	
  6-Dec-93

  	
   

  	
  89236

  	
   

  	
  1-Jun-98

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  1795669

  	
   

  	
  22-Dec-93

  	
   

  	
  1795669

  	
   

  	
  3-May-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  5578/93

  	
   

  	
  9-Dec-93

  	
   

  	
  140423

  	
   

  	
  20-Oct-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  France

  	
   

  	
  94/501595

  	
   

  	
  14-Jan-94

  	
   

  	
  94/501595

  	
   

  	
  14-Jan-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  1558518

  	
   

  	
  6-Jan-94

  	
   

  	
  1558518

  	
   

  	
  9-Apr-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  117051

  	
   

  	
  9-Dec-93

  	
   

  	
  117051

  	
   

  	
  19-Feb-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  9400158

  	
   

  	
  5-Jan-94

  	
   

  	
  199507472

  	
   

  	
  5-Sep-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Croatia

  	
   

  	
  Z940368A

  	
   

  	
  15-Feb-94

  	
   

  	
  Z940368

  	
   

  	
  30-Jun-97

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M9306231

  	
   

  	
  22-Dec-93

  	
   

  	
  141414

  	
   

  	
  4-Dec-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  158517

  	
   

  	
  6-Dec-93

  	
   

  	
  158517

  	
   

  	
  17-Jul-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  90194

  	
   

  	
  6-Dec-93

  	
   

  	
  90194

  	
   

  	
  1-Apr-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  India

  	
   

  	
  613708

  	
   

  	
  10-Dec-93

  	
   

  	
  613708

  	
   

  	
  20-Dec-03

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  31012003TO

  	
   

  	
  20-Nov-03

  	
   

  	
  1058013

  	
   

  	
  27-Aug-07

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  123226

  	
   

  	
  8-Dec-93

  	
   

  	
  3270506

  	
   

  	
  12-Mar-97

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  93-44079

  	
   

  	
  8-Dec-93

  	
   

  	
  40-311673

  	
   

  	
  17-Apr-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  186323

  	
   

  	
  15-Dec-93

  	
   

  	
  462289

  	
   

  	
  1-Jun-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  94/01373

  	
   

  	
  22-Feb-94

  	
   

  	
  94001373

  	
   

  	
  22-Feb-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  936041

  	
   

  	
  8-Dec-93

  	
   

  	
  170445

  	
   

  	
  21-Dec-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  232626

  	
   

  	
  6-Dec-93

  	
   

  	
  232626

  	
   

  	
  10-Jun-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  297942

  	
   

  	
  7-Feb-94

  	
   

  	
  297942

  	
   

  	
  15-May-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Russian Federation

  	
   

  	
  93054300

  	
   

  	
  9-Dec-93

  	
   

  	
  131021

  	
   

  	
  28-Aug-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  23232

  	
   

  	
  8-Dec-93

  	
   

  	
  325/19

  	
   

  	
  12-Nov-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  93-11699

  	
   

  	
  10-Dec-93

  	
   

  	
  260110

  	
   

  	
  5-Aug-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  S/100/94

  	
   

  	
  5-Jan-94

  	
   

  	
  T94/00100J

  	
   

  	
  5-Jan-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  93-1994

  	
   

  	
  19-Jan-94

  	
   

  	
  178156

  	
   

  	
  21-Oct-97

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  257945

  	
   

  	
  27-Dec-93

  	
   

  	
  TM26034

  	
   

  	
  27-Dec-93

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Turkey

  	
   

  	
  959023

  	
   

  	
  23-Aug-95

  	
   

  	
  164624

  	
   

  	
  23-Aug-95

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Uruguay

  	
   

  	
  267760

  	
   

  	
  19-Jan-94

  	
   

  	
  367182

  	
   

  	
  14-Feb-96

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  Viet Nam

  	
   

  	
  N0064/94

  	
   

  	
  8-Jan-94

  	
   

  	
  14178

  	
   

  	
  11-Nov-94

  	
   

  	
  Registered

  
	
  RECON-O-STAT (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  93/11537

  	
   

  	
  6-Dec-93

  	
   

  	
  93/11537

  	
   

  	
  8-Mar-96

  	
   

  	
  Registered

  
	
  REFINIAN (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1058266

  	
   

  	
  1-Jun-05

  	
   

  	
  1058266

  	
   

  	
  5-Dec-05

  	
   

  	
  Registered

  

 

16

 

	
  REFINIAN (BLOCK)

  	
   

  	
  Puerto Rico

  	
   

  	
  65597

  	
   

  	
  29-Jun-05

  	
   

  	
  65597

  	
   

  	
  30-Mar-06

  	
   

  	
  Registered

  
	
  RELIALITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53873/2005

  	
   

  	
  10-May-05

  	
   

  	
  534938

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  RELIALITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430161

  	
   

  	
  10-May-05

  	
   

  	
  4430161

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  RELIALITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1228/2005

  	
   

  	
  9-May-05

  	
   

  	
  548/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  RELIALITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504407

  	
   

  	
  11-May-05

  	
   

  	
  231202

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  REVALUME (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53875/2005

  	
   

  	
  10-May-05

  	
   

  	
  534940

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  REVALUME (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4429701

  	
   

  	
  10-May-05

  	
   

  	
  4429701

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  REVALUME (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1231/2005

  	
   

  	
  9-May-05

  	
   

  	
  551/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  REVALUME (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504388

  	
   

  	
  11-May-05

  	
   

  	
  234138

  	
   

  	
  8-Aug-06

  	
   

  	
  Registered

  
	
  REVELUME (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53874/2005

  	
   

  	
  10-May-05

  	
   

  	
  534939

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  REVELUME (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430088

  	
   

  	
  10-May-05

  	
   

  	
  4430088

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  REVELUME (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1230/2005

  	
   

  	
  9-May-05

  	
   

  	
  550/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  REVELUME (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504379

  	
   

  	
  11-May-05

  	
   

  	
  234137

  	
   

  	
  8-Aug-06

  	
   

  	
  Registered

  
	
  SIGNALITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53931/2005

  	
   

  	
  11-May-05

  	
   

  	
  535316

  	
   

  	
  4-Jul-05

  	
   

  	
  Registered

  
	
  SIGNALITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388708

  	
   

  	
  15-Apr-05

  	
   

  	
  4388708

  	
   

  	
  31-Mar-06

  	
   

  	
  Registered

  
	
  SIGNALITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1216/2005

  	
   

  	
  9-May-05

  	
   

  	
  536/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  SIGNALITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504399

  	
   

  	
  11-May-05

  	
   

  	
  231163

  	
   

  	
  3-Mar-06

  	
   

  	
  Registered

  
	
  SIGNILITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53932/2005

  	
   

  	
  11-May-05

  	
   

  	
  535352

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  SIGNILITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388691

  	
   

  	
  15-Apr-05

  	
   

  	
  4388691

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  SIGNILITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1217/2005

  	
   

  	
   

  	
   

  	
  537/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  SIGNILITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504400

  	
   

  	
  11-May-05

  	
   

  	
  231164

  	
   

  	
  3-Mar-06

  	
   

  	
  Registered

  
	
  SIGNYLITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53933/2005

  	
   

  	
  11-May-05

  	
   

  	
  535353

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  SIGNYLITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4388658

  	
   

  	
  15-Apr-05

  	
   

  	
  4388658

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  SIGNYLITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1218/2005

  	
   

  	
  9-May-05

  	
   

  	
  538/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  SIGNYLITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504370

  	
   

  	
  11-May-05

  	
   

  	
  231168

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  SPANSIFY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53934/2005

  	
   

  	
  11-May-05

  	
   

  	
  535308

  	
   

  	
  4-Jul-05

  	
   

  	
  Registered

  
	
  SPANSIFY (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4390531

  	
   

  	
  15-Apr-05

  	
   

  	
  4390531

  	
   

  	
  22-Feb-06

  	
   

  	
  Registered

  
	
  SPANSIFY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1219/2005

  	
   

  	
  9-May-05

  	
   

  	
  539/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  SPANSIFY (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504401

  	
   

  	
  11-May-05

  	
   

  	
  231171

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1054234

  	
   

  	
  6-May-05

  	
   

  	
  1054234

  	
   

  	
  19-Dec-05

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1256779

  	
   

  	
  6-May-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Allowed

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  30526985.2/05

  	
   

  	
  9-May-05

  	
   

  	
  30526985

  	
   

  	
  4-Nov-05

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  004390399

  	
   

  	
  15-Apr-05

  	
   

  	
  4390399

  	
   

  	
  22-May-06

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2650582

  	
   

  	
  9-May-05

  	
   

  	
  2650582

  	
   

  	
  27-Mar-06

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  France

  	
   

  	
  053357816

  	
   

  	
  9-May-05

  	
   

  	
  053357816

  	
   

  	
  9-May-05

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2391179

  	
   

  	
  6-May-05

  	
   

  	
  2391179

  	
   

  	
  21-Oct-05

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO2005C001417

  	
   

  	
  9-May-05

  	
   

  	
  1174403

  	
   

  	
  5-Mar-09

  	
   

  	
  Registered

  

 

17

 

	
  SPANTRIA (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2005-40340

  	
   

  	
  9-May-05

  	
   

  	
  4955745

  	
   

  	
  26-May-06

  	
   

  	
  Registered

  
	
  SPANTRIA (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  77/519175

  	
   

  	
  10-Jul-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Allowed

  
	
  SPOTLIGHT ON CONTRAST
  (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  78/698194

  	
   

  	
  23-Aug-05

  	
   

  	
  3129463

  	
   

  	
  15-Aug-06

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  1900473

  	
   

  	
  24-Nov-93

  	
   

  	
  1528255

  	
   

  	
  4-Feb-05

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  587230

  	
   

  	
  28-Sep-92

  	
   

  	
  587230

  	
   

  	
  14-Mar-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  817795391

  	
   

  	
  2-May-94

  	
   

  	
  817795391

  	
   

  	
  17-Sep-96

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  74332

  	
   

  	
  25-Sep-92

  	
   

  	
  523256

  	
   

  	
  1-Jun-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  714072

  	
   

  	
  2-Oct-92

  	
   

  	
  TMA424737

  	
   

  	
  4-Mar-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  6945

  	
   

  	
  24-Sep-92

  	
   

  	
  400733

  	
   

  	
  2-Jun-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  259642

  	
   

  	
  23-Nov-93

  	
   

  	
  777320

  	
   

  	
  13-Dec-96

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  95009562

  	
   

  	
  4-Feb-95

  	
   

  	
  902256

  	
   

  	
  21-Nov-96

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  361660

  	
   

  	
  10-Jun-92

  	
   

  	
  153287

  	
   

  	
  23-Feb-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  T2009/003630

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Costa Rica

  	
   

  	
  81821

  	
   

  	
  4-Aug-92

  	
   

  	
  81821

  	
   

  	
  7-Jan-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  D 51 613/1OWz

  	
   

  	
  24-Sep-92

  	
   

  	
  2045158

  	
   

  	
  17-Sep-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  6800353

  	
   

  	
  2-Apr-08

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  1722388

  	
   

  	
  29-Sep-92

  	
   

  	
  1722388

  	
   

  	
  5-Jun-95

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  France

  	
   

  	
  92/438877

  	
   

  	
  26-Oct-92

  	
   

  	
  92438877

  	
   

  	
  26-Oct-92

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  1514608

  	
   

  	
  6-Oct-92

  	
   

  	
  1514608

  	
   

  	
  10-Jun-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  1562156

  	
   

  	
  11-Feb-94

  	
   

  	
  1562156

  	
   

  	
  29-Sep-95

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  9312365

  	
   

  	
  19-Nov-93

  	
   

  	
  199510394

  	
   

  	
  12-Dec-95

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  MI92C006662

  	
   

  	
  29-Sep-92

  	
   

  	
  997788

  	
   

  	
  7-Jun-95

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  92-18467

  	
   

  	
  6-Jul-92

  	
   

  	
  40-271979

  	
   

  	
  18-Aug-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  144915

  	
   

  	
  15-Jul-92

  	
   

  	
  467513

  	
   

  	
  25-Jul-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  New Zealand

  	
   

  	
  235960

  	
   

  	
  14-Apr-94

  	
   

  	
  235690

  	
   

  	
  17-Jul-97

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Panama

  	
   

  	
  68625

  	
   

  	
  24-Nov-93

  	
   

  	
  68625

  	
   

  	
  12-Apr-96

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Peru

  	
   

  	
  240816

  	
   

  	
  22-Apr-94

  	
   

  	
  008856

  	
   

  	
  2-Aug-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  4-2003-003319

  	
   

  	
  10-Apr-03

  	
   

  	
  4-2003-003319

  	
   

  	
  12-Mar-07

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Puerto Rico

  	
   

  	
  31489

  	
   

  	
  13-Jul-92

  	
   

  	
  31489

  	
   

  	
  13-Jul-92

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Paraguay

  	
   

  	
  6642

  	
   

  	
  18-Apr-94

  	
   

  	
  276090

  	
   

  	
  30-Dec-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  23047

  	
   

  	
  21-Nov-93

  	
   

  	
  320/25

  	
   

  	
  19-Sep-94

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  92/08489

  	
   

  	
  25-Sep-92

  	
   

  	
  250937

  	
   

  	
  20-Aug-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  81-28809

  	
   

  	
  12-Jun-92

  	
   

  	
  592398

  	
   

  	
  1-Apr-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  74/254668

  	
   

  	
  12-Mar-92

  	
   

  	
  1812837

  	
   

  	
  21-Dec-93

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  98/15198

  	
   

  	
  14-Aug-98

  	
   

  	
  18128P-213637

  	
   

  	
  6-Aug-99

  	
   

  	
  Registered

  
	
  TECHNELITE (BLOCK)

  	
   

  	
  South Africa

  	
   

  	
  93/10973

  	
   

  	
  19-Nov-93

  	
   

  	
  93/10973

  	
   

  	
  10-Nov-95

  	
   

  	
  Registered

  
	
  TECHNELITE (STYLIZED)
  (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  74/254537

  	
   

  	
  12-Mar-92

  	
   

  	
  1812836

  	
   

  	
  21-Dec-93

  	
   

  	
  Registered

  

 

18

 

	
  TRULIGHT

  	
   

  	
  Iceland

  	
   

  	
  1221/2005

  	
   

  	
  9-May-05

  	
   

  	
  541/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  TRULIGHT (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53865/2005

  	
   

  	
  10-May-05

  	
   

  	
  534930

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  TRULIGHT (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430401

  	
   

  	
  10-May-05

  	
   

  	
  4430401

  	
   

  	
  3-Apr-06

  	
   

  	
  Registered

  
	
  TRULIGHT (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504374

  	
   

  	
  11-May-05

  	
   

  	
  231308

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Austria

  	
   

  	
  6793/2005

  	
   

  	
  11-Oct-05

  	
   

  	
  229299

  	
   

  	
  10-Jan-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Australia

  	
   

  	
  1079050

  	
   

  	
  4-Oct-05

  	
   

  	
  1079050

  	
   

  	
  4-Oct-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Benelux

  	
   

  	
  1086687

  	
   

  	
  3-Oct-05

  	
   

  	
  784454

  	
   

  	
  3-Oct-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53866/2005

  	
   

  	
  10-May-05

  	
   

  	
  534931

  	
   

  	
  23-Jun-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  4932559

  	
   

  	
  8-Oct-05

  	
   

  	
  4932559

  	
   

  	
  21-Feb-09

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Cyprus, Republic of

  	
   

  	
  71785

  	
   

  	
  5-Oct-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Pending

  
	
  TRULITE (BLOCK)

  	
   

  	
  Czech Republic

  	
   

  	
  430239

  	
   

  	
  3-Oct-05

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  TRULITE (BLOCK)

  	
   

  	
  Germany

  	
   

  	
  305587234

  	
   

  	
  4-Oct-05

  	
   

  	
  30558723

  	
   

  	
  12-Dec-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA0041682005

  	
   

  	
  3-Oct-05

  	
   

  	
  VR0048892005

  	
   

  	
  5-Dec-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Estonia

  	
   

  	
  M200501256

  	
   

  	
  3-Oct-05

  	
   

  	
  43141

  	
   

  	
  22-Sep-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4430435

  	
   

  	
  10-May-05

  	
   

  	
  4430435

  	
   

  	
  12-Apr-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Spain

  	
   

  	
  2672705M6

  	
   

  	
  4-Oct-05

  	
   

  	
  2672705M6

  	
   

  	
  30-May-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Finland

  	
   

  	
  200502574

  	
   

  	
  3-Oct-05

  	
   

  	
  236052

  	
   

  	
  31-May-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  France

  	
   

  	
  053383472

  	
   

  	
  3-Oct-05

  	
   

  	
  053383472

  	
   

  	
  10-Mar-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  United Kingdom

  	
   

  	
  2402992

  	
   

  	
  3-Oct-05

  	
   

  	
  2402992

  	
   

  	
  13-Oct-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Greece

  	
   

  	
  150993

  	
   

  	
  10-Oct-05

  	
   

  	
  150993

  	
   

  	
  19-Mar-07

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Hungary

  	
   

  	
  M0503232

  	
   

  	
  6-Oct-05

  	
   

  	
  187776

  	
   

  	
  11-Dec-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Ireland

  	
   

  	
  232688

  	
   

  	
  3-Oct-05

  	
   

  	
  232688

  	
   

  	
  3-May-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1222/2005

  	
   

  	
  9-May-05

  	
   

  	
  542/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Italy

  	
   

  	
  TO/2005/2839

  	
   

  	
  5-Oct-05

  	
   

  	
  1175185

  	
   

  	
  6-Mar-09

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Lithuania

  	
   

  	
  20051731

  	
   

  	
  3-Oct-05

  	
   

  	
  53450

  	
   

  	
  15-Dec-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Latvia

  	
   

  	
  M-05-1425

  	
   

  	
  30-Nov-05

  	
   

  	
  M57209

  	
   

  	
  20-Jan-07

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Malta

  	
   

  	
  44353

  	
   

  	
  5-Oct-05

  	
   

  	
  44353

  	
   

  	
  1-Feb-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504375

  	
   

  	
  11-May-05

  	
   

  	
  231310

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Poland

  	
   

  	
  Z-300786

  	
   

  	
  4-Oct-05

  	
   

  	
  191178

  	
   

  	
  25-Jun-07

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Portugal

  	
   

  	
  394583

  	
   

  	
  14-Oct-05

  	
   

  	
  394583

  	
   

  	
  11-Aug-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  2005/07334

  	
   

  	
  5-Oct-05

  	
   

  	
  378429

  	
   

  	
  3-Feb-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T05/19227A

  	
   

  	
  4-Oct-05

  	
   

  	
  T05/19227A

  	
   

  	
  5-Oct-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Slovenia

  	
   

  	
  Z-200571367

  	
   

  	
  3-Oct-05

  	
   

  	
  200571367

  	
   

  	
  24-Apr-06

  	
   

  	
  Registered

  
	
  TRULITE (BLOCK)

  	
   

  	
  Slovakia

  	
   

  	
  POZ-1821-2005

  	
   

  	
  3-Oct-05

  	
   

  	
  215215

  	
   

  	
  11-Sep-06

  	
   

  	
  Registered

  
	
  UDS RADIOPHARMACY (Design
  plus character (s))

  	
   

  	
  Australia

  	
   

  	
  1171037

  	
   

  	
  10-Apr-07

  	
   

  	
  1171037

  	
   

  	
  19-Nov-07

  	
   

  	
  Registered

  

 

 

	
  VERILUME (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53923/2005

  	
   

  	
  11-May-05

  	
   

  	
  535346

  	
   

  	
  5-Jul-05

  	
   

  	
  Registered

  
	
  VERILUME (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4429643

  	
   

  	
  10-May-05

  	
   

  	
  4429643

  	
   

  	
  21-Mar-06

  	
   

  	
  Registered

  
	
  VERILUME (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1232/2005

  	
   

  	
  9-May-05

  	
   

  	
  552/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  VERILUME (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504380

  	
   

  	
  11-May-05

  	
   

  	
  231319

  	
   

  	
  9-Mar-06

  	
   

  	
  Registered

  
	
  VERLUMIFY (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  53832/2005

  	
   

  	
  9-May-05

  	
   

  	
  535030

  	
   

  	
  27-Jun-05

  	
   

  	
  Registered

  
	
  VERLUMIFY (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  4421566

  	
   

  	
  4-May-05

  	
   

  	
  4421566

  	
   

  	
  25-Apr-06

  	
   

  	
  Registered

  
	
  VERLUMIFY (BLOCK)

  	
   

  	
  Iceland

  	
   

  	
  1234/2005

  	
   

  	
  9-May-05

  	
   

  	
  554/2005

  	
   

  	
  6-Jun-05

  	
   

  	
  Registered

  
	
  VERLUMIFY (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  200504402

  	
   

  	
  11-May-05

  	
   

  	
  231174

  	
   

  	
  6-Mar-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  United Arab Emirates

  	
   

  	
  58057

  	
   

  	
  30-Dec-03

  	
   

  	
  49157

  	
   

  	
  31-Oct-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Argentina

  	
   

  	
  2593926

  	
   

  	
  31-May-05

  	
   

  	
  2115120

  	
   

  	
  20-Sep-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Bahrain

  	
   

  	
  40542

  	
   

  	
  19-Jan-04

  	
   

  	
  40542

  	
   

  	
  3-Aug-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Brazil

  	
   

  	
  826255191

  	
   

  	
  13-Feb-04

  	
   

  	
  826255191

  	
   

  	
  24-Jul-07

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Canada

  	
   

  	
  1020047

  	
   

  	
  22-Jun-99

  	
   

  	
  TMA564418

  	
   

  	
  8-Jul-02

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Switzerland

  	
   

  	
  5519/1999

  	
   

  	
  23-Jun-99

  	
   

  	
  467778

  	
   

  	
  16-Dec-99

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Chile

  	
   

  	
  625992

  	
   

  	
  28-Oct-03

  	
   

  	
  694542

  	
   

  	
  3-Jun-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  China (People’s Republic)

  	
   

  	
  3785698

  	
   

  	
  5-Nov-03

  	
   

  	
  3785698

  	
   

  	
  21-Mar-05

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Colombia

  	
   

  	
  T2003/095329

  	
   

  	
  27-Oct-03

  	
   

  	
  287837

  	
   

  	
  9-Sep-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Denmark

  	
   

  	
  VA199902669

  	
   

  	
  24-Jun-99

  	
   

  	
  VR200005203

  	
   

  	
  13-Nov-00

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Egypt

  	
   

  	
  163012

  	
   

  	
  5-Nov-03

  	
   

  	
  163012

  	
   

  	
  16-Mar-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  European Community

  	
   

  	
  001219989

  	
   

  	
  25-Jun-99

  	
   

  	
  001219989

  	
   

  	
  6-Nov-00

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Hong Kong

  	
   

  	
  300101087

  	
   

  	
  27-Oct-03

  	
   

  	
  300101087

  	
   

  	
  24-Mar-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Israel

  	
   

  	
  167545

  	
   

  	
  24-Oct-03

  	
   

  	
  167545

  	
   

  	
  4-Jan-05

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  India

  	
   

  	
  1252700

  	
   

  	
  2-Dec-03

  	
   

  	
  1252700

  	
   

  	
  3-Jan-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Jordan

  	
   

  	
  72918

  	
   

  	
  9-Dec-03

  	
   

  	
  72918

  	
   

  	
  16-Jun-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Japan

  	
   

  	
  2003-106340

  	
   

  	
  1-Dec-03

  	
   

  	
  4862136

  	
   

  	
  13-May-05

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Korea, Republic of

  	
   

  	
  40-2003-47515

  	
   

  	
  29-Oct-03

  	
   

  	
  40-607324

  	
   

  	
  28-Jan-05

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Kuwait

  	
   

  	
  61870

  	
   

  	
  30-Nov-03

  	
   

  	
  51228

  	
   

  	
  30-Nov-03

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Lebanon

  	
   

  	
  96380

  	
   

  	
  8-Jan-04

  	
   

  	
  96380

  	
   

  	
  8-Jan-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Mexico

  	
   

  	
  627456

  	
   

  	
  31-Oct-03

  	
   

  	
  833792

  	
   

  	
  28-May-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Malaysia

  	
   

  	
  2003-16495

  	
   

  	
  5-Dec-03

  	
   

  	
  03016495

  	
   

  	
  12-May-03

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Norway

  	
   

  	
  199906219

  	
   

  	
  25-Jun-99

  	
   

  	
  199801

  	
   

  	
  7-Oct-99

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Oman

  	
   

  	
  32097

  	
   

  	
  16-Dec-03

  	
   

  	
  32097

  	
   

  	
  10-Oct-05

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Philippines

  	
   

  	
  4-2003-010942

  	
   

  	
  28-Nov-03

  	
   

  	
  4-2003-010942

  	
   

  	
  18-Sep-06

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Pakistan

  	
   

  	
  190236

  	
   

  	
  4-Dec-03

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Saudi Arabia

  	
   

  	
  86887

  	
   

  	
  27-Dec-03

  	
   

  	
  747/50

  	
   

  	
  20-Sep-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Sweden

  	
   

  	
  1999/04943

  	
   

  	
  1-Jul-99

  	
   

  	
  348244

  	
   

  	
  31-Aug-01

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Singapore

  	
   

  	
  T03/17389Z

  	
   

  	
  29-Oct-03

  	
   

  	
  T03/17389Z

  	
   

  	
  29-Oct-03

  	
   

  	
  Registered

  

 

20

 

	
  VIALMIX (BLOCK)

  	
   

  	
  Thailand

  	
   

  	
  538010

  	
   

  	
  1-Dec-03

  	
   

  	
  KOR202756

  	
   

  	
  10-Sep-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Taiwan

  	
   

  	
  092062698

  	
   

  	
  27-Oct-03

  	
   

  	
  1111085

  	
   

  	
  16-Jul-04

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  United States of America

  	
   

  	
  78/100860

  	
   

  	
  4-Jan-02

  	
   

  	
  2628446

  	
   

  	
  1-Oct-02

  	
   

  	
  Registered

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Venezuela

  	
   

  	
  15476/2003

  	
   

  	
  27-Oct-03

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Published

  
	
  VIALMIX (BLOCK)

  	
   

  	
  Viet Nam

  	
   

  	
  4-2003-11884

  	
   

  	
  26-Dec-03

  	
   

  	
  62987

  	
   

  	
  24-May-05

  	
   

  	
  Registered

  

 

21

 

SCHEDULE
III

 

LOCATIONS
OF GRANTORS

 

	
  LOCATION

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Lantheus
  MI Intermediate, Inc.

  	
   

  	
  Chief
  Executive Office of Lantheus MI

  
	
  331
  Treble Cove Road, North

  	
   

  	
  Intermediate, Inc.

  
	
  Billerica,
  MA 01862

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Lantheus
  Medical Imaging, Inc.

  	
   

  	
  Chief
  Executive Office of Lantheus Medical

  
	
  331
  Treble Cove Road, North

  	
   

  	
  Imaging, Inc.

  
	
  Billerica,
  MA 01862

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Lantheus
  MI Real Estate, LLC

  	
   

  	
  Chief
  Executive Office of Lantheus MI Real Estate,

  
	
  331
  Treble Cove Road, North

  	
   

  	
  Inc.

  
	
  Billerica,
  MA 01862

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Ben
  Venue Laboratories, Inc.

  	
   

  	
  Location
  contains Equipment, Fixtures, Inventory or

  
	
  300
  Northfield Road

  	
   

  	
  Other
  Goods

  
	
  Bedford,
  OH 44146

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  Mallinckrodt
  Inc. (Covidien)

  	
   

  	
  Location
  contains Equipment, Fixtures, Inventory or

  
	
  675
  McDonnell Blvd.

  	
   

  	
  Other
  Goods

  
	
  Hazelwood,
  MO 63042

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  8800
  Durant Road

  	
   

  	
   

  
	
  Raleigh,
  NC 27616

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  McKesson
  Specialty Care

  	
   

  	
  Location
  contains Equipment, Fixtures, Inventory or

  
	
  Distribution

  	
   

  	
  Other
  Goods

  
	
  401
  Mason Road

  	
   

  	
   

  
	
  LaVergne,
  TN 37086

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  4001
  Quest Way, Suite 114

  	
   

  	
   

  
	
  Memphis,
  TN 38115

  	
   

  	
   

  

 

1

 

SCHEDULE
IV

 

UCC
FINANCING STATEMENTS

 

UCC
Financing Statements have been filed in the jurisdictions below against the
Grantors:

 

	
  Name of Grantor

  	
   

  	
  Secretary
  of State

  	
   

  	
  UCC
  Type

  	
   

  	
  Secured
  Party

  
	
  Lantheus Medical Imaging
  Inc. 

  	
   

  	
  Delaware SOS 

  	
   

  	
  UCC-1 

  	
   

  	
  Harris N.A., as Collateral
  Agent 

  
	
  Lantheus MI Intermediate
  Inc. 

  	
   

  	
  Delaware SOS 

  	
   

  	
  UCC-1 

  	
   

  	
  Harris N.A., as Collateral
  Agent 

  
	
  Lantheus MI Real Estate,
  LLC 

  	
   

  	
  Delaware SOS 

  	
   

  	
  UCC-1 

  	
   

  	
  Harris N.A., as Collateral
  Agent 

  

 

1

 

SCHEDULE
V

 

COMMERCIAL
TORT CLAIMS

 

NONE

 

1

 

SCHEDULE
VI

 

PLEDGED
DEBT

 

NONE

 

1

 

SCHEDULE
VII

 

PLEDGED SHARES

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Percentage
  of

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Name
  of Pledged

  	
   

  	
  Number
  of

  	
   

  	
  Outstanding

  	
   

  	
   

  	
   

  	
  Certificate

  
	
  Grantor

  	
   

  	
  Issuer

  	
   

  	
  Shares

  	
   

  	
  Shares

  	
   

  	
  Class

  	
   

  	
  Number

  
	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  Lantheus MI Australia Pty
  Ltd 

  	
   

  	
  65 

  	
   

  	
  65% 

  	
   

  	
  Common 

  	
   

  	
  5

  
	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  Lantheus MI Canada Inc. 

  	
   

  	
  65 

  	
   

  	
  65% 

  	
   

  	
  Common 

  	
   

  	
  C-5

  
	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  Lantheus MI Real Estate
  LLC 

  	
   

  	
  n/a 

  	
   

  	
  100% 

  	
   

  	
  n/a 

  	
   

  	
  n/a

  
	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  Lantheus MI Radiopharmaceuticals,
  Inc. 

  	
   

  	
  650,000 

  	
   

  	
  65% 

  	
   

  	
  Common 

  	
   

  	
  3

  
	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  Lantheus MI UK Limited 

  	
   

  	
  65 

  	
   

  	
  65% 

  	
   

  	
  Common 

  	
   

  	
  3

  
	
  Lantheus MI Intermediate, Inc.
  

  	
   

  	
  Lantheus Medical Imaging, Inc.
  

  	
   

  	
  1000 

  	
   

  	
  100% 

  	
   

  	
  Common 

  	
   

  	
  C-3

  

 

1

 

SCHEDULE
VIII

 

INVESTMENT
PROPERTY, INSTRUMENTS, CHATTEL PAPER, LETTERS OF CREDIT

 

NONE

 

1

 

EXHIBIT A

 

PLEDGE
AMENDMENT

 

This Pledge Amendment,
dated                           ,
      , is delivered pursuant to Section 4
of the Pledge and Security Agreement referred to below. The undersigned hereby
agrees that this Pledge Amendment may be attached to the Pledge and Security
Agreement, dated May 10, 2010, as it may heretofore have been or hereafter
may be amended, restated, supplemented, modified or otherwise changed from time
to time (the “Security Agreement”)  and that the promissory notes
or shares listed on this Pledge Amendment shall be hereby pledged and assigned
to the Collateral Agent and become part of the Pledged Interests referred to in
such Pledge Agreement and shall secure all of the Secured Obligations referred
to in such Security Agreement.

 

Pledged
Debt

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Principal
  Amount

  	
   

  
	
  Grantor

  	
   

  	
  Name
  of Maker

  	
   

  	
  Description

  	
   

  	
  Outstanding
  as of

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

Pledged
Shares

 

	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
  Percentage

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
  Number

  	
   

  	
  of

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Name
  of

  	
   

  	
  of

  	
   

  	
  Outstanding

  	
   

  	
   

  	
   

  	
  Certificate

  	
   

  
	
  Grantor

  	
   

  	
  Pledged
  Issuer

  	
   

  	
  Shares

  	
   

  	
  Shares

  	
   

  	
  Class

  	
   

  	
  Number

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  	
   

  

 

 

	
   

  	
  [GRANTOR]

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
  Name:

  	
   

  
	
   

  	
  Title:

  	
   

  
	
   

  	
   

  
	
  HARRIS N.A.,

  	
   

  
	
  as the Collateral Agent

  	
   

  
	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  

 

 

EXHIBIT B

 

GRANT OF A
SECURITY INTEREST —[TRADEMARKS]

[PATENTS] [COPYRIGHTS]

 

WHEREAS,
                                
(the “Grantor”) [own the trademarks and service marks listed on the
attached Schedule A, which trademarks and service marks are registered or
applied for in the United States Patent and Trademark Office (the “Trademarks”)]
[own the letter patents, design patents and utility patents listed on the
attached Schedule A, which patents are issued or applied for in the
United States Patent and Trademark Office (the “Patents”)] [owns the
copyrights listed on the attached Schedule A, which copyrights are
registered in the United States Copyright Office (the “Copyrights”)];

 

WHEREAS, the Grantor has entered into a Pledge and
Security Agreement, dated May 10, 2010 (as amended, restated,
supplemented, modified or otherwise changed from time to time, the “Security
Agreement”), in favor of Harris N.A., as the Collateral Agent for itself
and certain lenders (in such capacity, together with its successors and
assigns, if any, the “Grantee”); and

 

WHEREAS, pursuant to the Security Agreement, the
Grantor has granted to the Grantee, and granted to the Grantee for the benefit
of the Secured Parties and the L/C Issuer (each such term as defined in the
Security Agreement), a continuing security interest in all right, title and
interest of the Grantor in, to and under the [Trademarks, together with, among
other things, the goodwill of the business symbolized by the Trademarks]
[Patents] [Copyrights] and the applications and registrations thereof, and all
proceeds thereof, including, without limitation, any and all causes of action
which may exist by reason of infringement thereof and any and all damages
arising from past, present and future violations thereof (the “Collateral”),
to secure the payment, performance and observance of the Secured Obligations
(as defined in the Security Agreement).

 

NOW, THEREFORE, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Grantor does
hereby grant to the Grantee and grant to the Grantee for the benefit of the
Secured Parties and the L/C Issuer, a continuing security interest in the
Collateral to secure the prompt payment, performance and observance of the
Secured Obligations.

 

The Grantor does hereby further acknowledge and
affirm that the rights and remedies of the Grantee with respect to the
Collateral are more fully set forth in the Security Agreement, the terms and
provisions of which are hereby incorporated herein by reference as if fully set
forth herein.

 

1

 

IN WITNESS WHEREOF, the
Grantor has caused this Assignment to be duly  executed
by its officer thereunto duly authorized as
of                                  ,
20    .

 

 

	
   

  	
  [GRANTOR]

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  
	
   

  	
  Name:

  	
   

  
	
   

  	
  Title:

  	
   

  

 

2

 

SCHEDULE
A TO GRANT OF A SECURITY INTEREST

 

[Trademark Registrations and Applications]

 

[Patents and Patent Applications]

 

[Copyright Registrations and Applications]

 

3

 

EXHIBIT C

 

FORM OF
SECURITY AGREEMENT SUPPLEMENT

 

[Date
of Security Agreement Supplement]

 

Harris N.A., as Collateral Agent

 

 

 

Ladies and Gentlemen:

 

Reference hereby is made to (i) the Credit
Agreement, dated as of May 10, 2010 (such agreement, as amended, restated,
supplemented, modified or otherwise changed from time to time, including any
replacement agreement therefor, being hereinafter referred to as the “Credit
Agreement”) by and among Lantheus MI Intermediate, Inc., a Delaware
corporation (the “Parent”), Lantheus Medical Imaging, Inc., a
Delaware corporation (the “Borrower”), the “Guarantors” from time
to time party thereto, the lenders from time to time party thereto (each a “Lender”
and collectively, the “Lenders”), Harris N.A., as collateral agent for
the Lenders (in such capacity, together with its successors and assigns in such
capacity, the “Collateral Agent”), Bank of Montreal, as administrative
agent for the Lenders (in such capacity, together with its successors and
assigns in such capacity, if any, the “Administrative Agent” and
together with the Collateral Agent, each an “Agent” and collectively,
the “Agents”), Bank of Montreal and NATIXIS, as joint bookrunners, Bank
of Montreal and NATIXIS, as joint lead arrangers, NATIXIS, as syndication
agent, and Jefferies Finance, LLC, as documentation agent, and (ii) the
Pledge and Security Agreement, dated as of May 10, 2010 (as amended,
restated, supplemented or otherwise modified from time to time, the “Security
Agreement”), made by the Grantors from time to time party thereto in favor
of the Collateral Agent. Capitalized terms defined in the Credit Agreement or
the Security Agreement and not otherwise defined herein are used herein as
defined in the Credit Agreement or the Security Agreement.

 

SECTION 1. Grant of Security. The
undersigned hereby grants to the Collateral Agent, for the ratable benefit of
the Secured Parties and the L/C Issuer, a security interest in, all of its
right, title and interest in and to all of the Collateral (as defined in the
Security Agreement) of the undersigned, whether now owned or hereafter acquired
by the undersigned, wherever located and whether now or hereafter existing or
arising, including, without limitation, the property and assets of the
undersigned set forth on the attached supplemental schedules to the Schedules
to the Security Agreement.

 

SECTION 2. Security for Obligations. The
grant of a security interest in the Collateral by the undersigned under this
Security Agreement Supplement and the Security Agreement secures the payment of
all Secured Obligations of the undersigned now or hereafter existing under or
in respect of the Loan Documents, whether direct or indirect,

 

1

 

absolute or contingent, and whether for principal, reimbursement
obligations, interest, premiums, penalties, fees, indemnifications, contract
causes of action, costs, expenses or otherwise. Without limiting the generality
of the foregoing, each of this Security Agreement Supplement and the Security
Agreement secures the payment of all amounts that constitute part of the
Secured Obligations and that would be owed by the undersigned to the Collateral
Agent or any Secured Party or the L/C Issuer under the Loan Documents but for
the fact that such Secured Obligations are unenforceable or not allowable due
to the existence of a bankruptcy, reorganization or similar proceeding
involving a Grantor.

 

SECTION 3. Supplements
to Security Agreement Schedules. The undersigned has attached hereto
supplemental Schedules I through VIII to Schedules I
through VIII, respectively, to the Security Agreement, and the
undersigned hereby certifies, as of the date first above written, that such
supplemental Schedules have been prepared by the undersigned in substantially
the form of the equivalent Schedules to the Security Agreement, and such
supplemental Schedules include all of the information required to be scheduled
to the Security Agreement and do not omit to state any information material
thereto.

 

SECTION 4. Representations and Warranties.
The undersigned hereby makes each representation and warranty set forth in Section 5
of the Security Agreement (as supplemented by the attached supplemental
Schedules) to the same extent as each other Grantor.

 

SECTION 5. Obligations Under the Security
Agreement. The undersigned hereby agrees, as of the date first above
written, to be bound as a Grantor by all of the terms and provisions of the
Security Agreement to the same extent as each of the other Grantors. The
undersigned further agrees, as of the date first above written, that each
reference in the Security Agreement to an “Additional Grantor” or a “Grantor”
shall also mean and be a reference to the undersigned.

 

SECTION 6. Governing Law. This Security
Agreement Supplement shall be governed by, and construed in accordance with,
the laws of the State of New York.

 

SECTION 7. Loan Document. In addition to
and without limitation of any of the foregoing, this Security Agreement
Supplement shall be deemed to be a Loan Document and shall otherwise be subject
to all of terms and conditions contained in Sections 12.10 and 12.11 of the
Credit Agreement, mutatis mutandi.

 

2

 

	
   

  	
   

  	
  Very truly yours,

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  [NAME OF ADDITIONAL CREDIT
  PARTY]

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  By:

  	
   

  
	
   

  	
   

  	
  Name:

  	
   

  
	
   

  	
   

  	
  Title:

  	
   

  
	
   

  	
   

  	
   

  
	
  HARRIS N.A.,

  	
   

  	
   

  
	
  as the Collateral Agent

  	
   

  	
   

  
	
   

  	
   

  	
   

  
	
  By:

  	
   

  	
   

  	
   

  
	
  Name:

  	
   

  	
   

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  

 

3Exhibit 10.3

 

Execution Copy

 

ADVISORY SERVICES AND MONITORING AGREEMENT

 

This ADVISORY SERVICES AND
MONITORING AGREEMENT (this “Agreement”)  is entered into as of January 8, 2007, by and
between ACP Lantern Acquisition, Inc., a Delaware corporation (the “Company”),  Avista Capital Holdings, LP, a
Delaware limited partnership (“Advisor”).

 

WHEREAS, the Company
proposes to acquire stock and assets pursuant to that certain Stock and Asset
Purchase Agreement, dated as of January 8, 2007, among Bristol-Myers Squibb
Company, a Delaware corporation, ACP Lantern Holdings, Inc., a Delaware
corporation, and ACP Lantern Acquisition, Inc., a Delaware corporation
(the “Acquisition”).

 

WHEREAS, in connection with the
Acquisition, Advisor (together with its affiliates) has provided and will
continue to provide services, advice and analysis, including management of and
assistance with due diligence and other investigatory matters related to the
Company, its subsidiaries and its parent companies (collectively, the “Group
Companies”)  and
the industries in which they operate, and advice with respect to financing
facilities and related arrangements and other matters;

 

WHEREAS, Advisor has staff skilled in
corporate finance, strategic corporate planning, and other management skills
and advisory and business monitoring services;

 

WHEREAS, the Group Companies will
require such skills and services from Advisor in connection with their business
operations and execution of strategic plans; and

 

WHEREAS, Advisor is
willing to provide such skills and services to the Company and other Group
Companies.

 

NOW, THEREFORE, in consideration of the
mutual covenants contained herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereto, intending to be legally bound, hereby agree as follows:

 

Section 1.              Appointment.

 

(a)           The Company hereby appoints Advisor, or its designees, as
one of its financial advisors with respect to the following services to the
extent appropriate and requested by the Company or other Group Companies: (i) assisting
the Company or other Group Companies in analyzing its operations and historical
performance; (ii) assisting the Company or other Group Companies in
analyzing future prospects; (iii) assisting the Company or other Group
Companies

 

 

with respect to future
proposals for tender offers, acquisitions, sales, mergers, financings, exchange
offers, recapitalizations, restructurings or other similar transactions that
may be consummated during the term of this Agreement; and (iv) providing
financial and business monitoring services, including assisting the Company or
other Group Companies in preparing a strategic plan (collectively, “Advisory
Services”).

 

(b)           Advisor does not
make any representations or warranties, express or implied, in respect of
Advisory Services provided hereunder.  In
no event shall Advisor or any of its respective affiliates be liable to the
Company, other Group Companies or any of their respective affiliates for any
act, alleged act, omission or alleged omission except for gross negligence or
willful misconduct of Advisor or its designee as determined by a final,
non-appealable determination of a court of competent jurisdiction.

 

(c)           Advisor shall devote
such time and efforts to provide Advisory Services contemplated hereby as it
deems reasonably necessary or appropriate (including, without limitation, by
making the management professionals employed or engaged by it available in
connection therewith); provided, however,
that no minimum number of hours shall be required to be devoted by Advisor
on a weekly, monthly, annual or other basis.

 

Section 2.             Payment of
Fees.

 

(a)           In consideration of Advisory Services
provided and to be provided by Advisor in connection with the transaction related
to the consummation of the Acquisition, the Company agrees to pay to Advisor
(or its designees) upon execution of this Agreement, a one-time fee of an
amount equal to $10,000,000.

 

(b)           In consideration of the ongoing
Advisory Services to be provided hereunder by Advisor to the Company and other
Group Companies, the Company will pay Advisor (or its designees) an annual fee
of $1,000,000.  Such annual fee shall be
paid in equal quarterly installments on the first day of each fiscal quarter of
each calendar year throughout the duration of this Agreement, provided, however,  that
such fee relating to the quarter in which this Agreement is signed shall be
payable on the date hereof and pro rated for the balance of the quarter
remaining on the date hereof and provided,
further,  that, prior to the termination or expiration of this
Agreement, all unpaid fees and expenses hereunder through, as applicable, the
termination or expiration of this Agreement shall be immediately due and
payable.

 

(c)           Upon any transaction entered into by
the Company or any other Group Company in which Advisor has provided advice and
assistance to the Company, Advisor shall be entitled, in addition to receiving
other fees hereunder, to receive from the Company reasonable and customary advisory
fees for such

 

2

 

advice and services as
Advisor may provide which may include assisting with the preparation and
presentation of offering memoranda and other data and assisting with the
process, structuring and negotiation of any resulting transaction or issuance,
such fee to be payable on the closing date of such transaction.

 

(d)           Notwithstanding the
provisions of Sections 2(b) and 2(c) of this Agreement, no fees shall
be paid thereunder if paying such fees is prohibited, or would cause a default
under the terms of the Company’s principal loan documents.  If paying such fees thereunder is prohibited
by this Section 2(d), such fees shall continue to be an obligation of the
Company and interest shall accrue on such fees (at the “prime rate”) until such
time as it, together with all or a portion of any other payments then due or
accrued hereunder, may be made without violation of this Section 2(d).

 

(e)           All payments and
reimbursements to be made to Advisor pursuant to this Section 2 will be
paid by wire transfer of immediately available funds to an account specified by
Advisor in writing to the Company.

 

Section 3.              Reimbursement
of Expenses. In consideration of the time, effort and expense
that have been and will be expended or incurred by or on behalf of Advisor in
connection with the Acquisition, the Company agrees to reimburse Advisor from
time to time upon request for all reasonable out-of-pocket costs, fees and
expenses incurred by or on behalf of Advisor in connection with or related to
the Acquisition, whether incurred before or after the date hereof, including
costs, fees and expenses relating to: (i) accountants, attorneys,
recruitment firms and other consultants hired by Advisor, to the extent not otherwise
paid by the Company; (ii) due diligence investigations by or on behalf of
Advisor; (iii) the preparation, negotiation and execution of any
agreements relating to the Acquisition between and among Advisor and the
Company, other Group Companies, and their respective senior executives and
shareholders; (iv) any subsequent amendments or waivers (whether or not
the same become effective) under or in respect of any such agreements; (v) governmental
and regulatory filings made by or on behalf of Advisor in connection with the
Acquisition; (vi) ongoing matters affecting the Company such as equity
incentive plans, acquisitions or financing transactions; and (vii) ongoing
monitoring of the affairs of the Company (including all reasonable travel and
related expenses and ongoing industry and company analyses).

 

Section 4.             No
Exclusive Duty to the Company.

 

(a)           In recognition that (i) Advisor
currently has, and will in the future have or will consider acquiring,
investments in numerous entities with respect to which Advisor may serve as an
advisor, a director or in some other capacity; (ii) Advisor may have
duties to various investors, stockholders and partners; (iii) Advisor (or
one or more affiliates, associated investment funds or portfolio Company) may
engage in the same or similar activities or lines of

 

3

 

business as the Company or
other Group Companies and have an interest in the same areas of corporate
opportunities; (iv) the Company will derive certain benefits hereunder;
and (v) Advisor, in desiring and endeavoring to satisfy its duties, may
confront difficulties in determining the full scope of such duties in any
particular situation, the provisions of this Section 4 are set forth to
regulate, define and guide the conduct of certain affairs of the Company and
other Group Companies as they may involve Advisor.

 

(b)           Notwithstanding
anything to the contrary contained herein, (i) Advisor and its affiliates
shall not be required to manage the Company or other Group Companies as their
sole and exclusive function; (ii) Advisor and its affiliates may have
other business interests and may engage in other activities in addition to
those relating to the Company and other Group Companies, and such other
business interests or activities may be of any nature or description, may be
competitive with the Company or other Group Companies and may be engaged in
independently or with others; and (iii) neither the Company nor any other
Group Companies shall have any right, by virtue of this Agreement or the
relationship created hereby, in or to such other ventures or activities of
Advisor or its affiliates or to the income or proceeds derived therefrom, and
the pursuit of such ventures or activities, even if competitive with the Company
or other Group Companies, shall not be deemed wrongful or improper.

 

(c)           Neither Advisor nor
any of its affiliates, members, partners, employees, advisors, consultants,
agents or representatives (collectively, the “Advisor Entities”)  shall have any duty (contractual or
otherwise) to communicate or present any corporate opportunities to the Company
or any of its affiliates or to refrain from any actions specified in Section 4(a),
and the Company, on its own behalf and on behalf of its affiliates, hereby
renounces and waives any right to require Advisor or any of its affiliates to
act in a manner inconsistent with the provisions of Section 4(a).

 

(d)           Neither Advisor nor
any of Advisor Entities shall be liable to the Company, other Group Companies
or any of their respective affiliates for breach of any duty (contractual or
otherwise) by reason of any actions or omissions of the types referred to in
Section 4(a) or its or its affiliates’ participation therein.

 

Section 5.             Term and
Termination.

 

(a)           This Agreement shall
continue in full force and effect for a term of 7 years.  This Agreement shall automatically renew on
each anniversary of the date hereof, and, in connection with each renewal, the
term of this Agreement shall be 7 years from the date of such renewal

 

(b)           This Agreement shall
terminate on the earlier to occur of (i) 7 years from the date hereof, or
(ii) the date upon which the Company pays to

 

4

 

Advisor all amounts that
would otherwise be payable pursuant to this Agreement for the remainder of the
term hereof.  No termination of Advisor’s
engagement hereunder shall affect any of the Company’s obligations hereunder,
including, without limitation, the Company’s indemnity obligations as set forth
herein.

 

Section 6.              Governing
Law; Submission to Jurisdiction; WAIVER OF JURY TRIAL.

 

(a)            Choice of Law. This Agreement shall be
governed by and construed, and interpreted in all respects, in accordance with
the laws of the State of New York without regard to conflicts of laws
principles thereof.

 

(b)           Consent to Jurisdiction.    Each of the parties agrees that
all actions, suits or proceedings arising out of or based upon this Agreement
or the subject matter hereof shall be brought and maintained exclusively in the
federal and state courts of the State of New York (collectively, “New York
Courts” and each a “New York Court”). 
Each of the parties hereto by execution hereof: (i) hereby
irrevocably submits to the jurisdiction of New York Courts for the purpose of
any action, suit or proceeding arising out of or based upon this Agreement or
the subject matter hereof; and (ii) hereby waives to the extent not
prohibited by applicable law, and agrees not to assert, by way of motion, as a
defense or otherwise, in any such action, suit or proceeding, any claim that it
is not subject personally to the jurisdiction of the above-named courts, that
it is immune from extraterritorial injunctive relief or other injunctive
relief, that its property is exempt or immune from attachment or execution,
that any such action, suit or proceeding may not be brought or maintained in
any New York Court, that any such action, suit or proceeding brought or
maintained in any New York Court should be dismissed on grounds of forum non conveniens, should be
transferred to any court other than a New York Court, should be stayed by
virtue of the pendency of any other action, suit or proceeding in any court
other than a New York Court, or that this Agreement or the subject matter
hereof may not be enforced in or by any New York Court.  Each of the parties hereto hereby consents to
service of process in any such action, suit or proceeding in any manner
permitted by the laws of the State of New York, agrees that service of process
by registered or certified mail, return receipt requested, at the address
specified in or pursuant to Section 16 is reasonably calculated to give
actual notice and waives and agrees not to assert by way of motion, as a
defense or otherwise, in any such action, suit or proceeding any claim that
service of process made in the manner set forth in Section 16 does not
constitute good and sufficient service of process.  The provisions of this Section 6(b) shall
not restrict the ability of any party to enforce in any court any judgment
obtained in a New York Court.

 

(c)            Waiver of Jury Trial.    TO THE EXTENT NOT PROHIBITED BY
APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES HERETO HEREBY
WAIVES, AND COVENANTS

 

5

 

THAT IT WILL NOT ASSERT
(WHETHER AS PLAINTIFF, DEFENDANT, OR OTHERWISE) ANY RIGHT TO TRIAL BY JURY IN
ANY FORUM IN RESPECT OF ANY ISSUE, CLAIM, DEMAND, CAUSE OF ACTION, ACTION, SUIT
OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT OR THE SUBJECT
HEREOF, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER
IN CONTRACT OR TORT OR OTHERWISE.  Each
of the parties hereto acknowledges that it has been informed by each other
party that the provisions of this Section 6(c) constitute a material
inducement upon which such party is relying and will rely in entering into this
Agreement and the transactions contemplated hereby.  Any of the parties hereto may file an original
counterpart or a copy of this Agreement with any court as written evidence of
the consent of each of the parties hereto to the waiver of its right to trial
by jury.

 

Section 7.              Liability
and Indemnity.    Neither Advisor
nor the Advisor Entities shall be liable to the Company or any of its
subsidiaries or affiliates for any loss, liability, damage or expense arising
from or in connection with any services provided hereunder, unless such loss,
liability, damage or expense is caused by the gross negligence or willful
misconduct of Advisor or Advisor Entities. 
The Company shall defend, indemnify and hold harmless Advisor and
Advisor Entities from and against any and all loss, liability, damage or
expenses arising from any claim by any person with respect to, or in any way
related to, all services provided hereunder (including reasonable attorneys’
fees), resulting from any act or omission of Advisor or Advisor Entities,
unless such claims are caused by the gross negligence or willful misconduct of
Advisor or Advisor Entities.

 

Section 8.              Limitation
of Liability.    In no event
will any party hereto be liable to any other party hereto for any indirect,
special, incidental or consequential damages, including lost profits or
savings, whether or not such damages are foreseeable, or for any third party
claims (whether based on contract, tort or otherwise), relating to any services
provided hereunder.

 

Section 9.              Non-Recourse.    No past, present or future
director, officer, employee, incorporator, member, partner, stockholder, agent,
attorney or representative of Advisor, the Company, other Group Companies or
any of their respective affiliates shall have any liability for any obligations
or liabilities of Advisor, the Company, other Group Companies or any of their
respective affiliates under this Agreement or for any claim based on, in
respect of or arising from the transactions or matters contemplated hereby.

 

Section 10.            Authority
to Enter Agreement.    Each party to
this Agreement represents and warrants to the other parties hereto that it has
all requisite power and authority to enter into this Agreement and the
transactions contemplated hereby, that this Agreement has been duly and validly
authorized by all necessary action on the part of such party and that when duly
executed and

 

6

 

delivered by such party,
this Agreement shall constitute a legal, valid and binding agreement of such
party, enforceable against it in accordance with its terms.

 

Section 11.           Amendments
and Waivers.    No amendment of
any term, provision or condition of this Agreement shall be effective, unless
in writing and executed by each of the parties hereto.  No waiver on any one occasion shall affect,
extend to, or be construed as a waiver of, any right or remedy on any future
occasion.  No course of dealing of any
person nor any delay or omission in exercising any right or remedy shall
constitute an amendment of this Agreement or a waiver of any right or remedy of
any party hereto.

 

Section 12.            Independent
Contractor.    The parties
agree and understand that Advisor is and shall act as an independent contractor
of the Company in providing Advisory Services. 
Advisor is not and, in providing Advisory Services, will not hold itself
out as an employee, agent or partner of the Company.

 

Section 13.            Information.    The Company shall furnish and
make available to Advisor all financial and other information as Advisor deems
appropriate in connection with providing Advisory Services and, in connection
therewith, will provide Advisor with reasonable access to its officers,
directors, employees, agents, accountants, counsel and other
representatives.  The Company
acknowledges and accepts that (a) Advisor will rely solely on such
information and information that is available from public sources in providing
Advisory Services without assuming any responsibility for independent
investigation or verification thereof; (b) Advisor will not be responsible
for the accuracy or completeness of such information or any other information
regarding the Company; and (c) Advisor will not be required to appraise
the value of the Company’s assets or liabilities.

 

Section 14.            Confidentiality.    No advice rendered by
Advisor, whether formal or informal, may be disclosed, in whole or in part, or
summarized, excerpted from or otherwise referred to without Advisor’s prior written
consent. Unless otherwise required by law, all information provided hereunder
(including the terms of this Agreement) by one party hereto (the “Disclosing  Party”)  to
another party hereto (the “Receiving Party”) shall be
confidential and shall not be disclosed to third parties without the prior
written approval of the Disclosing Party, except where such information is at
the time of the disclosure or thereafter becomes available (a) to the
general public (other than as a result of its disclosure by the Receiving
Party); or (b) to the Receiving Party on a non-confidential basis from a
person not bound by confidentiality obligations.  Notwithstanding the forgoing, without the
prior written approval of the Disclosing Party: (c) Advisor may disclose
any information to Advisor Entities in connection with providing Advisory
Services; and (d) the Receiving Party may disclose information and
material that it receives on the tax structure or tax treatment of services
provided hereunder, provided, however,
that such disclosure shall not include the name (or

 

7

 

other identifying
information not relevant to the tax structure or tax treatment) of any person
and shall not include information for which confidentiality is reasonably
necessary under securities laws.  The
Receiving Party shall be responsible for any breach of the obligation set forth
in this Section 14 by its affiliates, representatives and agents.

 

Section 15.            Entire
Agreement.    This Agreement
contains the entire understanding of the parties hereto with respect to the
specific subject matter hereof and supersede any prior communication or
agreement with respect thereto.

 

Section 16.           Notice.    All notices, requests,
consents and other communications hereunder to any party shall be deemed to be
sufficient if contained in a written instrument delivered in person or sent by
facsimile, nationally-recognized overnight courier or first class registered or
certified mail, return receipt requested, postage prepaid, addressed to such
party at the address set forth below or such other address as may hereafter be
designated in writing by such party to the other parties:

 

	
  If
  to the Company, to:

  	
  ACP Lantern
  Acquisition, Inc.

  
	
   

  	
  331 Treble Cove Road

  North Billerica, Massachusetts

  Attention:    President

  Facsimile:

  
	
   

  	
   

  
	
  If
  to Advisor, to:

  	
  Avista Capital Holdings,
  LP

  
	
   

  	
  65 East 55th Street

  18th Floor

  
	
   

  	
  New York, NY 10022

  Attention:    Ben Silbert, Esq.

  Facsimile:    212-593-6959

  

 

All
such notices, requests, consents and other communications shall be deemed to
have been received: (a) in the case of delivery in person or by facsimile,
on the date of such delivery; (b) in the case of delivery by
nationally-recognized overnight courier, on the next business day following
such delivery; and (c) in the case of delivery by mail, on the third
business day after the posting thereof.

 

Section 17.            Severability.    If in any judicial or
arbitral proceedings a court or arbitrator shall refuse to enforce any
provision of this Agreement, then such unenforceable provision shall be deemed
eliminated from this Agreement for the purpose of such proceedings to the
extent necessary to permit the remaining provisions to be enforced.  To the full extent, however, that the
provisions of any applicable law may be waived, they are hereby waived to the
extend that this Agreement be deemed to be a valid and binding agreement
enforceable in accordance with its terms, and in the event that any provision
hereof shall be

 

8

 

found to be invalid or
unenforceable, such provision shall be construed by limiting it so as to be
valid and enforceable to the maximum extent consistent with and possible under
applicable law.

 

Section 18.            Counterparts.    This Agreement may be
executed in any number of counterparts, each of which when so executed shall be
deemed to be an original and all of which together shall constitute one and the
same instrument.

 

Section 19.            Headings.    All headings in this
Agreement are inserted for convenience only and shall be disregarded in
construing and enforcing provisions of this Agreement.

 

Section 20.            Prevailing
Party.    If any action or other
proceedings is brought for a breach of this Agreement, the prevailing party
shall be entitled to recover its reasonable attorneys’ fees and other costs
incurred in bringing such action or proceeding, in addition to any other relief
to which such party may be granted or entitled.

 

9

 

IN WITNESS WHEREOF, each of
the parties has caused this Agreement to be executed on its behalf by its duly
authorized officer or representative as of the date first above written.

 

	
   

  	
  ACP LANTERN
  ACQUISITION, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ David Burgstahler

  
	
   

  	
   

  	
  Name:

  	
  David Burgstahler

  
	
   

  	
   

  	
  Title:

  	
  Authorized Representative

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  AVISTA CAPITAL HOLDINGS, LP

  
	
   

  	
   

  
	
   

  	
  By:

  	
  Avista Capital, Inc.

  
	
   

  	
  Its:

  	
  General Partner

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ David Burgstahler

  
	
   

  	
   

  	
  Name:

  	
  David Burgstahler

  
	
   

  	
   

  	
  Title:

  	
  Authorized Representative

  

 

Signature
Page to Advisory Services and Monitoring Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}]]